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Laminin-2 is a member of the laminin family of heterodimeric multidomain 
glycoproteins. This isoform is expressed in the endoneurial basal lamina 
surrounding axon-Schwann cell units and in the skeletal muscle basal lamina. The 
dy/dy mouse has a form of muscular dystrophy in which expression of the laminin 
a2 chain and consequently of the laminin-2 heterotrimer is substantially reduced. 
This mutant exhibits extensive abnormalities in peripheral nerves, principally 
abnormal Schwann cell ensheathment of axons and myelination. This suggests a 
vital role for laminin-2 in either the establishment or maintenance of Schwann cell- 
axon interactions. In this project I have examined various aspects of Schwann cell 
behaviour both in vivo and in vitro to determine the role of laminin-2 in Schwann 
cell-axon interactions. 
Examination of laminin a2 chain expression in dy/dy mice showed differences in 
the extent of a2 chain down-regulation in myogenic and neural tissues. 
Immunohistochemistry and electron microscopy confirmed the abnormal 
interactions of Schwann cells and axons in dy/dy peripheral nerves. Transection of 
mutant sciatic nerves resulted in less extensive sprouting of axons into the distal 
stump and crush injuries to dy/dy nerves resulted in delayed and less extensive 
remyelination. Cryoculture using mutant nerve substrates showed significantly 
slower migration of normal Schwann cells on laminin-2-deficient substrates. 
Mutant dissociated Schwann cells showed an abnormal multipolar morphology. 
dy/dy Schwann cells were also found to migrate significantly faster from explants 
of mutant dorsal root ganglia. In addition mutant Schwann cells were a poor 
substrate for neunte branching in co-cultures with neurons. 
The observations made on Schwann cell behaviour in dy/dy mice in this thesis 
suggest several roles for laminin-2. It promotes Schwann cell migration and neurite 
branching, facilitating axonal sprouting in regenerating nerves. Laminin-2 promotes 
Schwann cell differentiation into a bipolar myelin forming phenotype that 
ensheaths and interacts with axons, a pre-requisite for both myelination and 
remyelination. The multiple roles of laminin-2 in the peripheral nervous system 
support the theory that there is a major neurogenic as well as a myogenic 
component to this dystrophy. 
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Chapter 1: General Introduction 
In this chapter I set the scene for various aspects of the experiments carried out in 
this thesis. Firstly I have described the phenotype of the dy/dy mouse, a mouse with 
a spontaneous mutation resulting in a form of muscular dystrophy that affects both 
skeletal muscles and peripheral nerves. This mutation results in a down-regulation 
of laminin a2 chain expression in the basal laminae of skeletal muscle and of 
Schwann cells. I have described the expression and function of the laminin a2 
chain-containing heterotrimer, laminin-2, and given a brief description of other 
laminin heterotrimers, particularly those that are also expressed in the nervous 
system. I have then described the two principal laminin receptor, the integrins and 
the dystrophin associated glycoproteins. This is followed by a description of how 
the peripheral nervous system is generated and in particular how Schwann cells 
arise from the neural crest. I have then detailed various aspects of Schwann cell 
maturation and myelination. Finally I have described the events involved in 
regeneration and remyelination in the peripheral nervous system following injury. 
1.1: The dy/dy mouse 
1.1.1: The dy/dy mouses uffers from muscular dystrophy 
The dystrophia muscularis (dy/dy) mutation arose spontaneously and was described 
as a "myopathic mutation in mice", with similarities to human muscular dystrophy 
(Michelson et al., 1955). The pattern of transmission suggested that the mutation is 
passed on in an autosomally recessive manner. Mice suffering from this hereditary 
condition were substantially smaller than normal littermates throughout their life- 
spans and began to display an overt phenotype at three to four weeks of age. 
19 
Symptoms included occasional dragging of the hind-limbs and convulsive up and 
down nodding of the head. By about 8 weeks of age the muscular atrophy was more 
established and paralysis spread from the hind-limbs through to the axial and fore- 
limb musculature. These mice usually died by about 6 months of age of unknown 
causes, now known to be respiratory failure and were unable to breed (fig. 1.1). 
In this initial characterisation of the dy/dy mouse, histopathological investigations 
revealed several abnormalities in the skeletal muscle but none were detectable at 
that time in both the central nervous system (CNS) and the peripheral nervous 
system (PNS). Fat cells were found between the muscle fibres and connective tissue 
hypertrophied and invaded the muscle. What appeared to be degenerating muscle 
fibres were found to be mixed with normal muscle fibres (Michelson et al., 1955). 
These degenerative changes included muscle fibre necrosis, myophagocytosis and 
small muscle fibres indicating the presence of regenerating foci (Ringelmann et al., 
1999; Wewer and Engvall, 1996). Infiltration by mononuclear cells such as 
fibroblasts, myoblasts and inflammatory cells and an expanded interstitium 
(Michelson et al., 1955; Ringelmann et al., 1999; West and Murphy, 1960) have 
also been observed in the skeletal muscle of dy/dy mice. 
Further investigation revealed other abnormalities in the skeletal muscle beyond the 
primary myopathy described above. An analysis of the number of motor units in 
dy/dy skeletal muscle revealed a decrease in motor units and in the twitch tension 
they generated compared to normal muscle fibres (Harris and Wilson, 1971). A 
decline in the number of nerve fibres innervating the mutant skeletal muscle and in 
particular in the number of myelinated nerve fibres was an early indication 
associated neural abnormalities. The twitch tension although reduced was within a 
20 
Figure 1.1: dy/dy mice are smaller than their unaffected littermates and suffer 
from hindlimb paralysis. A four week old Re129 dy/dy mouse and an unaffected 
littermate (ua). (a) The dy/dy mouse on the right (white arrow) appears much smaller 
than its unaffected littermate and can be seen to be dragging one of its hindlimbs 
(arrowhead). One or both of the eyes in many dy/dy mice may have thinning fur and 
scabs surrounding it (*). (b) When observed from the rear the dy/dy mouse can be 
seen to be suffering from hindlimb paralysis in both legs (arrowheads). dy/dy mice 
often develop a curvature of the spine (black arrow). 
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normal range of amplitude, suggesting that these neural abnormalities were not 
necessarily secondary to skeletal muscle fibre loss (Harris and Wilson, 1971). It 
was proposed that a primary neuropathy, might be partially responsible for the 
myopathy observed in dy/dy skeletal muscle (Banker et al., 1979). Thus the neural 
abnormalities that I have described in detail in chapter 1.1.2, may result in 
denervation of skeletal muscle and consequently in skeletal muscle atrophy. 
Abnormalities detected at the neuromuscular junction (NMJ), could have been a 
consequence of the neural or skeletal muscle abnormalities or a combination of 
both. The post-synaptic area and membrane length was substantially reduced at the 
NMJ in dy/dy mice and Schwann cells abnormally extended processes into rather 
shallow synaptic clefts (Banker et al., 1979). The junctional folds in the post- 
synaptic terminal were poorly defined in the mutant NMJ with few secondary 
synaptic folds (Banker et al., 1979; Desaki et al., 1995; Law et al., 1983), a feature 
common in developing and regenerating muscle fibres. Choline acetyltransferase 
activity is reduced in dy/dy nerve fibres (Jablecki and Brimijoin, 1974). 
1.1.2 The dy/dy mouse exhibits myelination abnormalities in the PNS 
The preliminary finding that dy/dy mice had fewer myelinated fibres than normal 
mice was borne out by subsequent detailed investigations of its PNS (Bradley and 
Jenkison, 1973). Large areas of bare axons were found in lumbosacral dorsal and 
ventral roots and in areas of the sciatic nerve proximal to the spinal cord. These 
axons were not invested by Schwann cell cytoplasm or myelin (Bradley and 
Jenkison, 1973). dy/dy mice had approximately 10% of the normal number of 
myelinated axons in their spinal roots and about a third in proximal parts of the 
sciatic nerve (Bradley and Jenkison, 1973; Bray and Aguayo, 1975). It appeared 
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that amyelinated fibres became myelinated in more distal parts of the sciatic nerve. 
The nerves were described as being amyelinated as they resembled neither 
unmyelinated nor remyelinating regenerating nerve fibres. 
The cranial nerves were also found to have the same abnormalities as the dorsal and 
ventral roots. There were closely packed, bare and amyelinated axons seen in all the 
cranial nerves from III to XII, although the abnormality was less pronounced in 
nerves V, VII and VIII (Biscoe et al., 1974). Both larger axons that would normally 
be myelinated and smaller axons that would normally remain unmyelinated were 
incompletely ensheathed or unensheathed by Schwann cells. Detailed analysis of 
the extent of the neural abnormality showed that in fact ventral and dorsal roots at 
all levels of the neuroaxis from cervical to sacral were amyelinated (Stirling, 
1975a). Near the spinal cord entry and exit points of the dorsal and ventral roots, 
respectively, nerves appeared to be normally myelinated. The amyelination 
abnormality began in the roots within a short distance (<_Imm) of the spinal cord 
interface. Myelinated fibres became more frequent as the dorsal and ventral roots 
joined to make the mixed spinal nerve at the base of the dorsal root ganglia (DRG) 
(Stirling, 1975a). 
The dy/dy mouse had focal deficiencies in Schwann cell numbers in the spinal roots 
but amyelination was also apparent in areas where Schwann cells were present. 
More distally in the peroneal nerve, there was in fact a substantial increase in the 
numbers of Schwann cells (Jaros and Bradley, 1979). In some parts of the ventral 
root, cells lacking a basal lamina and morphologically resembling oligodendrocytes 
were seen wrapping larger axons (Bray and Aguayo, 1975). The loose wrapping of 
axons by Schwann cells was reminiscent of foetal nerve ensheathment (Bradley and 
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Jenkison, 1973). Thus, groups of axons in developing nerves and small 
unmyelinated axons in mature nerves are usually bundled together within a 
Schwann cell and in mutant nerves large axons were often seen bundled together 
surrounded by a Schwann cell that failed to completely ensheath them and that 
lacked an intact basal lamina (Bray and Aguayo, 1975). 
It was found that in myelinated fibres, particularly those distal to the spinal cord, 
the nodes of Ranvier were often abnormally wide, while myelin at the internodes 
was extremely thin. Closer inspection of the nodes of Ranvier revealed that there 
was also a retraction of Schwann cell cytoplasm and paranodal myelin in dy/dy 
mice at the nodes of Ranvier and in some cases complete detachment of the 
terminal myelin loops (Bradley et al., 1977). In addition it appears that the number 
of sodium channels at the node of Ranvier in dy/dy mice is reduced to levels 
comparable to those in normal internodes and unmyelinated fibres (Bradley and 
Jaros, 1979). 
Similar neural abnormalities have been observed in another mutant with a mutation 
in the laminin a2, the less severely dystrophic dy'/dy2J mouse (see chapter 1.1.6). 
Amyelination was less extensive in these mice than in the dy/dy mice but was 
evident in cervical and lumbosacral dorsal and ventral roots and in cranial nerves V 
and VII to XII (Bradley and Jenkison, 1975). Both dorsal and ventral roots of 
1 /dy21 were amyelinated proximal to the spinal cord, becoming myelinated d1 
towards the DRG and amyelinated again in the mixed spinal nerves before 
becoming myelinated again in the distal peripheral nerves, a similar pattern to dy/dy 
mice (Bradley and Jenkison, 1975; Stirling, 1975a). As in the dy/dy mouse, groups 
of large naked axons were seen in the dy2J/dy2', many in direct contact with the 
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endoneurium rather than ensheathed by Schwann cells. Those Schwann cells which 
did extend processes lacked basal lamina and did not completely ensheath the 
axons (Brown and Radich, 1979; Weinberg et al., 1975). Another feature rarely 
seen in normal nerves but observed with greater frequency in both dy/dy and 
dy22/dy22 mice is polyaxonal myelination. Schwarm cells were sometimes seen to 
extend processes to and myelinate more than one axon or to myelinate one in a 
group of axons that it ensheathed while the remainder in the group remained 
unmyelinated, whereas normally myelin forming Schwann cells form a one-to-one 
relationship with the axons they ensheath (Brown and Radich, 1979; Jaros and 
Bradley, 1979; Okada et al., 1977). 
1.1.3: Abnormal conduction of impulses in mutant nerves 
Conduction in larger myelinated axons occurs in a saltatory fashion from node to 
node, the structural abnormalities observed at the nodes of Ranvier of dy/dy mice 
may account for the reduced conduction velocity recorded in mutant mice. The 
conduction velocity in dy/dy dorsal and ventral roots was found to range from 0.1 to 
2 m/sec compared to 10 to 100 m/sec in dorsal roots and 50 to 70 m/sec in ventral 
roots in normal mice (Biscoe et al., 1977). Although sciatic nerves are more heavily 
myelinated than spinal roots, conduction velocity is also reduced in dy/dy sciatic 
nerves by 25% (Huizar et al., 1975). 
Impulses are usually directed towards the spinal cord in dorsal roots and away from 
it in ventral roots, but in dy/dy mice impulses have been recorded in both directions 
(Rasminsky, 1978). A large number of high amplitude spontaneous potentials are 
generated mid-root in unstimulated dy/dy nerve fibres (Carbonetto, 1977; 
Rasminsky, 1978). These ectopic impulses were almost always associated with 
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impulses passing by in neighbouring axons. The fact that many axons in dy/dy 
nerve fibres are bare with little or no Schwann cell or myelin ensheathment and are 
directly apposed suggests that as well as spontaneous potentials there is 
communication or "cross-talk" of impulses in these fibres (Rasminsky, 1978). It is 
known that the junction between myelinated and unmyelinated portions of axons in 
normal nerves can be hyperexcitable. Areas of amyelination in dy/dy mice may 
make these axons hyperexcitable too and thus more susceptible to spontaneous 
potentials and "cross-talk". 
1.1.4: The dy/dy mouse has abnormal Schwann cell basal laminae 
In a normal peripheral nerve, a myelin forming or non-myelin forming Schwann 
cell will completely ensheath an axon or group of axons so that they are not 
exposed to the endoneurium. The Schwann cells themselves are surrounded on their 
outer surface by a continuous endoneurial basal lamina (fig. 1.9). This was clearly 
not the case in dy/dy peripheral nerves; mutant myelinated fibres had a patchy 
deficiency of the basal lamina, which was thinner and discontinuous, leaving 
amyelinated axons bare without Schwann cell ensheathment or basal lamina 
coverage (Madrid et al., 1975). The basal lamina of other peripheral nerve cells 
such as perineurial and endothelial cells and of skeletal muscle fibres in dy/dy mice 
however appeared to be of normal thickness and continuous (Jaros and Bradley, 
1979; Madrid et al., 1975). Although it was known at that time that Schwann cells 
were able to produce basal lamina (Church et al., 1973), the specific component of 
the endoneurial basal lamina that was deficient in dy/dy mice was not known. 
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1.1.5: The laminin a2 chain gene is the target for the mutation in the dy/dy mouse 
With the discovery of the laminin family of extracellular matrix (ECM) molecules 
(see chapter 1.2), it became possible to specifically determine the nature of the 
basal lamina deficiency in dy/dy mice. The laminin-2 (merosin in the old 
nomenclature; see fig. 1.2) heterotrimer was found to be expressed in both 
Schwann cell and skeletal muscle basal lamina (Leivo and Engvall, 1988). As 
Schwann cells and skeletal muscle fibres are the principal targets of the dy/dy 
mutation (Bradley and Jenkison, 1973; Michelson et at., 1955), laminin-2 appeared 
to be a good candidate as the molecule primarily responsible for the abnormalities 
in the dy/dy mouse. 
Immunoflourescence and immunoblotting techniques were used to establish the 
expression of a variety of basal lamina components, including two of the chains 
that make up the laminin-2 heterotrimer, the a2 and ß1 chains. Fibronectin, type IV 
collagen and the PI chain were all normally expressed in dy/dy tissues, but there 
appeared to be minimal expression of the laminin a2 chain protein in the skeletal 
muscle, cardiac muscle and peripheral nerves of the dy/dy mice (Arahata, 1993). 
Moreover the lama2 gene messenger ribonucleic acid (mRNA) encoding the a2 
chain was barely detectable in dy/dy skeletal muscle. By using reverse 
transcriptase-polymerase chain reaction (RT-PCR), it was possible to determine 
that the small quantity of lama2 mRNA expressed in dy/dy mice was however the 
same size as in unaffected mice. This implied that there was no major deletion in 
the a2 chain transcript in mutant mice. 
Negligible expression of a2 chain protein in skeletal muscle, cardiac muscle and 
peripheral nerves was confirmed by other groups using a variety of antibodies in 
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immunofluorescence and immunoblotting (Sunada et al., 1994; Xu et al., 1994a). 
Densitometric analysis of immunoblots showed a reduction in the expression of the 
a2 chain in skeletal muscle of 94%, in cardiac muscle of 96% and in peripheral 
nerves of 97% (Sunada et al., 1994). Lowered levels of lama2 mRNA were also 
detected in the cardiac muscle of dy/dy mice as well as in skeletal muscle (Xu et al., 
1994a). Mapping of the lama2 gene by analysis of the progeny of two genetic 
crosses, revealed that lama2 was localised to the same region of mouse 
chromosome 10 as the dy locus. This region also showed conservative linkage to 
human chromosome 6q to which the human lama2 gene has been mapped (Sunada 
et al., 1994). 
1.1.6: Other mouse mutants in which the a2 chain gene is targeted 
The nature of the mutation in the lama2 gene that causes the muscular dystrophy in 
dy/dy mice has not yet been identified, but the dy2j/dy2J mouse and transgenic mice 
with targeted mutations of the laminin a2 chain have similar symptoms to the dy/dy 
mouse. In the less severely dystrophic dy22/dy4 mouse, the laminin a2 chain is 
expressed in a truncated form (Sunada et al., 1995b; Xu et al., 1994b). There was a 
small decrease detected in the level of a2 chain expression in skeletal muscle in 
dy2j/dy2J mice and in the levels of lama2 mRNA in cardiac and skeletal muscle but 
not as substantial as in dy/dy mice (Xu et al., 1994b). It was found that the 
truncation of the a2 chain was in the 300 to 325 kilo Dalton (kDa) N-terminus 
fragment of the a2 chain (Sunada et al., 1995b; Xu et al., 1994b). An antibody 
which detects the amino-terminus (N-terminus) fragment at 325 kDa in unaffected 
mice, showed that the truncated a2 chain was 270 kDa in skeletal muscle, 290 kDa 
in cardiac muscle and 300 kDa in peripheral nerves. Two similar mutations were 
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found in the dy2i/dyZi lama2 gene, both of which resulted in deletions in potential N- 
glycosylation sites in domain VI of the a2 chain near the N-terminus (fig. 1.2). A 
single base G to A mutation in a splice donor site results in the expression of 
multiple mRNA variants, the largest of which is translated with a 55 amino acid 
deletion (Xu et al., 1994b). A 171 base in-frame deletion was also found, a 
glutamine to glutamic acid substitution at residue 91 resulted in a 57 amino acid 
deletion at residues 34 to 90 (Sunada et al., 1995b). The deletion of this region in 
dy2l/dye' mice destabilises domain VI of the a2 chain and compromises its ability to 
form polymers with other laminin heterotrimers (Colognato and Yurchenco, 1999), 
resulting in a patchy basal lamina and in similar although less severe symptoms as 
the muscular dystrophy in dy/dy mice. 
dyw/dyw and dy3k/dy3k mice are laminin a2 chain null mutants with targeted 
deletions and like dy/dy mice, they appeared normal at birth (Kuang et al., 1998b; 
Miyagoe et al., 1997). However within two or three weeks they were substantially 
smaller than controls and were exhibiting hind-limb paralysis. The complete 
absence of the a2 chain in these mice meant that the dystrophy was far more severe 
and progressed at a faster rate than in dy/dy mice and consequently the dy/dy' and 
dy3k/dy3k mice usually died at one to two months of age. 
1.1.7: Downstream effects of the a2 chain deficiency in dy/dy mice on the 
expression of other ECM molecules 
Although the primary defects in dy/dy and dy2j/dy22 mice are almost both certainly 
caused by a mutation in the lama2 gene, there also appears to be a downstream 
effect on the expression of other laminin chains, ECM molecules and laminin 
receptors in dy/dy mice. The laminin a4 chain is usually only found in 
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extrasynaptic basal lamina up to the first postnatal week, but is ectopically 
expressed in the endoneurial basal lamina of dy/dy mice and is also upregulated at 
the synaptic basal lamina. Although the functional consequence is unknown, it 
results in ectopic expression of the a4 chain-containing laminin-8 heterotrimer in 
the endoneurial basal lamina (Patton et al., 1997). The laminin a4 chain also seems 
to ectopically expressed in place of the a2 chain in the skeletal muscle of dy/dy 
mice, particularly in regenerating muscle fibres (Patton et al., 1999; Ringelmann et 
al., 1999; Sorokin et al., 2000). Expression of the laminin a5 chain in skeletal 
muscle is usually down-regulated postnatally but persists in dy/dy mice up to 
postnatal day (P) 7 (Patton et al., 1999; Ringelmann et al., 1999). The ectopic 
expression of the a4 chain in dy/dy tissues appears to be a specifically linked to the 
deficiency in the a2 chain, whereas the continued expression of the a5 chain is 
probably due to the presence of immature or regenerating muscle fibres in dy/dy 
skeletal muscle fibres (Ringelmann et al., 1999). 
Fibronectin and tenascin-C are both ECM molecules that are normally expressed in 
the interstitium between skeletal muscle fibres of neonatal control mice. In mature 
fibres tenascin-C is restricted to the myotendenous junction and fibronectin to the 
myotendenous junction, between muscle fibres and surrounding blood vessels, 
however in dy/dy mice expression of both these molecules persists in the 
interstitium (Ringelmann et al., 1999). Like laminin a5 chain expression in dy/dy 
mice the increased expression of tenascin-C and fibronectin may be related to the 
presence of regenerating muscle fibres. 
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1.1.8: The dy/dy mouse is a model for human congenital muscular dystrophy 
The dy/dy mouse was suggested as a model for human muscular dystrophies even 
before the cause of the dystrophy could be explained (Michelson et al., 1955). It has 
since become clear that there is indeed a type of human muscular dystrophy known 
as merosin (laminin-2) deficient congenital muscular dystrophy (CMD) in which a 
similar deficiency of the laminin a2 chain was identified soon after the a2 chain 
deficiency was characterised in the dy/dy mouse. It was found that a large 
proportion of the most severe cases of autosomal recessive CMD, with early onset 
of muscle weakness at birth or within a few months of birth, had a specific 
deficiency of the laminin a2 chain in their skeletal muscle (Tome et al., 1994). 
Splice site and nonsense mutations were identified in the same region of human 
chromosome 6q22-23 that the human lama2 gene maps to (Helbling-Leclerc et al., 
1995). This is a region which also shows conservative linkage to the portion of 
mouse chromosome 10 to which the murine lama2 gene and the dy/dy locus have 
been mapped (Sunada et al., 1994). 
Like dy/dy mice, humans with merosin deficient CMD also exhibit neural 
abnormalities. Histopathological data on PNS abnormalities in merosin-deficient 
CMD is limited, but a mild demyelinating neuropathy has been detected in patients 
with both severe and mild forms of merosin deficient CMD (Morandi et al., 1999). 
Motor nerve conduction velocity was correlated to a2 chain expression in a group 
of people with CMD. Only those with merosin deficient CMD where a2 chain 
expression was negligible, also had reduced motor nerve conduction velocity 
(Shorer et al., 1995) mirroring the decreased conduction velocity recorded in dy/dy 
mice (Biscoe et al., 1977; Huizar et al., 1975) and PNS amyelination in merosin- 
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deficient CMD could account for the deficit. Several groups have also reported 
white matter changes in the CNS of some subjects with merosin deficient CMD 
using magnetic resonance imaging (MRI). These do not appear to be degenerative 
and are not correlated to the clinical severity of the CMD (Caro et al., 1999; 
Herrmann et al., 1996; Morandi et al., 1999; Sunada et al., 1995a; Tan et al., 1997). 
The white matter changes are consistent with some deficit in myelination and 
autopsies have revealed spongy myelin and astrocytosis in some cases (Morandi et 
al., 1999). Changes in the MRIs of subjects with merosin deficient CMD also 
suggest that there may be some abnormalities of neuronal and oligodendrocyte 
migration in the CNS of these subjects (Sunada et al., 1995a). 
Antibodies have detected differences in the extent of a2 chain expression in 
merosin-deficient DMD; in some cases there is only a minimal reduction in 
expression of the 80 kDa carboxy-terminus (C -terminus) fragment and a 
substantial reduction in the expression of the N-terminus 300 kDa fragment, others 
show partial expression of both or only of the 300 kDa fragment (Morandi et al., 
1999; Sewry et al., 1997). Nonsense mutations and base pair deletions have been 
identified in the lama2 gene of subjects with merosin deficient CMD that cause 
truncations in both the C-terminus and the N-terminus fragment (Guicheney et al., 
1997). 
In some cases of mild merosin deficient CMD, expression of the 80 kDa C- 
terminus fragment was normal whereas the 300 kDa N-terminus fragment was 
truncated and severely deficient (Allamand et al., 1997). This truncation was due to 
a one base substitution, resulting in a 63 amino acid deletion in domain IVa of the 
a2 chain in the N-terminus region. The dystrophy in dy2J/dy21 mice is also caused by 
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a mutation that truncates the region of the N-terminus of the a2 chain involved in 
polymerisation of the laminin-2 heterotrimer (Colognato and Yurchenco, 1999) and 
it may be that this is also the case in mild forms of merosin deficient CMD. 
1.2: The laminins 
1.2.1: Laminins are a family of heterotrimeric ECM molecules 
Laminins are a rapidly expanding family of heterotrimeric glycoproteins that are 
major constituents of the basal lamina, combining with type IV collagen, 
fibronectin, tenascins and proteoglycans such as agrin to form an ECM. Sheets of 
this ECM are then arranged into a basal lamina between the cells and the 
connective tissue. Laminins have a variety of roles within the ECM, they 
polymerise with each other to form a network within the basal lamina and they also 
provide a structural link through receptor complexes between the cytoskeleton of 
the cells and the basal lamina. Laminin binding to these receptor complexes serves 
a dual purpose, as well as providing a structural link between the cell and the ECM, 
laminins act as cell signalling molecules through the same receptor complexes. 
The first laminin heterotrimer to be isolated was from the ECM of Engelbreth- 
Holm-Swarm (EHS) tumour cells, now known as laminin-1 (Chung et al., 1979; 
Timpl et al., 1979). In this initial isolation of laminin, the protein was found to be 
made up of two components of approximately 440 kDa and 220 kDa. In a sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) gel, the 
components when unreduced migrated through the gel with the characteristics of a 
molecule that contained two 220 kDa and a 440 kDa component (Timpl et al., 
1979). An antibody raised against the laminin protein isolated from the matrix 
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showed that it was also expressed in the basal lamina of tissues such as skin, kidney 
and placenta. 
The heterotrimeric structure of laminins was verified by electron micrography, 
which showed, in rotary shadowing, a cross-shaped structure made up of three short 
arms and one long arm (Engel et al., 1981) (fig. 1.2). Two globular domains were 
visible at the end of each of the short arms and a larger structure at the end of the 
long arm. It became clear that the laminin-1 heterotrimer was composed of three 
distinct glycosylated chains, an A chain of 450 kDa, aBI chain of 240 kDa and a 
B2 chain of 230 kDa (Cooper et al., 1981), encoded by distinct but homologous 
genes (Martin and Timpl, 1987). The three short arms of the laminin cross were 
composed of the N-terminus regions of the A, B1 and B2 chains, which then 
aligned to form the long arm cross-linked by an a helix to form a coiled-coil (fig. 
1.2). Substantial homology was found between the N-terminus of A, B1 and B2 
chains (Sasaki et al., 1988). This included globular domains IV and VI, made up of 
approximately 250 residues, plus a globular domain IVa in the A chain and the rod- 
like domains III and V composed of consecutive epidermal growth factor-like 
(EGF) cys-rich repeats of about 50 residues. At the C-terminus, the BI and B2 
chains form a disulphide bridge and the A chain extends to form the globular G- 
domain (Ott et al., 1982; Paulsson et al., 1985; Timpl, 1989). 
A structural role was soon assigned to laminin-1, normally situated between type 
IV collagen and the cell in the basal lamina. It promoted the attachment of 
epithelial cells both as an isolated substrate and when bound to type IV collagen 
(Terranova et al., 1980). It was soon shown that laminin is expressed very early in 
development, at the morula stage even before the formation of the blastocyst (Leivo 
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et al., 1980), suggesting that it may be an important signalling and adhesive 
molecule during embryogenesis. 
The A, B1 and B2 chains were the first of many laminin chains to be identified. In 
recent years, a new nomenclature has been introduced for laminins such that in the 
laminin-1 heterotrimer the heavy A chain is known as the at chain, the B1 chain as 
ßl and the B2 chain as yl. The A, B1 and B2 laminin isoforms that have been 
subsequently found have the same nomenclature and are identified as a, ß and y 
chains, numbered according to the order in which they have been discovered 
(Burgeson et al., 1994). There are now twelve known laminin heterotrimers; each 
composed of one a, one ß and one y chain. Currently five a, three ß and three y 
chains have been identified (Colognato and Yurchenco, 2000) (table 1.1). 
1.2.2: A new laminin: The a2 chain and laminin-2 heterotrimer 
Following the identification of laminin-1, it was to be some years before other 
laminin chains and heterotrimers were identified and the true diversity of laminin 
expression and function fully realised. The first one to follow laminin-I was 
merosin, now known as laminin-2, composed of the a2, ß1 and yl chains. 
Antibodies prepared against placental extracts recognised an ECM-associated 
protein that, unlike laminin-1, showed a very restricted pattern of expression. 
Whereas laminin-1 appeared to be expressed in most epithelial and endothelial 
cells, expression of laminin-2 was more restricted to placental trophoblasts, the 
basal lamina of skeletal muscle, the Schwarm cell basal lamina and in heart (Leivo 
et al., 1989; Schuler and Sorokin, 1995). A 65 kDa fragment of an 80 kDa 
precursor, most probably the C-terminus fragment of the a2 chain, was detected 





Figure 1.2: The laminin heterotrimer. laminin heterotrimers are composed 
of an a (red), ß (blue) and y chain (green), generally forming a cruciform sha 
-pe. The N-terminal of each chain forms a short arm and the C-terminals are 
joined together by an a helix to form a coiled coil. Some a chains are trunca 
-ted and do not have a short arm. The short arms contain 2 globular domains 
(large circles) in the ß and y chains known as domains IV and VI and 2 rod- 
like domains composed of cysteine-rich repeats known as domains Ill and V 
(squares). Full-length a chains have 3 globular domains, IVa, IVb and VI, 
and three rod-like domains, Illa, IIIb and V, in the short arm. Domains I and 
II are located in the coiled-coil of the long arms of the laminin chains, bound 
by an a helix in the ß chain. The C-terminal of the a chain has a receptor- 




Table 1.1: Summary of laminin heterotrimers and their expression 
Laminin heterotrimer Components Expression 
Laminin-1 alplyl Early embryogenesis, in the morula, 
developing kidney 
Laminin-2 a2ß1y1 Endoneurial basal lamina in peripheral 
nerves, skeletal and cardiac muscles, 
placenta, capillaries, brain 
Laminin-3 a1ß2y1 NMJ, immature glomerulus, 
perineurium 
Laminin-4 a2(32y1 NMJ- the primary cleft and junctional 
folds 
Laminin-5 a3Aß3y2 Skin and other epithelial cells 
Laminin-6 a3Aßly1 Skin and other epithelial cells 
Laminin-7 a3Aß2y1 Skin and other epithelial cells 
Laminin-8 a4ß1y1 Mesenchymal cells: blood vessels, 
lung, muscle, NMJ in Schwann cell 
basal lamina; expression may be lost 
in adulthood 
Laminin-9 a4ß2y1 Primary cleft and perineurial basal 
lamina 
Laminin-10 a5(31y1 Developmental expression at synaptic 
basal lamina and in skeletal muscle, 
kidney and blood vessels 
-* continued on next page 
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Table 1.1 continued 
Laminin-11 a5(32y1 
Laminin-12 a2ß 1y3 
NMJ- primary cleft and junctional 
folds and perineurial basal lamina 
Placenta, peripheral nerves; restricted 
expression at the dermal-epidermal 
junction? 
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1, type IV collagen and fibronectin (Leivo and Engvall, 1988). These initial 
immunological surveys failed to detect laminin-2 expression in developing mouse 
embryos. Since it was only detectable in new-born mice, it was concluded that 
laminin-2 may have a limited role in early developmental processes (Leivo and 
Engvall, 1988). More recently laminin-2 chains have been detected as early as 
embryonic (E) day 11.5 in mouse embryos (Lentz et al., 1997) (discussed below). 
Laminin isolated from mouse hearts was found to contain a 300 kDa polypeptide 
that was not antigenically related to any of the laminin-1 chains but an unreduced 
fraction contained epitopes also found on laminin-1, suggesting that the new 
laminin was bound to one of the laminin-1 chains (Paulsson and Saladin, 1989). 
The amino acid sequence of laminin-2 was deduced and was found to share a 40% 
sequence identity with the C-terminus region of the al chain (Ehrig et al., 1990). 
Thus a peptide had been characterised which had sequence homology with the al 
chain, which was similar in size and which was found to be covalently bound to the 
ß1 and yl chains in the centre of a cruciform structure (Ehrig et al., 1990; Paulsson 
et al., 1991). 
1.2.3: The lama2 gene 
The human lama2 gene was found to encode a full-length a chain with a primary 
structure closely resembling that of the al chain. The overall homology was 46.6%, 
highest in the short arm especially in domain VI, less so in the long arm domains I 
and II (Vuolteenaho et al., 1994). This is also true of the murine lama2 gene, 
located on chromosome 10; it encodes an a2 chain with an overall 45.9% 
homology to the murine al chain. Again the highest degree of homology, 77.3%, is 
found at the N-terminus with only 30.3% homology in the C-terminus long arm 
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domain (Bernier et al., 1995). The high degree of homology in the short arm may 
be linked to its role in the self-assembly of the laminin heterotrimers although there 
is evidence that the C-terminus long arm domains may also be involved (Utani et 
al., 1995; Yurchenco et al., 1992; Yurchenco and Schittny, 1990). The internal 
repeats of the a2 chain G-domain share a 30 to 50% homology with those of the al 
chain. As this is a receptor binding domain for both integrins and for the 
dystrophin-associated glycoproteins (DAG), this differences in the G-domain may 
reflect differences in receptor-ligand interactions in the two chains (Vuolteenaho et 
al., 1994). 
The human lama2 gene has 64 exons, which makes it approximately three times 
larger than the lamb] and lamcl genes encoding the smaller ßl and yl genes. It 
encodes a 9500 nucleotide transcript and a 3110 residue a2 chain (Zhang et al., 
1996). a2 chain mRNA has now been detected during embryogenesis in mice from 
E11.5 onwards and in neonates (Lentz et al., 1997; Miner et al., 1997). Expression 
in developing mice as well as in mature mice was found in cells of mesenchymal 
origin rather than epithelial or endothelial cells, such as cardiac muscle, skeletal 
muscle, lung, skin, liver and kidney, but also in neural crest derivatives such as 
Schwann cells. This early expression is consistent with a role for laminin-2 (and 
laminin-4) in the formation and maintenance of tissues such as skeletal muscle and 
peripheral nerves (Bernier et al., 1995; Vuolteenaho et al., 1994). 
1.2.4: Formation of the laminin-2 heterotrimer 
The first step in the formation of the laminin-2 heterotrimer appears to be mediated 
by the C-terminus long arm domains where the triple stranded coiled-coil is 
formed. Deletion mapping detected two neighbouring sites on the ß1 chain and 2 
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adjacent sites on the yl chain which involved in trimerisation (Utani et al., 1994). 
The a2 chain contained one site for trimerisation directed by charged amino acid 
residues. Stabilisation of the coiled-coil structure was found to be mediated by 
iosleucine residues in the a2 and yl chains (Nomizu et al., 1994). A specific 25 
amino acid sequence in the C-terminus of the a2 chain was found to be particularly 
important in the electrostatic interactions between the a2,31 and yl chains and also 
contained an a-helical structure vital in the initiation of trimerisation (Utani et al., 
1995). Spectroscopy showed that the a2 and yl chains subsequently undergo 
conformational changes with a drastic increase in the a-helix content particularly at 
the extreme C-terminus. Proper folding of the a2 chain at the C-terminus end 
ensured the stability of the newly formed heterotrimer. 
1.2.5: Polymerisation of laminin-2 
While the C-terminus is vital for trimerisation, the N-terminus of each of the a, ß 
and y chains mediate the self or co-polymerisation of laminin heterotrimers in full 
length trimers such as laminins-1,2 and 4, in a temperature, concentration and 
calcium-dependent manner (Cheng et al., 1997; Yurchenco and Cheng, 1993). 
Laminin heterotrimers such as laminins-5 and 6, truncated in the N-terminus, are 
not able to co-polymerise with full-length laminins, stressing the importance of the 
N-terminus domain. Moreover it has recently been shown that the dy2J/dI1 mouse, 
which suffers from a deletion in the N-terminus domain VI of the a2 chain is not 
able to polymerise the laminin-2 or laminin-4 heterotrimer very efficiently 
(Colognato and Yurchenco, 1999). Receptor interactions may also play a vital role 
in the polymerisation of laminin heterotrimers. The al and a2 laminin chains both 
bind to dystroglycan and integrin a7ß 1 receptors in their C-terminus domain. In 
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muscle cells laminin-1,2 and 4 heterotrimers showed preferential self- 
polymerisation when bound to either of these two receptors. Polymerised laminin is 
then able to induce the reorganisation of these receptors into a reciprocal network 
as a consequence of the rearrangement of cytoskeletal components, actin 
reorganisation and tyrosine phosphorylation (Colognato et al., 1999). 
Laminin polymers interact with proteoglycans such as perlecan and with the type 
IV collagen polymer through bridges formed by entactin/nidogen which binds 
laminins in the centre of the heterotrimer (Timpl and Brown, 1996; Yurchenco and 
Schittny, 1990) to complete the supramolecular architecture of the ECM (fig. 1.3). 
Laminins are expressed in the basal lamina in early development and adulthood and 
since the initial discovery of laminins-1 and 2, many more laminin chains and 
heterotrimers have been detected, a brief introduction to these follows (Table 1.1). 
1.2.6: Expression and function of other laminin chains 
Soon after the discovery of laminin-2, a basal lamina protein specific to the NMJ 
was discovered (Hunter et al., 1989b). The S-laminin heterotrimer is known as 
laminin-3 and the S-laminin chain as the ß2 chain. The ß2 chain was enriched at 
synaptic sites in muscle and also found to a lesser extent in peripheral nerves in 
perineurial but not endoneurial basal lamina, in the glomerular basal lamina in 
kidney and in arterial basal lamina. In fact the ß2 chain was detected in locations 
where the basal lamina was apposed on both sides by a cellular membrane (Hunter 




Figure 1.3: Laminin self-polymerisation: Laminin heterotrimers self- 
polymerise through interactions (double arrow) between a, ß and y chains 
in their globular N-terminal domains (red circles). Receptor (r) interactions 
(arrow) enhances laminin self-polymerisation. 
Modified from Cheng et al. (1997) and Colognato and Yurchenco (2000). 
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The location of ß2 at the neuromuscular junction indicated that it may exert an 
influence on neurons and in fact ß2 substrates were found to be selectively adhesive 
for embryonic motomeurons rather than for sensory neurons (Hunter et al., 1989b). 
Targeted deletion of the ß2 chain resulted in mice with abnormal NMJs; the 
number of active zones containing synaptic vesicles and the number of junctional 
folds was reduced and Schwann cells extended processes into the synapse (Noakes 
et al., 1995). The lamb2 gene was found to be located on mouse chromosome 9 and 
encoded a cysteine-rich protein with N-glycosylation sites showing homology with 
the al, yl chains and particularly the 31 chain (Hunter et al., 1989a; Porter et al., 
1993). The ß2 chain is currently known to be incorporated in several laminin 
heterotrimers, in laminin-4 (a2ß2y1) (Engvall et al., 1990), laminin-7 (a3Aß2y1), 
laminin-9 (a4p2y1) and laminin-11 (a5(32y1); all except laminin-7 can be detected 
at the synaptic basal lamina (fig. 1.4). 
Laminins-5,6 and 7 have been detected at the dermal-epidermal junction in 
epithelia in hemidesmosome-like anchoring filaments. Laminin-5 (a3Aß3y2; also 
known as kalinin or epiligrin) was isolated from keratinocytes and contained 
similarly sized non-identical chains of 165 to 170 kDa, 145 to 155 kDa and of 135 
to 140 kDa (Carter et al., 1991; Rousselle et al., 1991). Laminin-5 was found to 
exert an adhesive effect on keratinocytes and facilitated the attachment of growing 
keratinocytes in culture, a property that corresponds with its expression in vivo. 
These adhesive properties appear to be mediated by the a6ß1 and a3ß1 integrin 
receptors (Carter et al., 1991; Marinkovich et al., 1992a; Rousselle and Aumailley, 
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Figure 1.4: Expression of laminin chains and heterotrimers in the 
PNS. (a) A myelinated axon; the axon(A) is surrounded by a myelin 
sheath (MS) produced by the Schwann cell (SC) that is ensheathing it. 
Individual nerve-Schwann cell units in the PNS are surrounded by an 
endoneurial basal lamina in which the major non-collagenous constit 
-uent is laminin-2 (Ln-2). (b) At the NMJ, the nerve is surrounded by 
a terminal Schwann cell and a variety of laminin heterotrimers are 
present. Laminins-2 and 8 are expressed in the Schwann cell basal la 
-ina, although expression of the latter may be lost in adulthood. The 
laminin-2 heterotrimer is also expressed in the basal lamina of the 
skeletal muscle around the NMJ. Laminins-4,9, and 11 are expressed 
in the primary cleft of the synapse and lam inins-4 and II are also to 
be found in the junctional folds. 
Modified from Patton et al. (1997). 
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Immunochemical investigation of laminin-6 ((x3Aßlyl; K-laminin) revealed that it 
contained two chains that were common to laminin-1, the ß1 and 71 chains and 
another a chain that was common to laminin-5 (Marinkovich et al., 1992b). The 
laminin-7 (a3Aß2y1) heterotrimer was also found to be expressed in the dermal- 
epidermal junction and in amniotic fluid (Champliaud et al., 1996). It was proposed 
that laminin-5 complexes with either laminin-6 or 7 at the dermal-epidermal 
junction through interactions in the novel truncated a chain that is common to all 
three (Champliaud et al., 1996). 
The lama3 gene encoding the a3A chain produces two distinct transcripts of 
different sizes. It has a truncated N-terminus region that undergoes proteolytic 
processing (Ryan et al., 1994). The lama3B transcript encoded a longer chain with 
more EGF repeats and a globular domain similar to a al chain globular domain but 
with only two rather than three globular domains (Miner et al., 1997; Ryan et al., 
1994). Laminin-5 also contained a novel 0 chain, the ß3 chain (Pulkkinen et al., 
1995) and a novel y2 chain (Pulkkinen et al., 1994). The lamb3 gene is compact 
relative to other ß chains and was found to encode aß3 chain that is truncated with 
only one globular domain instead of two at the N-terminus of the short arm 
(Colognato and Yurchenco, 2000; Pulkkinen et al., 1995). The lamc2 gene encoded 
two transcripts of the y2 chain that are highly homologous to the yl chain (Airenne 
et al., 1996). 
Another truncated laminin a chain was identified that was expressed in heart, 
pancreas, lung and muscle and other mesenchymal tissues. The a4 chain has a long 
arm sequence similar to those found in other a chains but is truncated at the N- 
terminus and contains only a few EGF repeats in domain IIIa and no globular 
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domains (Iivanainen et al., 1995; Richards et al., 1996; Richards et al., 1994). The 
human lama4 gene is located on chromosome 6g21 close to the lama2 gene on 
chromosome 6q22 (Richards et al., 1994). This may account for the specific 
upregulation of the a4 chain in place of the a2 chain in dy/dy mice and in humans 
with merosin-deficient CMD. The a4 chain has currently been allocated to two 
laminin heterotrimers, laminin-8 (a4ßlyl) expressed in the endoneurial basal 
lamina during development but down-regulated neonatally and in the basal lamina 
of blood vessels, lung and skeletal muscle fibres (Miner et al., 1997). Laminin-9 
(a4ß271) is expressed at the synaptic basal lamina and particularly in the primary 
synaptic cleft and in the perineurial basal lamina surrounding axon fascicles (Miner 
et al., 1997). 
The laminin-10 (a5ß171) and laminin-11 (a5P271) heterotrimers both contain the 
novel a5 chain (Miner et al., 1997). The lamas gene encodes a full length a chain 
that is somewhat longer in the N-terminus region due to a greater number of EGF 
repeats in domain V (Miner et al., 1997). Laminin-10 is expressed during 
development at the synaptic basal lamina and in skeletal muscle (Miner et al., 1997; 
Patton et al., 1997; Ringelmann et al., 1999) and in hematopoietic cells and kidney 
(Gu et al., 1999; Miner et al., 1997). The laminin-11 heterotrimer is aß2 chain- 
containing laminin and is therefore largely restricted to synaptic basal lamina in the 
primary cleft and junctional folds (fig. 1.4), but can also be found in perineurial 
basal lamina (Miner et al., 1997; Patton et al., 1997). The presence of the a5 chain 
appears to be important as a stop signal for Schwann cells in the formation of the 
NMJ (Patton et al., 1998). 
Recently a further laminin heterotrimer has been characterised which incorporates a 
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new y chain. The laminin-12 heterotrimer (a2ßly3) contains the y3 chain (Koch et 
al., 1999) which appears to be a full-length y chain containing all the expected 
domains (livanainen et al., 1999; Koch et al., 1999). The y3 chain is expressed in 
heart, in skin at the point of nerve penetration at the dermal-epidermal junction and 
on the apical surface of the lung and a variety of reproductive tissues. The y3 chain 
is not found in structurally defined basal laminae, suggesting that laminin-12 may 
be involved in the formation and maintenance of ciliated processes in these cells. 
The most important of the three known y chains is the 71 chain encoded by the 
lamcl gene. The wide expression of this chain in all but two of the twelve known 
heterotrimers, laminins-5 and 12, both of which show limited patterns of 
expression, results in severe consequences if it is deleted. Targeted deletion of the 
yl chain in mice using homologous recombination results in fatality at E5.5 in 
homozygous mutant embryos due to their failure to produce a proper basal lamina 
(Smyth et al., 1999). Instead, extracellular deposits of type IV collagen and 
perlecan were found. Although small amounts of the al chain and the glycoprotein 
nidogen/elastin were detected, it was insufficient in the absence of almost all the 
laminin heterotrimers to assemble the ECM necessary for formation of the basal 
lamina. The early death of homozygous embryos indicated that a basal lamina is 
vital from the time of endoderm differentiation. 
1.2.7: The role of laminins in the developing nervous system 
The functional significance of these laminins in vivo has become clearer recently 
with the characterisation by the Sanes laboratory of the spatio-temporal pattern of 
expression of laminin chain genes in the pathways and targets of the developing 




with targeted deletions in a number of laminin chain genes. It appears that while 
laminin chain genes are highly expressed in the developing PNS, expression in the 
CNS is limited. In E11.5 mouse embryos, in situ hybridisation showed wide 
expression of ß1 and yl chain mRNA. Expression of al, a2 and a4 chain mRNA 
was restricted to the spinal cord meninges and to non-neural cells around the DRG, 
the a4 chain mRNA was also expressed in unidentified cells along peripheral 
nerves (Lentz et al., 1997). 
Laminin chain mRNA expression was detected in target tissues for sensory and 
motor axons, such as skin and muscle. There was wide expression of ß1 and yl 
chain mRNA in limb-buds in both skin and muscle at E13, although expression of 
the PI chain mRNA was more diffuse in muscle. Expression of a2 and a4 chain 
mRNA was restricted to muscle and the a5 chain mRNA to skin at this stage (Lentz 
et al., 1997). 0, ß3 and y2 chain mRNA is widely expressed in skin at this stage as 
well as in adulthood where they form the laminin-5 heterotrimer expressed at the 
dermal-epidermal junction. By E15.5 high expression of a2, a4, (31 and yl chain 
mRNA can be detected in the DRG, although whether or not expression of these 
chains is neuronal or not is unclear. a4 and a2 chain containing laminins such as 
laminin-2 and 8 are expressed in dorsal and ventral roots and along peripheral 
axonal pathways at a time during development when sensory and motor axon 
outgrowth and Schwann cell migration occurs. 
The NMJ is a specialised structure that occurs where motor axons synapse on their 
target tissues, the skeletal muscle fibres, and begins to form at around E13 to E14 in 
mice. There is restricted expression of laminin chains here, whereas the a2, a4, a5, 
f31 and yl chains appear to be widely expressed in both synaptic and extrasynaptic 
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regions of the developing peripheral nerves, the ß2 chain is exclusively expressed 
in synaptic basal lamina throughout (Patton et al., 1997). Expression of these 
laminin chains changes with maturation such that a4 chain expression is lost from 
extrasynaptic sites and expression of the PI chain is lost from synaptic basal 
lamina. Thus it appears that while laminins-2,8 and 10 may be expressed early on 
in the formation of the NMJ, only laminins-4,9 and 11 are retained. 
Laminins expressed at the NMJ have a specialised function that has been 
demonstrated in both in vitro assays and in targeted deletions of the lamb2 gene. 
Although the number of NMJs appeared to be normal in mice lacking the ß2 chain, 
the morphology differed substantially. In the mutants both the post and pre-synaptic 
terminus were relatively unbranched. The active sites where synaptic vesicles are 
concentrated were sparse and the synaptic vesicles themselves were scattered 
throughout the nerve terminus. Finally Schwann cells extended processes into the 
synaptic cleft instead of simply capping the nerve terminus (Noakes et al., 1995). 
Targeted deletion of the ß2 chain gene also results in the loss of a5 chain 
expression and consequently the loss of laminin-11 in synaptic basal lamina. This 
laminin heterotrimer appears to have a particularly important role in the formation 
of the NMJ. Whereas other laminin heterotrimers that motor axons may encounter 
during development, such as laminins-2,4 and 8 promote neunte outgrowth 
laminin-11 was found to be inhibitory. When embryonic motor neurons 
encountered laminin-11 in vitro their processes were short and bore large flattened 
growth cones (Cho et al., 1998). Moreover Schwann cells do not adhere well to a 
laminin-11 substrate and are inhibited from extending processes on it (Cho et al., 
1998; Patton et al., 1998). Thus laminin-11 stops the motor axons during 
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development and prevents the Schwann cells from entering into the synaptic cleft. 
The expression of a lama2 transgene in the skeletal muscle of mice with targeted 
deletions in the lama2 gene does not obliterate all the symptoms. The persistence of 
lameness in the hind-limbs is linked to the loss of laminin-2 expression in the PNS 
(Kuang et al., 1998b), which results in a variety of Schwann cell ensheathment and 
myelination abnormalities in all mice deficient in laminin-2 (Bradley and Jenkison, 
1973). It has long been known that an intact basal lamina is necessary for 
maintaining Schwann cell-axon interactions and promoting myelination (Bunge and 
Bunge, 1978; Bunge et al., 1986). As laminin-2 is produced by Schwann cells 
(Hsiao et al., 1993) and is the major laminin heterotrimer expressed 
extrasynaptically in the PNS (Patton et al., 1997), it clearly has a vital role to play 
in these processes. 
Laminin-2's role in maintaining the integrity of the PNS has been demonstrated 
recently by its link to peripheral neuropathy in leprosy. The Myobacterium leprae 
bacteria responsible for causing leprosy were known to target Schwann cells but 
their mode of action was unknown. A 21 kDa protein on the Myobacterium leprae 
bacteria has been found to bind specifically to the C-terminus of the a2 chain in the 
G-domain (Shimoji et al., 1999). This then serves as a bridge for the bacteria to 
bind to the laminin receptors expressed in the Schwann cells such as the a6ß4 
integrin and the dystroglycan receptor. Thus the link between the ECM and the 
Schwann cell cytoskeleton that is vital for maintaining peripheral nerves is 
disrupted (Rambukkana et al., 1997; Rambukkana et al., 1998). 
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1.2.8: Laminins-1 and 2 in skeletal muscle development 
Both laminins-1 and 2 can affect the behaviour of myoblasts in vitro, suggesting 
that both may be involved in myogenesis. Myoblasts are certainly capable of 
synthesising the laminin a2 chain (Vilquin et al., 1999; Vilquin et al., 1996). While 
laminin-1 promotes myoblast proliferation and fusion and the formation of 
myotubes, expression is downregulated as the myoblasts differentiate, this may 
explain why there is no need for laminin-1 expression in mature muscle fibres. 
Laminin-2 is expressed in myoblasts as laminin-1 expression is downregulated and 
myoblasts begin to differentiate. Although both laminin-1 and laminin-2 were able 
to induce fusion of myoblasts in cell lines, only laminin-2 was found to promote 
stability in the myotubes that were formed (Vachon et al., 1996). 
When expression of the lama2 gene was disrupted in embryonic stem cells, they 
were still capable of generating a variety of muscle cell types in vitro such as 
myotubes of skeletal muscle, smooth muscle cells and cardiomyocytes. As soon as 
they differentiated into a mature, contracting phenotype these a2 chain-deficient 
myotubes began to detach and degenerate (Kuang et al., 1998a). Like dy/dy mice, 
the deficiency in laminin-2 causes muscle fibres to degenerate within ten days of 
birth in mice with targeted deletions in the lama2 gene, probably as a result of 
apoptotic cell death (Miyagoe et al., 1997). Skeletal muscle fibres in mice which do 
not express the laminin a2 chain also show poor regenerative properties which can 
be corrected with the expression of a human lama2 transgene in skeletal muscle 
(Kuang et al., 1999). All of these findings are consistent with a role for laminin-2 in 
the basal lamina of mature skeletal muscle fibres in maintaining the stability of 
muscle fibres, preventing them from degenerating and helping them to acquire and 
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maintain their mature phenotype. 
1.3: Laminin receptors 
1.3.1: The integrin receptor family 
Integrins are a large family of heterodimeric cell surface receptors which bind a 
variety of ECM molecules, including the laminins. The integrin heterodimers are 
composed of one of at least 16 a subunits and 8ß subunits that make up over 
twenty distinct subunit combinations (Hynes, 1992; Rosales et al., 1995). Most 
cells will express more than one integrin receptor throughout the course of their 
development and most integrins act as receptors for more than one ECM molecule. 
All integrin subunits have a large extracellular ligand binding domain and a small 
cytoplasmic domain except for the ß4 subunit, which has a rather large cytoplasmic 
domain. The N-terminus of a and ß subunits in the extracellular domain contains 
the ligand binding domain (Arnaout, 1990; D'Souza et al., 1994; Loftus et al., 1990; 
Smith and Cheresh, 1990; Wardlaw et at., 1990). Binding to this region of the 
integrin receptor is thought to be promoted by the presence of three to five divalent 





Figure 1.5: The integrin receptor complex: The extracellular matrix 
(ECM) binds to the integrin receptor subunits in their large extracellular N- 
terminus(N) domains. There are usually three to five divalent cations (+) in 
the N-terminus region which may be associated with ligand binding. 
Cytoskeletal proteins such as talin (tal), paxillin (pax) and vinculin (vin) 
bind to the short C-terminus (C) domain of the 13 integrin subunit. As the 
receptor binds to the ECM protein tyrosine kinases such as the focal adhesion 
kinase (FAK) pathway are activated and autophosphorylated, creating binding 
sites for Src kinases. The Src kinases phosphorylate focal adhesion kinases 
such as paxillin which have signalling as well as structural functions and the 
docking protein p13OCAS. Src phosphporylation may result in activation of the 
Ras-ERK (extracellular signal-related kinase) cascade. Receptor activation 
also induces assembly of actin filaments in the cytoskeleton and aggregation 
of ECM molecules and of their integrin receptors. 
Modified from Giancotti and Ruoslahti (1999). 
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When the integrin receptor is bound to ECM molecules, the cytoplasmic domain of 
the integrin subunits will associate with cytoskeletal proteins and signalling 
complexes, promoting the assembly of actin filaments and resulting in aggregates 
of ECM molecules and cytoskeletal proteins on either side of the cell membrane 
(Giancotti and Ruoslahti, 1999). The binding of ECM molecules to integrin 
receptors provides both a structural link between the basal lamina and also activates 
signal transduction through the cytoskeletal proteins to which it binds (fig. 1.5). 
Integrins mediate signal transduction through activation of protein tyrosine kinases, 
when integrin receptors were clustered they induced phosphorylation of a complex 
of proteins termed pp130 (Kornberg et al., 1991), now known as the focal adhesion 
complex. Most integrins activate the focal adhesion kinase (FAK) pathway 
(Parsons, 1996). The FAK pathway may interact either directly with the 
cytoplasmic tail of the integrin ß subunit or through cytoskeletal proteins such as 
talin and paxillin. 
The Src family of kinases, Src, Fyn, and Yes are thought to play a role in both FAK 
and Shc pathways. FAK activation creates a binding site for the Src homology 2 
(SH2) domains of Src and Fyn resulting in phosphorylation of cytoskeletal focal 
adhesion proteins such as paxillin by Src kinases (Schaller et al., 1995; Schaller and 
Parsons, 1994; Schlaepfer and Hunter, 1996a; Schlaepfer and Hunter, 1996b). Both 
the FAK and Shc pathway may then activate the Ras-extracellular signal-regulated 
kinase (ERK) class of mitogen-activated protein (MAP) kinases and downstream 
signalling cascades. 
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1.3.2: Laminin-integrin interactions 
Laminins in particular bind to a wide variety of integrins in different tissues and 
possess several binding domains for them. Most laminin-receptor binding 
interactions occur in the C-terminus domain of the long arm of laminin chains but 
some have also been identified in the short arm N-terminus domains. Although 
many integrins are recognised by a variety of ECM molecules, a6 integrins are 
largely specific for the laminins. The a6ß 1 integrin binds to the laminin a2 chain in 
its C-terminus end in domain I and in the G-domain (Deiwel et al., 1993; Hall et al., 
1990) as does the a6ß4 integrin (Rambukkana et al., 1997; Spinardi et at., 1995). 
The a3(31 and a7ß 1 integrins also act as receptors for a2 chain containing laminins 
and bind the heterotrimer in the C-terminus domain I and G-domain region (Cohen 
et al., 2000; Deiwel et al., 1994; Gehlsen et al., 1989; Kramer et al., 1991; Schober 
et al., 2000; Yao et al., 1996). The a11 and a2ß 1 integrin receptors bind to 
laminins in the short arm N-terminus domains (Hall et al., 1990; Tomaselli et al., 
1990). Specific binding sites, which promote cell adhesion and neunte extension, 
have been found for these two receptors in domain VI of the laminin a2 chain 
(Colognato et al., 1997). 
1.3.3: Integrins in the developing nervous system 
Laminin-integrin interactions are thought to mediate several processes in the 
development and maintenance of the nervous system and in skeletal muscle. The 
a1ß 1 integrin is not widely expressed in adult tissues but is expressed transiently in 
both the CNS and PNS during early development; between E3 and E5 in the quail 
CNS and in the PNS from E3 when laminin-1 expression is first detected in neural 
crest cells regrouping into prospective DRGs (Duband et al., 1992). The a1ß1 
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integrin receptor appears to promote neural crest cell migration when bound to 
laminin-1 in vitro (Desban and Duband, 1997). Laminin-1 binding to the alß1 
integrin receptor has different effects on neural crest cell spreading depending on 
whether it is bound to the laminin heterotrimer in the N-terminus domain which 
induces poor spreading or in the C-terminus domain which induces flattening and 
spreading of the neural crest cells (Desban and Duband, 1997). 
PNS expression of the alß1 dimer was strong at E4 to 4.5 up to E9 tolO in quail 
spinal sensory ganglia where sensory axons were extending neuntes and in ciliary 
ganglia from E3.5 to ElO (Duband et al., 1992). Corresponding expression of the 
P1 integrin subunit has also been detected on ciliary ganglion neurons concurrent 
with laminin-1 expression (Weaver et al., 1995). In fact several ßl integrins were 
detected on the surface of the cell bodies of ciliary ganglion neurons from E4 to 8, 
but only the OPI, and the a6ß 1 and not the alp 1 integrins mediated neunte 
outgrowth on laminin-1 in vitro. The same ßl integrins are expressed on the surface 
of DRG neurons and exhibit differential selectivity in promoting neunte outgrowth 
on laminins-1 and 2. Neunte extension on laminin-2 is more efficient on the a3ß1 
integrin receptor and on laminin-1 the alß1 integrin receptor is preferred 
(Tomaselli et al., 1993). The neurite promoting properties of integrins are clearly 
dependent on the neuronal cell type and the laminin isoform to which it is bound. 
1.3.4: Integrins and glial cells 
Integrin binding is also involved in mediating the response of glial cells in both the 
CNS and PNS to ECM molecules. The ßl and ß4 integrins are major Schwann cell 
laminin receptors, both are expressed by Schwann cells in human foetuses from 
about the eleventh to the twenty-second week but are down-regulated subsequently 
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(Jaakkola et al., 1993). The P1 integrin receptor subunit can be expressed by 
Schwann cells in the absence of axonal contact, (Einheber et al., 1993). In fact the 
alp! integrin is expressed mostly on mature non-myelin-forming Schwann cells 
and is only upregulated when axonal contact is lost following injury in non-myelin- 
forming Schwann cells (Stewart et al., 1997). P1 integrins are able to promote 
laminin-1 and 2-mediated Schwann cell migration in vitro, a necessary prerequisite 
to myelination in developing and regenerating nerves (Milner et al., 1997). 
Schwann cell migration is also promoted on another ECM substrate, fibronectin, 
through interactions with av integrins. It is likely that laminin-mediated Schwann 
cell migration occurs through interactions with the (x6ß1 integrin, which is most 
highly expressed in undifferentiated Schwann cells before they begin to myelinate 
(Fernandez-Valle et al., 1994). The attachment of Schwarm cells to the ECM 
preceding myelination is probably also mediated by the a6ß1 receptor as blocking 
the activity of the PI subunit inhibits myelination as the Schwann cells are most 
likely unable to attach to the ECM (Fernandez-Valle et al., 1994). Once the 
Schwann cells have attached to the ECM and are able to ensheath and myelinate the 
axon, expression of the a6ß 1 dimer is down-regulated and it is not normally 
expressed in myelinating Schwann cells. Myelination in the CNS by 
oligodendrocytes may also be regulated by laminin-integrin interactions. Blocking 
the activity of the (x6ß1 integrin receptor on oligodendrocytes, affects their ability 
to terminally differentiate and to form myelin membranes on a laminin-2 substrate 
in vitro (Buttery and ffrench-Constant, 1999). 
The ß4 integrin is expressed by Schwane cells only when in contact with axons and 
particularly upon myelination, when expression of the a6ß1 integrin receptor is 
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downregulated (Einheber et al., 1993; Feltri et al., 1994; Fernandez-Valle et al., 
1994). Thus the peak of ß4 integrin expression occurs in late development and early 
adulthood, concurrent with the time of myelination. P4 integrin mRNA expression 
reaches it peak following the peak of myelin gene mRNA expression. It is 
downregulated again following injury to peripheral nerves and the loss of axonal 
contact and reinduced by contact with regenerating axons (Feltri et al., 1994). 
Expression of the a6ß4 receptor is localised mostly to the outer plasma membrane 
of Schwann cells and to the Schmidt-Lanterman clefts/incisures (Einheber et al., 
1993). 
Integrin receptors have also been detected at the NMJ and may regulate its 
formation. The al integrin subunit has been detected at the NMJ in presynaptic 
cells such as Schwann cells and at nerve terminals (Martin et al., 1996). The a3ß1 
integrin, which is a laminin-binding integrin, is concentrated in the active zones 
where synaptic vesicles are gathered and released in the NMJ (Cohen et al., 2000). 
The a5ß1 integrin, which is known to act predominately as a fibronectin receptor 
(Lefcort et al., 1992) is highly expressed in terminal Schwann cells at the NMJ 
(Cohen et al., 2000). This particular a5ß1 integrin receptor is usually only 
expressed in neurites and Schwann cells along the axon during development and 
regeneration. The expression of these integrin receptors probably mediates the 
specific way in which terminal Schwann cells respond to laminins in the basal 
lamina of the NMJ. Terminal Schwarm cells do not adhere very well to the synaptic 
basal lamina, preventing Schwann cell process extension into the NMJ. This may 
occur if the integrin receptors expressed there lack a cognate ligand, a laminin 
isoform with which they can interact. 
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1.3.5: Integrins in skeletal muscle 
The al integrin is expressed in the myotomes in quail at E4 as the myoblasts begin 
to separate from the myotome, migrate and differentiate. Expression is maintained 
in skeletal muscle up to Ell when the myotubes have fused and become 
differentiated (Duband et al., 1992). Myoblast proliferation and differentiation up to 
myotube fusion are processes which are promoted by both laminins-1 and 2 
(Vachon et al., 1996). One of the major laminin receptors in skeletal muscle is the 
a7ß1 integrin receptor. The ability of laminins-1,2 and 4 to promote adhesion and 
migration appears to be mediated in vitro by all three isoforms of the a7 integrin, 
a7A, a7B and a7C, in HEK293 and MCF-7 cell lines (Schober et al., 2000; Yao et 
al., 1996). All of these isoforms are capable of combining with the PI integrin 
subunit to form a receptor that binds well to laminins-1,2 and 4. 
In adult mice a7A integrin mRNA was detected exclusively on skeletal muscle 
whereas 013 integrin mRNA showed a less restricted pattern of expression, in 
cardiac muscle, in brain and skeletal muscle (Collo et al., 1993). a7A mRNA was 
expressed postnatally once myoblasts had begun to differentiate and fuse and 
exclusively at the synapse and may therefore be involved in stabilising these 
structures (Martin et al., 1996). Proliferating skeletal muscle myoblasts exclusively 
expressed a7B integrin mRNA but although it was detected in developing skeletal 
muscle, it also appeared to be restricted to the synapse within a couple of weeks of 
birth. The a7C integrin subunit is the only one which appears to be expressed 
throughout skeletal muscle in both synaptic and extrasynaptic sites both during 
development and in adult skeletal muscle (Martin et al., 1996). The spatio-temporal 
expression patterns of these different isoforms of the a7 integrin subunit, suggests 
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different roles in the development and maintenance of skeletal muscle and the 
synapse. Mutations that cause a deficiency of 0 integrins result in congenital 
myopathy and indicates that this receptor is probably predominant in skeletal 
muscle (Hayashi et al., 1998). 
1.3.6: Integrin receptor expression is regulated by laminins 
Neunte outgrowth from embryonic chick DRG neurons is promoted by laminin-1 
in vitro through interactions with the a6ß 1 integrin receptor. When the amount of 
laminin-1 on the substrate was lowered ten-fold, there was an increase in the 
adhesion of these DRG neurons and in neunte outgrowth from them (Condic and 
Letourneau, 1997). This was due to a compensatory four to fivefold increase in the 
number of neuronal a6ß1 integrin receptors. However a6 mRNA and protein was 
decreased, suggesting that the increase in the number of receptors on the cell 
surface was due to post-translational regulation, i. e. activation, of a6 integrin 
induced by low levels of laminin-1. 
Laminin regulation of integrin receptor levels has also been observed in vivo. In 
dy/dy mice and humans with merosin-deficient CMD, there is decreased expression 
of the OPI integrin receptor in skeletal muscle. This is not seen in mice and 
humans where the muscular dystrophy is caused by a deficiency of the cytoskeletal 
protein dystrophin (Hodges et al., 1997; Vachon et al., 1997). Thus the decrease in 
the levels of a2 chain-containing laminins in skeletal muscle leads to regulation of 
a7ß 1 integrin levels at both the gene expression and post-transcriptional levels. 
Moreover this regulation appears to selectively affect the levels of the a7A and 
ß1D transcripts in particular. These are 'exclusively expressed in differentiated 
muscle in which laminin-2 promotes stability (Hodges et al., 1997; Vachon et al., 
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1996; Vachon et al., 1997). Mice with targeted deletions of the synapse-specific 
laminin ß2 chain also exhibit secondary changes in the distribution of integrins at 
the NMJ. Of the two synapse-specific a7 integrin isoforms, only the a7B isoform 
was lost (Martin et al., 1996). Integrin expression may also affect expression of 
laminins; embryoid bodies are normally capable of depositing a basal lamina 
incorporating laminin-1, but when embryoid bodies were derived from ßl integrin 
null embryonic stem cells, there was no basal lamina deposition. The lack of PI 
integrin expression resulted in laminin al chain synthesis being terminated, without 
which a basal lamina could not be assembled (Aumailley et al., 2000). 
1.3.7: Laminin-integrin binding and growth factors 
Activated integrin receptors bound to ECM molecules such as the laminins are able 
to form complexes with growth factors and their receptors through shared 
signalling pathways resulting in optimal activation of these growth factors. Thus 
activation of the EGF receptor results in the phosphorylation of tyrosine residues on 
the ß4 subunit of the a6ß4 integrin when bound to laminin-5 (Mainiero et al., 
1996). However this does not result in activation of the Shc pathway and instead 
EGF signals may suppress signalling in activated a6ß4 integrin receptors. Ligand- 
bound clusters of integrin receptors are able to stimulate fibroblast growth factor 
(FGF) receptor aggregation (Plopper et al., 1995) and phosphorylation of platelet 
derived growth factor-ß (PDGF) receptors (Sundberg and Rubin, 1996). The 
synergism between ligand-bound integrins and growth factors is linked to 
downstream signalling mechanisms, thus EGF, PDGF and basic FGF (bFGF) all 
activate the ERK pathway in ligand-bound and aggregated integrins (Miyamoto et 
al., 1996). Aggregation and phosphorylation of the receptors for all these growth 
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factors was in turn stimulated by the presence of ligand-bound integrins. Thus 
binding of laminin and other ECM molecules to integrin receptors not only 
provides a structural link between the basal lamina and cytoskeleton but also results 
in the activation of complex signalling pathways. 
1.3.8: The dystrophin-associated glycoprotein receptor complex 
The DAG receptor also binds ECM molecules, but its distribution, ligand 
specificity and function is far more restricted than that of the integrins. The first 
major component of this transmembrane complex to be identified was dystrophin in 
smooth and skeletal muscle. This was identified as the 400 kDa protein product of 
the gene that is mutated in Duchenne's muscular dystrophy (DMD) (Hoffman et al., 
1987). Dystrophin had a 240 amino acid N-terminus domain that showed homology 
to the actin-binding domain of a-actinin, followed by a spectrin-like rod shaped 
domain with a triple helical structure, a cysteine-rich domain with a-actinin 
homology and finally a unique 420 kDa C-terminus domain (Koenig et al., 1988). 
Dystrophin was found to associate to a transmembrane complex in skeletal muscle 
that included a 50 kDa and 156 kDa component (Ohlendieck et al., 1991b). The 
large 156 kDa component formed the extracellular part of the complex and bound 
to the transmembrane 43 kDa component, which in turn bound a variety of 
intracellular cytoskeletal proteins (Ervasti and Campbell, 1991). Both components 
are encoded by the same gene, a 5.8 kilobase (kb) mRNA transcript was detected in 
skeletal muscle, cardiac muscle, lung and brain (Ibraghimov-Beskrovnaya et al., 
1992). The transcript encoded a 97 kDa precursor protein that underwent post- 
translational modification, the N-terminus region of this precursor was processed 
into the extracellular 156 kDa component known as a-dystroglycan and the C- 
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terminus into the 43 kDa transmembrane component known as ß-dystroglycan. The 
156 kDa protein was found to be processed into a lower molecular weight protein 
in non-muscle tissues such as lung and brain of approximately 120 kDa (Gee et al., 
1993; Ibraghimov-Beskrovnaya et al., 1992). The differences in molecular weight 
could be due to differential glycosylation of the extracellular component in various 
tissues (fig. 1.6). 
1.3.9: Different cytoskeletal proteins are associated with the DAG receptor 
complex in different tissues 
The composition of the DAG receptor complex differs from tissue to tissue, 
especially in the variety of cytoskeletal proteins associated with it. ß-dystroglycan 
associates with several transmembrane and cytoskeletal proteins in skeletal muscle. 
The sarcoglycan complex is composed of a, ß, y and S-sarcoglycan, four 
transmembrane proteins of between 35 to 50 kDa that are associated with ß- 
dystroglycan (Durbeej et al., 1998; Ervasti and Campbell, 1991; Hemler, 1999). 
Dystrophin binds to ß-dystroglycan and is also bound to the actin cytoskeleton and 
syntrophins in skeletal muscle. The syntrophins are 58-60 kDa proteins (Froehner 
et al., 1987), that associate with dystrophin (Ahn and Kunkel, 1995; Suzuki et al., 
1995). 
The composition of the DAG receptor complex in skeletal muscle at the NMJ 
differs from that in extrasynaptic skeletal muscle. An autosomal transcript was 
cloned from skeletal muscle encoded a 427 kDa cytoskeletal protein, utrophin, that 
had a high homology to dystrophin (Love et al., 1989) and was restricted to the 
NMJ in skeletal muscle (Ohlendieck et al., 1991a). Utrophin is associated with the 
same transmembrane and cytoskeletal proteins as dystrophin including the 
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sarcoglycans and actin (Matsumura et al., 1992). Rapsyn is a transmembrane 
protein associated with acetylcholine receptors, which is thought to provide a link 
between these receptors and the DAG receptor complex by binding to ß- 
dystroglycan at the NMJ (Apel et al., 1995; Cartaud et al., 1998; Qu et al., 1996). 
The DAG receptor complex has also been detected in peripheral nerves in a thin 
sheet surrounding the outermost layer of the myelin sheath (Matsumura et al., 
1993). The a-dystroglycan protein could not be detected at the nodes of Ranvier, 
where myelin is not found, thus it appears that in peripheral nerve the DAG 
receptor complex is exclusively associated with the myelin sheath (Yamada et al., 
1994). Utrophin, a 120 kDa a-dystroglycan, ß-dystroglycan, a 59 kDa and a 35 kDa 
protein and Dpi 16 (a 116 kDa product of the gene that encodes dystrophin) but not 
the sarcoglycan complex were all co-localised in the peripheral nerve (fig. 1.6). 
The DAG receptor complex varies in its composition but has now been detected in 
skeletal muscle, smooth muscle, cardiac muscle, at the NMJ, in the PNS, the CNS, 
the digestive system, respiratory system, skin, in basal epithelia such as kidney and 
in the reproductive system (Durbeej et al., 1998). Moreover expression of the DAG 
receptor complex has been detected during development as early as E5.5, in 
Reichert's membrane and in the basement membrane between the visceral 
endoderm and the ectoderm (Williamson et al., 1997; Yotsumoto et al., 1996). 
Homozygous mice with a null allele of the Dag-1 gene encoding dystroglycan have 
a disrupted Reichert's membrane. 
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Figure 1.6: The DAG receptor complex in Schwann cells: (a) The 
transmembrane and extracellular components of the DAG (dystrophin associated 
glycoproteins) receptor complex, ß-dystroglycan and a-dystroglycan have been 
detected on the Schwann cell outer membrane. The cytoskeletal proteins that bind 
to ß-dystroglycan are found in the Schwann cell cytoplasm, between the Schwann 
cell outer membrane and the compacted myelin sheath surrounding the axon (A). 
(b) Laminin-2 in the basal lamina surrounding the axon- Schwann cell units binds 
to the extracellular component of the DAG receptor complex, a-dystroglycan (a- 
DG), through the fourth and fifth G-domain repeats in the C-terminal of the laminin 
a2 chain (a2LG4/5). a-Dystroglycan binds to ß-dystroglycan (ß-DG), which is a 
transmembrane protein found in the Schwann cell outer membrane. Dpi 16 and 
utrophin are cytoskeletal proteins that bind to ß-dystroglycan in its intracellular 
domain in the Schwann cell cytoplasm. Downstream binding of utrophin and 
Dp 116 to other cytoskeletal proteins and actin has not been well characterised for 
the DAG receptor complex in peripheral nerves. 
Modified from Yamada et al. (1996) and Hemler (1999). 
67 
























cytoplasm Actin ? 
Utrophin 
Compact myelin 
1.3.10: The DAG receptor complex binds laminin-1 and 2 in the ECM 
Laminin-1 but not fibronectin was found to bind to the 156 kDa component of the 
DAG receptor complex (Ibraghimov-Beskrovnaya et al., 1992). This was also the 
case with the 120 kDa a-dystroglycan produced in non-muscle tissue, which bound 
laminin-1 with equal affinity and specificity as the 156 kDa a-dystroglycan (Gee et 
al., 1993). The expression of the DAG receptor complex in skeletal muscle and in 
peripheral nerves where the laminin-2 heterotrimer is the principal laminin isoform 
suggested that it too might bind a-dystroglycan. 
Purified skeletal muscle DAG receptor complex was overlaid with 125I-laminin-2 
and shown to specifically bind this laminin isoform in a Cat+-dependent manner 
(Sunada et al., 1994). As with skeletal muscle, the 120 kDa peripheral nerve 
isoform of a-dystroglycan showed a Cat+-dependent binding affinity for laminin-2 
(Yamada et al., 1994). In vivo, the principle ligand for a-dystroglycan is most likely 
to be laminin-2; The ECM is anchored to the Schwann cell cytoplasm by binding of 
the a-dystroglycan receptor by laminin-2 in the ECM, the a-dystroglycan is in turn 
bound to ß-dystroglycan in the transmembrane domain. ß-dystroglycan binds 
through its C-terminus cytoplasmic domain to either Dp116 or utrophin in the 
abaxonal Schwane cell cytoplasm (Saito et al., 1999; Yamada et al., 1996). 
The binding region of the 120 kDa a-dystroglycan was determined to be in the 
heparin-binding region of the laminin-1 heterotrimer in the C-terminus G-domain 
(Gee et al., 1993). In fact heparin inhibits the binding of both laminin-1 and 
laminin-2 to the 156 kDa a-dystroglycan (Pall et al., 1996), consistent with a 
similar binding domain for the different a-dystroglycan isoforms on both the 
laminin al and a2 chains. Analysis of the crystal structure of the G-domain of the 
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laminin a2 chain reveals binding sites for a-dystroglycan in the fourth and fifth G- 
domains (LG4 and LG5, nearest to the laminin a2 chain C-terminus) (Hohenester 
et al., 1999; Tisi et al., 2000). A calcium ion was detected at the tip of both the 
a2LG4 and LG5 domains, consistent with the Cat+-dependent manner of laminin- 
binding to a-dystroglycan. 
The DAG receptor complex clearly acts as a structural link between the basal 
lamina and the cytoskeleton, but its role in signal transduction is not clear. However 
among the cytoskeletal proteins that ß-dystroglycan is able to bind to is growth 
receptor bound protein 2 (Grb2), an adapter protein that binds through its Src 
homology 3 (SH3) domains to the C-terminus of ß-dystroglycan (Yang et al., 
1995). The N-terminus SH3 domains of Grb2 shows a particularly strong affinity 
for the cytoplasmic tail of ß-dystroglycan (Russo et al., 2000). As with the 
integrins, the SH3 domains are involved in signal transduction and cytoskeletal 
organisation and these domains in Grb2 are able to activate Ras signalling through 
receptor tyrosine kinases (Lowenstein et al., 1992). In addition the SH2 domains of 
Grb2 are able to associate with both EGF and PDGF receptors. 
It is not clear whether the DAG receptor complex or integrins are more prominent 
in the pathology of the dy/dy mouse or humans with merosin-deficient CMD. 
Blocking the interaction of laminin-2 with a-dystroglycan in differentiated mouse 
myotubes disrupts the ability of laminin-2 to stabilise differentiated skeletal muscle 
(Vachon et al., 1996). A dystrophic phenotype is induced in these myoblast 
cultures, with reduced myotube size and loss of contractile activity (Brown et al., 
1999). However expression of the DAG receptor complex is not affected in humans 
with merosin-deficient CMD even though expression of the a7ß I integrin receptor 
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is (Vachon et al., 1997). The interaction of laminin-2 with a-dystroglycan in 
Schwann cells may play an important role in myelination. The Myobacterium 
leprae bacteria responsible for causing leprosy bind to the laminin a2 chain in the 
G-domain blocking the sole binding sites for a-dystroglycan on laminins and 
results in peripheral neuropathy (Rambukkana et al., 1998). 
1.4: Formation of the peripheral nervous system 
1.4.1: Generation of the neural crest 
Prospective neural crest cells lie on the border of the neural plate and the 
neuroepithelium, the prospective epithelium (fig. 1.7). Neural crest cells do not 
appear to be a segregated population; both neural tube and neural crest cells are 
derived from this region, consistent with a common lineage for some PNS and CNS 
cells (Bronner-Fraser and Fraser, 1989; Bronner-Fraser and Fraser, 1988). 
Inductive interactions between the neuroepithelium and the neural plate results in 
"dorsalisation" of the neural tube prior to the emergence of neural crest cells. The 
ability of non-neural ectoderm/neuroepithelium to generate signals that result in 
dorsalisation of the neural tube and generation of the neural crest is determined by 
the developmental stage of the non-neural ectoderm and the neural plate. 
Slug can be induced in the neural plate of both stage 4 and stage 8 to 10 chick 
embryos but Wnt-1 and Wnt-3a can only be induced in stage 8-10 neural plate. 
Thus early inductive interactions are capable of inducing neural crest only whereas 
later signals can generate both neural crest cells and dorsalised cells (Dickinson et 
al., 1995; Selleck and Bronner-Fraser, 1996). The inductive signalling properties of 
the neuroepithelium may be mediated by members of the bone morphogenetic 
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protein (BMP) family such as BMP-4 or BMP-7 and both are expressed in the 
neuroepithelium (Liem et al., 1995). 
1.4.2: The PNS is generated from the neural crest 
Neural crest cells migrate from the neural plate in a rostro-caudal wave and go on 
to form a wide range of neural and non-neural cells. Iontophoretic labelling of 
individual cells in dorsal neural tube also showed that these cells had multiple 
derivatives. As well as being able to generate both neural tube and neural crest 
cells, individual clones were able to generate sensory and sympathetic neurons, 
Schwann cells, melanocytes (Bronner-Fraser and Fraser, 1989; Bronner-Fraser and 
Fraser, 1988). Neural crest cells can also generate smooth muscle and bone as well 
as enteric neurons. The multipotent nature of neural crest cells appears to become 
restricted with age, thus when neuroepithelium confronts early neural plate (stages 
4 to 5) both melanocytes and sympathoadrenal cells are generated but when placed 
next to later neural plate tissue only melanocytes are generated (Seileck and 
Bronner-Fraser, 1995). These fates are also determined by the factors encountered 
along the paths of migrating neural crest cells (see overleaf). There is however 
some recent evidence that suggests that the fate of neural crest cells may be 
determined before they begin to migrate. Neuronal cells in vitro derived from early 
neural crest cells expressed Delta] that encodes a Notch receptor (Wakamatsu et 
al., 2000). Notch suppresses neurogenesis, but lateral inhibition upon contact with 
Notch antagonists such as Numb suppresses the anti-neurogenic effects of Notch. 
Early expression of ligands such as Notch in specific neural crest cells may 
determine which neural crest cells differentiate into glial and which into neuronal 
cells before they encounter environmental cues during migration. 
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Figure 1.7: Neural crest cell development: (a) The blastula undergoes 
gastrulation through involution of a group of cells from the involuting marginal 
zone at the blastopore, these cells go on to form the mesoderm, one of the primary 
germ layers, the endoderm consists of the innermost layer of cells. The blastocoel is 
formed at the point where the cells have involuted at the blastopore to from the 
mesoderm and have induced the overlying ectodermal cells to form a layer of 
neurogenic cells known as the neural plate. 
(b) Prospective neural crest cells arise from the border between the neuroepithelium 
and the neural plate. (c) The neural plate folds at the border of the neuroepithelium 
and forms a tube. The cells at the neural folds will become neural crest cells, while 
the tube formed by fusion at the neural folds will become the neural tube. The 
neuronal and glial cells whose cell bodies lie within the CNS arise from the neural 
tube, while the majority of neuronal and glial cells within the PNS will arise from 
neural crest cells. Cells in the mesoderm underlying the neural tube condense to 
form a rod-like structure known as the notochord. (d) The neural tube fuses and 
separates from the epithelium, the neural crest cells which arise from the point of 
fusion and from the dorsal neural tube begin to migrate away, following two main 
pathways. The neural tube is surrounded by a mesodermally-derived somite on 
either side, from which the sclerotome, myotome and dermatome arise. Neural crest 
cells migrate firstly through a ventral pathway (VP) in the anterior half of the 
sclerotome, these neural crest cells will form the DRG cells, sympathetic ganglion 
cells and adrenal medulla cells. A second wave of neural crest cell migration 
follows a dorsolateral pathway (DLP), above the somites and these cells will 
become melanocytes. 
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In the trunk, migrating neural crest cells follow two main pathways, the first is a 
ventral pathway through the somites which generates DRG and sympathetic 
ganglion cells and adrenal cells, the second dorsolateral pathway over the top of the 
somites follows later and generates melanocytes (Selleck and Bronner-Fraser, 
2000). Furthermore neural crest migration pathways are defined by inhibitory 
mechanisms in the trunk which restricts migration to the rostral half of the 
sclerotome. The eph family of ligands may mediate these inhibitory signals, 
Ephrin-B1 and Ephrin-B2 are expressed in the caudal half of the somite avoided by 
both neural crest cells and motor axons. Both neural crest cells and motor axons 
express receptors for these ligands, predominantly EphB2 in neural crest (Wang 
and Anderson, 1997). Sema III (Collapsin-1), a member of the semaphorin family, 
is expressed in areas surrounding neural crest migration pathways and neural crest 
cells express the neuropillin receptor for it. In vitro experiments show that neural 
crest cells avoid collapsin-1 and undergo changes similar to neuronal growth cone 
collapse in the presence of collapsin-1 (Eickholt et al., 1999). The ECM molecule 
F-spondin may also exert an inhibitory guiding influence on neural crest cell 
migration and is expressed in regions of the somite avoided by neural crest cells 
(Debby-Brafman et al., 1999). F-spondin overexpression inhibited migration of 
neural crest cells into normally permissive substrates and antibody blockade of F- 
spondin activity allowed migration of neural crest cells along normally inhibitory 
pathways. 
The fate of neural crest cells is thought to be defined by factors encountered along 
their migratory pathway (fig. 1.7). BMPs-2 and 4 appear to be the primary inducers 
of autonomic derivatives of neural crest cells and both are expressed in regions 
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where autonomic nerves are generated (Bitgood and McMahon, 1995; Lyons et al., 
1995; Shah et al., 1996). BMP-2 can induce the expression of the basic helix-loop- 
helix (bHLH) protein mammalian achaete-scute homologue (MASH-1) (Shah et al., 
1996) required for the differentiation of autonomic neurons (Sommer et al., 1995). 
BMP-2 can also induce the expression of Phox 2b, a homeobox gene that induces 
the expression of the ret receptor and thus allows transduction of the glial-derived 
neurotrophic factor (GDNF), which is necessary for the production of sympathetic 
and enteric neurons (Durbec et al., 1996; Pattyn et al., 1999). 
The signals that induce neural crest-derived sensory neurons may also involve 
another group of bHLH proteins, the neurogenins. Expression of neurogenin leads 
to the expression of neuroD, a transcription factor required for neuronal 
differentiation. Two chick neurogenin genes, c-ngn-1 and c-ngn-2, have been 
detected in a subset of early migrating neural crest cells next to the neural tube at 
around stage 16 to 17 and is followed by expression of neuroD (Perez et al., 1999). 
C-ngn-2 is expressed from stage 18 to 24 in the DRG, whereas c-ngn-1 is expressed 
in the DRG at slightly later stages from stage 27 to 31. Expression of c-ngn-1 
spreads to the periphery of the DRG where neuronal precursors and non-neuronal 
cells are located and is lost from the differentiating neurons of the DRG. Both c- 
ngn-1 and c-ngn-2 are also expressed in ventral and dorsal regions of the neural 
tube. Ectopic expression of mouse ngn-1 in chick embryos biased neural crest cells 
towards the DRG and can induce the expression of neuronal markers specific to 
sensory neurons in the dermamyotome (Perez et al., 1999). 
Some neural crest clones treated with BMP-2 and 4, which are members of the 
transforming growth factor-ß (TGF-ß) superfamily, can also become smooth 
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muscle cells. Addition of TGF-ßs1,2 and 3 increased the proportion of smooth 
muscle cells and expression of TGF-ßs in vivo is consistent with an instructive role 
for them in the generation of smooth muscle from neural crest cells (Shah et al., 
1996). Presumptive melanocytes appear to express a bHLH transcription factor, 
Mitf that may instruct their fate as melanocytes (Opdecamp et al., 1997). 
Schwann cells in the trunk are largely generated from the neural crest along with 
other glial cells such as the satellite cells. Glial growth factor (GGF; neuregulin), a 
member of the TGF-a superfamily (Marchionni et al., 1993), was known to be 
mitogenic for Schwane cells (Lemke and Brockes, 1984) but was found to have an 
effect earlier in the lineage, suppressing neurogenesis while promoting glial 
differentiation in neural crest cells (Shah et al., 1994). When colonies of neural 
crest cells were grown in recombinant GGF-2, neurogenesis was almost completely 
abolished and the majority of cells expressed a marker of immature Schwann cells, 
glial fibrillary acidic protein (GFAP). In addition the recombinant GGF-2 was able 
to inhibit the expression of MASH-1 necessary for neurogenesis. While the 
neurogenic BMP-2 and the smooth muscle cell inducer TGF-ß 1 are codominant, in 
neural crest cell cultures the ability of GGF-2 to inhibit neurogenesis, by 
downregulating MASH-1 expression, occurs only when BMP-2 expression is low 
(Shah and Anderson, 1997). In addition neural crest cells require 48 to 96 hours to 
respond to GGF-2 and commit to a glial fate and only about 24 hours to respond to 
TGF-(31 (Shah and Anderson, 1997). In vivo glial cells are generated later than 
neurons, this may be due to the slow response to GGFs of neural crest cells and to 
the fact that they are only able to inhibit neurogenesis once expression of BMP-2 
has fallen, perhaps after neurogenesis is largely complete. Thus neural crest cells 
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will respond first to the neurogenic signals of BMP-2 rather than the gliogenic 
signals of GGFs, negative feedback signals from transient Notch activation 
dominates BMP-2 signalling and prevents all neural crest cells following the 
neurogenic pathway (Morrison et al., 2000). 
1.4.3: Outgrowth of sensory and motor axons 
Ventrally migrating neural crest cells aggregate in the anterior half of the 
sclerotomes to form the DRG (Bronner-Fraser, 1993; Keynes and Stern, 1984). 
DRG neurons are bipolar, with growth cones extending in two opposite directions 
within the anterior half of the sclerotome. There are several possible candidate 
repulsion molecules expressed in the posterior half of the sclerotome, which may 
determine the pathway of sensory axon outgrowth within the anterior half of the 
sclerotome. These molecules include those that are thought to restrict motor axon 
outgrowth and neural crest migration to the anterior sclerotome, such as the eph 
transmembrane ligands, Ephrin-B 1 and Ephrin-B2 (Wang and Anderson, 1997) and 
collapsin-1, which can cause DRG growth cone collapse (Luo et al., 1993) as well 
as PNA (peanut agglutinin) (Davies et al., 1990). However explants of posterior 
half-sclerotomes do not exert significant long-distance repulsion of DRG axons 
growing from stage 28 DRGs or from stage 17 to 19 anterior half-sclerotomes 
containing DRGs (Keynes et al., 1997). The linear guidance cues that dictate the 
bipolar direction of growth cone extension may be sufficient to restrict sensory 
axon outgrowth to the anterior half of the sclerotomes. 
One growth cone extends dorsomedially from the DRGs towards the dorsal root 
entry zone and CNS, while the other extends in a ventrolateral direction between 
the dermamyotome and notochord. Growth cones extending along the ventrolateral 
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pathway unite with motor axons to form the mixed spinal nerves of the PNS. It 
seems likely that the prominent mode of sensory axon guidance is through surround 
repulsion by molecules in surrounding structures both medially and laterally, such 
that the sensory axons follow the path of least resistance. Axonal outgrowth from 
DRG explants is repelled rather than inhibited in the presence of explants of tissue 
lateral to the DRGs, such as dermamyotome and surface ectoderm. This is also true 
when DRG explants are cocultured with explants of tissue medial to the DRGs, 
notochord exerts strong repulsion on sensory axons and the floor plate of the neural 
tube is also weakly repulsive (Keynes et al., 1997). To determine whether sensory 
axons extending dorsomedially towards the dorsal root entry zone, were guided by 
chemoattractants, DRG explants were cocultured with explants of the alar plate, the 
dorsal half of the neural tube. It was found that the alar plate did not act as a 
chemoattractant for sensory axons, but DRG explants sandwiched between explants 
of dermamyotome and notochord were able to direct bipolar extension of axons 
from the DRG (Keynes et al., 1997). Thus surround repulsion from the notochord 
and dermamyotome may be sufficient to direct sensory axon outgrowth in both 
directions in vivo. The molecules involved in this surround repulsion are not yet 
defined but it is known that neither chondroitin sulphate proteoglycans (CSPG) nor 
Sonic hedgehog (Shh) are involved. 
The same environmental cues as migrating neural crest cells encounter are found 
along the path of the growing motor neuron and help to guide its growth towards its 
target tissues, skeletal muscles. The Eph transmembrane ligands Ephrin-B 1 and 
Ephrin-B2 are expressed in the posterior sclerotome while motor axons express the 
EphB2 receptor that recognises these ligands (Henkemeyer et al., 1994; Wang and 
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Anderson, 1997). This interaction may contribute to the avoidance of the posterior 
sclerotome by motor axons during the first part of their outgrowth towards the 
limbs. Semaphorins are chemorepellents that have been detected in the ventral 
region of the developing spinal cord and may mediate guidance of both motor and 
sensory axons by repelling them towards the periphery. Sema III was initially 
shown to cause growth cone collapse of sensory axons in the NGF-responsive sub- 
population (Kolodkin et al., 1993; Messersmith et al., 1995). The neuropilin-1 and 
neuropilin-2 receptors mediate the chemorepellent activity of class 3 semaphorins, 
these two receptors mediate guidance and fasciculation of distinct but overlapping 
populations of CNS and PNS projections, such as cranial and spinal nerves (Giger 
et al., 2000). 
1.5: Schwann cells 
1.5.1: Schwann cell precursors generated from migrating neural crest cells are 
dependent on axonal signalling 
Migrating neural crest cells as discussed above are induced to become glial cells 
through the suppression of neurogenic signalling by BMP-2 and the induction of 
gliogenesis by GGFs (Morrison et al., 2000; Shah and Anderson, 1997; Shah et al., 
1994). These Schwann cell precursors can be detected in mice at E12 to 13 and in 
rats at E14 to 15. They have distinct properties which distinguish them from 
immature Schwann cells that are generated at E15 in mouse and E17 in rat and 
from mature non-myelin-forming and myelin-forming Schwarm cells (Doug et al., 
1999; Jessen et al., 1994). At this stage of development Schwann cell precursors are 
dependent on axonal contact for their survival, but Schwann cell signalling to the 
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axons at this precursor stage and at later stages is also vital for the formation of the 
PNS. In the PNS of E14 rats, Schwann cell precursors were spread across the 
surface of axons, separating them from surrounding tissue, but not associated with 
basal lamina. The precursors were also found between the axons, spreading thin 
cytoplasmic sheets that contacted each other and separated the axons (Jessen et al., 
1994). 
The first property that differentiated these Schwann cell precursors from more 
mature Schwane cells, was their inability to survive in vitro in the absence of 
axonal contact. Thus precursor cells from E14 rats were unable to survive when 
plated at moderate to high density in neuron-free cultures. When neuron- 
conditioned medium was added to Schwane cell precursors in neuron-free cultures 
they were able to survive, this confirmed that Schwane cell precursor survival was 
dependent on axonal signalling (Jessen et al., 1994). The number of Schwane cell 
precursors that died by apoptotic cell death in the absence of neurons, or neuron- 
conditioned medium, decreased with age such that by E16 some rat Schwane cell 
precursors were able to survive under these conditions and by E17 all the plated 
cells survived. Mouse Schwane cell precursors had similar properties, at E13 90% 
of Schwane cell precursors died in vitro when cultured in the absence of neurons, 
but by E15,90% of the mouse cells were able to survive under the same conditions 
(Dong et al., 1999). Thus by E17 in rats and E15 in mice, the precursors have 
differentiated into immature Schwane cells that are no longer reliant on axonal 
signals for survival and have their own autocrine survival loops, mediated by a 
variety of growth factors (Meier et al., 1999). 
A combination of a variety of FGFs and insulin-like growth factors-1 or 2 (IGF) 
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can rescue rat Schwann cell precursors in the short term from the apoptotic cell 
death that they undergo when axonal contact is lost, but without being mitogenic 
(Gavrilovic et al., 1995). In adult Schwann cells bFGF and IGF-1 are both 
mitogenic (Schumacher et al., 1993; Stewart et al., 1991). In cultures of E12 mouse 
Schwann cell precursors without neurons, FGF-2 was found to be mitogenic. 
However the total number of Schwann cells remained constant, indicating that 
while some Schwann cell precursors were proliferating, others were unable to 
survive in the long term in the absence of axonal contact (Dong et al., 1999). 
Schwann cell precursors were found to differ from Schwann cells in several distinct 
ways during the period that they were dependent on axons for survival. Schwann 
cell precursors in both rats and mice tended to cluster and presented a flattened 
multipolar morphology, whereas E18 and new-born rat Schwann cells were very 
similar to each other and adopted a gradually more elongated bi- or tripolar 
morphology (Dong et al., 1999; Jessen et al., 1994). Like neural crest cells, 
Schwane cell precursors are highly motile, significantly more so than Schwarm 
cells (Jessen et al., 1994). During the time that Schwann cell precursors are 
dependent on axonal survival they do not express the cytoplasmic Cat+-binding 
protein, S100, commonly used as a marker for Schwane cells. Schwane cell 
precursors in both mice and rats also failed to express the 04 lipid antigen, which is 
expressed in all immature, myelin forming and non-myelin forming Schwane cells 
(Dong et al., 1999; Jessen et al., 1994; Jessen and Mirsky, 1991). 
Despite the lack of S 100 immunoreactivity in Schwane cell precursors the 
expression of other molecules, such as growth-associated protein 43 (GAP-43), 
indicated that these cells were a distinct population and not neural crest cells 
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(Jessen et al., 1994). Almost all Schwann cell precursors in culture express other 
proteins besides GAP-43 that have been associated with more mature Schwann 
cells, particularly immature Schwann cells and mature non-myelin forming 
Schwane cells. Laminin-1 immunoreactivity has been observed in Schwann cells at 
all stages of development and in both myelin forming and non-myelin forming 
Schwann cells. Other proteins such as cell adhesion molecules neural cell adhesion 
molecule (N-CAM) and L1 and the low affinity neurotrophin receptor (p75) are 
expressed on Schwann cell precursors, immature Schwane cells and non-myelin 
forming Schwane cells, but not myelin forming Schwane cells (Dong et al., 1999; 
Jessen et al., 1994). GFAP is expressed a little later and can be detected in 
immature and non-myelin forming Schwane cells (Jessen and Mirsky, 1991; Jessen 
et al., 1990). 
1.5.2: Neuregulins regulate the survival of Schwann cell precursors 
Although growth factors such as the FGFs and IGFs are able to promote survival of 
Schwann cell precursors in the short term and their conversion to Schwann cells 
(Dong et al., 1999; Jessen et al., 1994), these are not the neuronally-derived signals 
that directly regulate the survival of Schwann cell precursors. The strongest 
candidates for this appear to be the neuregulins. Neu differentiation factor (NDF) is 
one of the products of the neuregulin gene; the mRNA encodes a group of 
alternatively spliced EGF-related peptides, such as acetylcholine receptor inducing 
activity (ARIA) and heregulin, as well as GGFs and NDFs (Falls et al., 1993; 
Lemke, 1996; Marchionni et al., 1993). NDF mRNA is highly expressed in both 
sensory and motor neurons but not in glia (Marchionni et al., 1993; Meyer and 
Birchmeier, 1994; Orr-Urtreger et al., 1993). Neuregulin signalling is mediated by a 
83 
family of receptor protein tyrosine kinases, ErbB2, ErbB3 and ErbB4, all of which 
have been detected in Schwane cells (Levi et al., 1995). 
The addition of NDF-ß to Schwane cell precursors in culture produces much the 
same effects as addition of neuron-conditioned medium. The EGF-like domains of 
NDF-ß are sufficient to promote the long-term survival of E14 rat Schwann cell 
precursors. Blocking the activity of NDFs in neuron-conditioned medium with a 
soluble protein that contained the NDF-ß binding site of the ErbB4 receptor 
resulted in the abolition of the survival activity of neuron-conditioned medium 
(Dong et al., 1995; Jessen et al., 1994). Deoxyribonucleic acid (DNA) synthesis in 
Schwann cell precursors exposed to NDF-ß indicated that it can act as a mitogen 
and is able to promote proliferation too (Dong et al., 1995). Moreover Schwane cell 
precursors in defined medium exposed to NDF-P undergo the transition from 
precursor to immature Schwann cell at the same rate as in vivo. 
Schwann cell precursors fail to develop in neuregulin"' mice in adequate numbers 
and there is a subsequent lack of mature Schwann cells (Meyer and Birchmeier, 
1995). Targeted mutations in the genes encoding the neuregulin receptors have 
produced ErbB3'/' null mutants in which both Schwann cell precursors and 
Schwann cells are absent. This receptor may therefore be involved in both the 
neuregulin-mediated conversion of neural crest cells to Schwann cell precursors 
and of precursors to Schwann cells (Riethmacher et al., 1997). In ErbB2 mutants, 
Schwane cell precursors are present in the DRGs but fail to differentiate and 
migrate out of the DRGs (Morris et al., 1999). 
Neuregulins continue to be expressed by axons and the ErbB2 and ErbB3 receptors 
are also expressed in mature Schwann cells. Neuregulins may regulate early 
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postnatal survival of Schwann cells, when numbers are controlled so as to ensure 
that the one-to-one relationship between axons and myelin forming Schwann cells 
is attained. Apoptosis of Schwann cells during normal development and following 
axotomy in vivo and of early postnatal Schwann cells in serum-free medium can be 
inhibited with the addition of exogenous neuregulin/NDF-ß, mediated by an 
ErbB2/ErbB3 receptor heterodimer (Grinspan et al., 1996; Syroid et al., 1996). 
Terminal Schwane cells rely on neuregulins for survival following neonatal 
denervation (Trachtenberg and Thompson, 1996). Thus Schwane cell numbers in 
early postnatal nerves are regulated by apoptotic cell death caused by competition 
between ErbB2/ErbB3-expressing Schwane cells for neuronally-derived 
neuregulins (Grinspan et al., 1996; Nakao et al., 1997; Syroid et al., 1996; 
Trachtenberg and Thompson, 1996). 
1.5.3: Autocrine survival loops in developing Schwann cells 
Upon conversion from Schwane cell precursors to immature Schwane cells at E15 
in mice and E17 in rats, growth factors ensure that the Schwane cells are able to 
block apoptosis without being entirely dependent on the neuronally-derived signals. 
Both rat E18 and new-born Schwann cells, but not E14 precursors, survived in 
purified cultures in a density-dependent manner. Schwarm cell death can be rescued 
in low-density cultures by the addition of conditioned medium from dense cultures 
of Schwann cells, indicating that Schwann cells were secreting factors that ensured 
their own survival. Several growth factors were tested to determine which 
mimicked the properties of Schwane cell conditioned medium. Of those tested, 
only IGFs, neurotrophin-3 (NT-3) and PDGF-BB were capable of enhancing 
Schwane cell survival in low-density cultures. In combination, they mimicked the 
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properties of Schwann cell conditioned medium through activation of the MAP 
kinase pathway. Moreover blocking antibodies to these growth factors inhibited the 
ability of Schwane cell-conditioned medium to rescue low-density cultures (Meier 
et al., 1999). It seems likely that these growth factors are involved in mediating 
autocrine survival loops both in vitro and in vivo as Schwane cells express both the 
ligands and their receptors (Eccleston et al., 1990; Meier et al., 1999). 
Other growth factors may also be involved in regulating aspects of Schwann cell 
behaviour throughout development. Schwann cell precursors, immature Schwann 
cells and mature non-myelin forming Schwane cells all express the low affinity 
neurotrophin receptor, p75 (Jessen et al., 1994; Jessen and Mirsky, 1991). 
Expression of NGF (nerve growth factor) is also elevated in Schwane cells during 
development; the expression of both the p75 receptor and NGF indicates that 
Schwane cell activity may be regulated by NGF signalling. Schwane cell migration 
along growing axons is a vital part of the development of the PNS and NGF may be 
involved in this process. Addition of NGF enhances Schwane cell migration from 
DRG explants on denervated sciatic nerve substrates that, like Schwane cell 
precursors and immature Schwann cells, are rich in the p75 receptor. Antibodies to 
both NGF and the p75 receptor partially inhibit Schwane cell migration from these 
explants (Anton et al., 1994b). Thus NGF may be one of several factors that 
mediates Schwane cell migration during development. 
1.5.4: Transcription factors in developing Schwann cells 
As Schwane cells mature and begin to interact with axons, they express a variety of 
transcription factors that are thought to regulate the prospective Schwane cell 
phenotypes. The final stages of Schwane cell development occur during late 
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embryogenesis and in the first few postnatal weeks. Immature Schwann cells 
develop either into non-myelin-forming Schwann cells, similar in molecular 
phenotype to immature Schwann cells (Jessen and Mirsky, 1991) or they begin to 
express myelin proteins and differentiate into myelin forming Schwann cells (fig. 
1.8). As such they express different sets of transcription factors that are thought to 
regulate their differentiation. 
The transcription factors expressed in immature and non-myelin-forming Schwarm 
cells are also expressed in myelin forming denervated Schwarm cells as they 
dedifferentiate to the immature Schwane cell phenotype (Mirsky and Jessen, 1996) 
and are thought to suppress the expression of myelin genes. An inverse relationship 
was observed between expression of the Pax3 gene (expressed from the precursor 
stage onwards and in mature myelin-forming Schwane cells) and expression of the 
myelin protein myelin basic protein (MBP) in developing and regenerating sciatic 
nerves and in vitro (Kioussi et al., 1995). Schwane cells exposed to Pax3 in vitro 
expressed molecular markers for immature and non-myelin forming Schwane cells 
and repressed endogenous expression of MBP. 
Krox-24/egrl is a zinc finger transcription factor expressed in immature and non- 
myelin forming Schwane cells. An increase in the expression of Krox-24/egrl in 
cultured Schwann cells leads to a corresponding increase in the level of the p75 
receptor that is expressed on immature and non-myelin forming Schwane cells 
(Nikam et al., 1995). In fact, Krox-24/egrl binds to the p75 promoter and a direct 
interaction is necessary between the gene encoding the p7S and the Krox-24/egrl 
gene in order for the receptor to be expressed in Schwann cells. 
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Figure 1.8: Schwann cell differentiation and myelination: (a) The Schwann cell 
(SC) precursor is generated from neural crest cells at E12 tol3 in mice and E14 to 
15 in rats. The precursor is multipolar and extends processes between the axons, but 
does not ensheath them. (b) Immature Schwann cells are generated from Schwann 
cell precursors at E15 in mice and E17 in rats. They adopt a bi- or tripolar 
morphology and are able to survive without neuronal contact. (c) Immature 
Schwarm cells form a basal lamina and ensheath individual axons of more than 1 
µm in diameter shortly before birth. Differentiation towards the premyelinating 
phenotype is initiated before differentiation towards the non-myelin forming 
phenotype. (d) Immature Schwann cells differentiate towards the non-myelin 
forming phenotype in the early postnatal period. These Schwann cells have several 
small diameter axons embedded in grooves. The Schwann cell plasma membrane 
becomes apposed at the mesaxon and axons are enveloped by Schwann cell 
cytoplasm, the Schwann cell is then surrounded by the endoneurial basal lamina. (e) 
During myelination the mesaxon of the Schwann cell rotates around the axon, 
enveloping it in concentric circles of Schwann cell cytoplasm. Differentiation 
towards the myelin and non-myelin forming phenotypes is reversible upon loss of 
axonal contact. (1) A myelinated axon in transverse section. The inner leaflets of the 
apposing Schwann cell plasma membranes fuse to form the major dense lines and 
Schwann cell cytoplasm is extruded. Concentric layers of plasma membrane 
surrounding the axon constitute the myelin sheath. The axon, myelin sheath and 
Schwann cell cytoplasm are surrounded by endoneurial basal lamina. (g) 
Myelinated axon in longitudinal section. Each segment of axon surrounded by a 
Schwann cell is termed an internode. The unmyelinated segments between 
internodes aid saltatory conduction and are known as the nodes of Ranvier. 
Schwann cell cytoplasm is not completely excluded from the myelin sheaths and 
can be found at the paranodal loops and the Schmidt-Lanterman clefts. 
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Suppressed, cAMP-inducible POU-domain protein (SCIP; also known as Oct-6 or 
Tst-1) is a POU domain transcription factor expressed in developing Schwann cells 
as well as in CNS glia. The expression pattern of SCIP and the phenotype of SCIP 
null mutant mice, in which Schwann cells show a transient delay in differentiation 
at the premyelinating stage, suggested a role in premyelinating Schwann cells. 
SCIP is therefore involved, but not essential, in the transition of Schwarm cells 
from the premyelinating to the myelinating phenotype (Arroyo et al., 1998; Jaegle 
et al., 1996). SLIP mRNA and protein can be detected from about E14 in rat in 
Schwann cell precursors and expression increases as the Schwarm cells mature, 
peaking at PI but still detectable at P12 in myelin forming Schwane cells 
(Blanchard et al., 1996; Jaegle et al., 1996; Monuki et al., 1990; Monuki et al., 
1989). The expression of this transcription factor is regulated by axonal contact, 
thus axotomy leads to a sharp fall in SCIP mRNA levels followed by upregulation 
during regeneration (Scherer et al., 1994a). However SCIP is barely detectable in 
mature myelin forming Schwane cells once myelination is complete although non- 
myelin forming Schwane cells continue to express SCIP in adulthood (Blanchard et 
al., 1996; Zorick and Lemke, 1996). SCIP also represses the transcription of the Po 
myelin gene promoter by binding to it through its POU domain and an N-terminus 
domain (Monuki et al., 1993). Thus SCIP may regulate terminal differentiation of 
Schwann cells into a myelin-forming phenotype by repressing the activity of 
myelin genes. 
Krox-20/Egr2 encodes a zinc finger transcription factor, which has several roles in 
the developing nervous system. The phenotype of krox-20"' mice, in which 
Schwane cells form a one-to-one association and begin to ensheath axons that 
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would normally be myelinated but do not actually myelinate, suggests that krox-20 
is either directly or indirectly involved in the final stages of differentiation of 
myelin forming Schwann cells. Krox-20"4 mice express only the early myelin 
marker, myelin associated glycoprotein (MAG), and do not express later myelin 
proteins such as P0 and MBP (Topilko et al., 1994). Krox-20 was detected in 
Schwane cells 24 to 36 hours after SCIP expression, as Schwane cells underwent 
the transition from precursor to immature Schwarm cell, but expression of the krox- 
20 gene was restricted to myelin forming Schwann cells only, where it continued to 
be expressed postnatally (Zorick et al., 1996). Krox-20 expression is induced by 
axonal contact, thus in co-cultures only those Schwane cells that were in direct 
contact with neurons showed induction of krox-20 expression (Murphy et al., 
1996). The exclusive expression of krox-20 on myelin forming Schwann cells 
suggests that it may activate myelin gene expression in these Schwann cells. 
Myelin gene promoters do not contain any binding sites for krox-20, which 
suggests that intermediate genes may be involved (Topilko et al., 1994). One such 
gene may be SCIP; in krox-2e mice expression of the SCIP transcription factor is 
sustained rather than transient (Zorick et al., 1999). 
1.5.5: Neuronal development and Schwann cell signalling 
Recent work has shown that there is a mutual aspect of the dependence of neurons 
and Schwann cells for their survival and differentiation. Targeted deletions of the 
ErbB3 neuregulin receptor have revealed the extent to which neuronal development 
is dependent on the trophic support of Schwane cells. ErbB3ý mice lack Schwane 
cell precursors and Schwane cells, and although DRG neuronal development is 
normal at E12.5, by E14.5 there was a 70% reduction and by E18.5 an 82% 
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reduction in the number of neurons. The vast majority of apoptotic cells were 
identified as post-mitotic sensory neurons (Riethmacher et al., 1997). Similarly the 
number of motor neurons in the ventral horn was normal in E12.5 ErbB3ý mice, 
but by E18.5 79% had died. The neuronal degeneration observed was far more 
severe than in any mutants lacking neurotrophins or neurotrophin receptors. Loss of 
trophic support from developing Schwann cells was responsible for the widespread 
loss of neurons. 
Targeted deletion of another neuregulin receptor, ErbB2, suggests that Schwann 
cells not only provide trophic support to developing neurons but also regulate axon 
guidance (Morris et al., 1999; Woldeyesus et al., 1999). By rescuing the cardiac 
defect of ErbB2-"- mice, they can survive till birth, allowing axon pathways to form. 
The ErbB2-" mutants, with the cardiac defect rescued, do have Schwann cell 
precursors, but these do not migrate properly and do not mature such that Schwann 
cells are completely absent in their peripheral nerves. There is a severe reduction of 
both motor and sensory neurons in ErbB2" mice, with 70% fewer motor neurons in 
the spinal cord of mutants by E18.5 (Morris et al., 1999; Woldeyesus et al., 1999). 
Surviving axons were severely defasciculated and their projections to their target 
tissues was aberrant and disorganised. Although acetylcholine receptors were 
present, their morphology and dispersal was abnormal. Addition of exogenous 
Schwann cells to an in vitro neunte outgrowth assay enhanced neurite outgrowth in 
mutant DRG neurons in contact with the exogenous Schwann cells (Morris et al., 
1999). This was consistent with a loss of Schwann cell trophic support as the cause 
of the neuronal degeneration and defasciculation in ErbB2ý mice. 
Growth factors expressed by Schwann cells may regulate neuronal survival and 
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guidance and include brain derived neurotrophic factor (BDNF), leukaemia 
inhibitory factor (LIF), NT3, ciliary neurotrophic factor (CNTF) and GDNF 
(Davies, 1998). CNTF can prevent the degeneration of motor neurons in mice with 
motor neuronopathy and cne mice lose approximately 20% of their motor 
neurons. However this growth factor is expressed only in mature Schwann cells in 
intact Schwann cell-axon units, suggesting that CNTF may have a limited 
developmental role (Friedman et al., 1992; Masu et al., 1993; Sendtner et al., 1992). 
GDNF is widely expressed during development and has been detected in Schwann 
cell precursors (Wright and Snider, 1996). Moreover it is a potent survival factor 
for motor neurons, preventing the degeneration of motor neurons that have been 
deprived of target-derived trophic support due to axotomy (Henderson et al., 1994). 
Loss of GDNF expression results in a 20 to 30% reduction in the number of 
motorneurons, as well as loss of some sensory and enteric neurons (Moore et al., 
1996; Sanchez et al., 1996). Motor neurons express receptors for both GDNF and 
for cardiotrophin-1 (CT-1; a growth factor expressed in myotubes) and are 
receptive to synergistic trophic and tropic support from both Schwann cell derived 
and target-derived growth factors. 
Sensory neurons may rely on other growth factors for survival. NT-3 is secreted by 
developing Schwann cells and is part of the autocrine survival loop of immature 
Schwann cells (Meier et al., 1999). Antibody neutralisation of NT-3 activity during 
gangliogenesis results in a 30% reduction in the number of sensory neurons, 
consistent with a role for Schwann cell-derived NT-3 contributing to the survival of 
sensory neurons (Gaese et al., 1994). Thus it appears that growth factors support 
the survival of different subpopulations of sensory and motor neurons. However 
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neither sensory nor motor neurons are solely dependent on any single growth 
factor, most neurons are probably dependent on the synergistic activity of several 
Schwane cell-derived growth factors and on growth factors derived from target 
tissues such as skeletal muscle. 
Laminins are known to have neurite-promoting properties (Anton et al., 1994a; Cho 
et al., 1998; Cohen and Johnson, 1991; Engvall et al., 1992) and Schwann cells are 
a rich source of laminin-2 in particular (Hsiao et al., 1993). This is consistent with a 
role for Schwane cell-derived laminins as contributory factors in axon growth and 
guidance during development. Immature and non-myelin forming Schwann cells 
express the cell adhesion molecule L1 (Jessen and Mirsky, 1991). Antibody 
blockade of L1 in co-cultures of retinal explants on Schwann cell monolayers 
results in a 95% inhibition of neunte outgrowth from the explants (Kleitman et al., 
1988). Its role in axonal guidance may be linked to its ability to influence growth 
cone behaviour and actin distribution (Burden-Gulley et al., 1997). Growth cone 
filopodial contact with Schwane cells is sufficient to induce veil extension in 
sensory neurons in vitro. This Schwane cell-mediated veil extension can be 
inhibited with antibodies to neural cadherin (N-cadherin) a cell adhesion molecule 
expressed on Schwann cells (Letourneau et al., 1991; Letourneau et al., 1990; 
Polinsky et al., 2000). Stabilisation of this veil extension by continued Schwane 
cell-filopodial contact results in the advancement of the growth cone (Polinsky et 
al., 2000). Thus Schwane cell-mediated signalling through cell adhesion molecules 
may aid growth cone advancement in developing neurons. 
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1.5.6: Schwann cells and basal lamina formation 
Periphernal nerves contain three layers of basal lamina, which serve to strengthen 
the nerve fibre and contain ECM molecules that are capable of regulating the 
behaviour of cells such as neurons and Schwann cells in the nerve fibre. The first 
layer, the endoneurium, surrounds axon-Schwann cell units (fig. 1.4,1.9). The 
second perineurial layer surrounds axon bundles and the third outer layer directly 
outside of the perineurium is the epineurium. Although Schwarm cells are capable 
of synthesising some basal lamina components such as laminin (Hsiao et al., 1993), 
elaboration of basal lamina requires the presence of other components of the nerve 
fibre. E15 Schwane cells were co-cultured with E15 DRG neurons to determine the 
influence of neuronal contact on basal lamina assembly. Schwann cells grown in 
the absence of neurons or not in direct contact with them in co-cultures, deposited 
only short segments of basal lamina that were neither continuous nor adherent 
(Clark and Bunge, 1989). 
Although the basal lamina formed in Schwann cell-neuron co-cultures already 
contains laminins, type IV collagen and heparan sulphate proteoglycan (HSPG), the 
addition of fibroblasts increases the deposition of basal lamina (Obremski et al., 
1993a; Obremski et al., 1993b). Fibroblasts are mesenchymal cells found in the 
epineurium, perineurium and in endoneurium and enhance basal lamina deposition 
by augmenting the deposition of basal lamina components such as laminins-1 and 2 
and type IV collagen. Schwane cells produce some of the components necessary for 
endoneurial basal lamina formation but Schwann cell-derived signalling to 
mesenchymal tissue is also involved in controlling basal lamina deposition in the 
PNS. Desert hedgehog (Dhh) is expressed in mouse Schwann cell precursors from 
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E11.5 and in Schwann cells up to P10 and its Patched receptor in mesenchymal 
tissue surrounding the nerve from E15.5, at the time that the perineurium begins to 
form (Bitgood and McMahon, 1995; Mirsky et al., 1999). Dhh4 mice had extensive 
abnormalities in perineurial basal lamina formation in particular but also in the 
epineurial and endoneurial basal lamina (Parmantier et al., 1999). The epineuria and 
perineuria of Dhh""- mice were less compacted; contained fewer layers and the basal 
lamina was patchy and disorganised. The basal lamina in return regulates Schwann 
cell ensheathment and myelination. Basal lamina formation in vitro leads to 
Schwane cell differentiation, elongation and finally ensheathment of axons (Carey 
et al., 1986; Obremski and Bunge, 1995; Obremski et al., 1993b). The extent of 
Schwann cell ensheathment is correlated to the condition of the basal lamina, the 
addition of fibroblasts to Schwane cell-neuron co-cultures resulted in a continuous 
basal lamina and consequently more complete ensheathment of neuntes (Obremski 
et al., 1993a). The presence of basal lamina induced differentiation of Schwann 
cells in co-culture with neurons into functional Schwann cell phenotypes that 
ensheathed the neuntes and was a prerequisite for myelination in long-term cultures 





Figure 1.9: Electron micrograph of a peripheral nerve. The nerve fibre 
contains both non-myelinated axons (NMA) and myelinated axons (A). The 
compacted myelin sheath (M) produced by each Schwann cell in a myelinated 
axon terminates in paranodal loops (L) that contain Schwann cell cytoplasm. 
These paranodal loops border the nodes of Ranvier (R). The Schwann cell 
cytoplasm (S) surrounds the myelin sheath and extends over the paranodal 
loops and nodes of Ranvier. Schwann cell cytoplasm can also be seen between 
non-myelinated axons. Schwann cells are surrounded by an endoneurial basal 
lamina (EL) and collagen (C) fibrils are found in the surrounding 
endoneurium. Scale bar =2 pm. Magnification x 14000. 
Taken from Wheater's Functional Histology by B. Young and J. W. Ileath. 
Fourth edition (2000): p125. 
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1.5.7: Schwann cell ensheathment; myelin -forming, non-myelin forming and 
terminal Schwann cells 
As Schwann cells mature their relationship with axons changes (fig. 1.8). Schwann 
cell precursors extend multiple flattened processes between bundles of axons but do 
not actually ensheath them. As they differentiate into immature Schwarm cells they 
loose their multipolar morphology and groups of bi- or tripolar Schwann cells 
ensheath axon bundles. Just before birth, Schwarm cells begin to differentiate 
towards their final mature phenotype (Jessen and Mirsky, 1999; Mirsky and Jessen, 
1996; Scherer, 1997). Small diameter axons are ensheathed by non-myelin forming 
Schwane cells. The small diameter axon will become embedded in one of several 
channels in the non-myelin forming Schwane cell. The plasma membranes at the 
opening of each channel become apposed and the axon is surrounded by Schwann 
cell cytoplasm, providing it with physical protection. 
Myelin forming Schwane cells ensheath larger diameter axons of 0.7µm or more 
(Webster, 1971; Windebank et al., 1985). Immature Schwann cells differentiate 
into myelin gene-expressing premyelinating Schwann cells that form a one to one 
relationship with axons. Terminally differentiated myelin forming Schwann cells 
ensheath the axon; the mesaxon of the Schwane cell rotates around the axon and 
completely envelopes it in concentric layers of Schwane cell cytoplasm beginning 
the process of myelination (fig. 1.8). Phosphatidylinisitol (PI) 3-kinase may also be 
involved in signalling pathways between axons and myelin forming Schwane cells 
during myelination. Inhibition of PI 3-kinase blocks the initial interaction between 
axons and Schwane cells and consequently prevents terminal differentiation, 
elongation and myelination by myelin forming Schwann cells (Maurel and Salzer, 
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2000). Myelin sheaths were shorter and the rate of accumulation of myelin proteins 
was decreased in Schwann cell-neuron cocultures where PI 3-kinase activity was 
blocked, although maintenance of mature myelin sheaths was not affected. This 
recent work highlights the importance of axonal contact for the final stages of 
Schwann cell differentiation preceding myelination. 
Terminal Schwane cells differ phenotypically from both myelin forming and non- 
myelin forming Schwane cells. They are located exclusively at the NMJ where they 
cover the terminal arborisations of the motor nerves, but do not extend into the 
synaptic cleft. They do not myelinate, but unlike non-myelin forming Schwann 
cells elsewhere they do not normally express GAP-43 (Woolf et al., 1992). 
Upregulation of GAP-43 expression after nerve transection occurs within a day and 
is far more rapid in terminal Schwann cells than in myelin-forming Schwann cells 
that can take several weeks to upregulate GAP-43 (Curtis et al., 1992). The rapid 
upregulation of GAP-43 may be linked to the rapid extension of processes by 
terminal Schwane cells following denervation of motor endplates. These processes 
extend to neighbouring innervated endplates, providing a guide for axons to sprout 
from the innervated to the denervated endplates to form new nerve terminals (Son 
and Thompson, 1995a; Son and Thompson, 1995b). 
1.5.8: Myelination 
As myelin-forming Schwane cells envelope the axons, the Schwane cell cytoplasm 
becomes extruded and the inner leaflets of the plasma membranes become fused to 
form the major dense lines. The close apposition of the outer leaflets of the 
Schwane cell plasma membranes forms the intraperiod lines. Some cytoplasm can 
be detected at the Schmidt-Lanterman clefts providing a cytoplasmic channel 
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between the narrow band of Schwann cell cytoplasm adjacent to the axon and the 
bulk of the cytoplasm surrounding the outside of the myelin sheath. Schwann cell 
cytoplasm is also present in the paranodal loops that border the nodes of Ranvier, 
but in general the extrusion of the cytoplasm leaves a lipid-rich myelin sheath 
surrounding the axons. The segment of nerve ensheathed and myelinated by each 
myelin forming Schwann cell is known as an intemode. A small gap remains 
between each internode, a specialised structure known as the node of Ranvier (fig. 
1.9). 
The myelin sheath is composed of a mixture of lipids such as cholestorols, 
galactolipids and phospholipids, glycoproteins, basic proteins and other proteins. 
Po, a 28 kDa integral membrane glycoprotein, makes up about 50 to 70% of the 
protein composition of myelin and is expressed exclusively in the PNS (Greenfield 
et al., 1973; Kitamura et at., 1976; Roomi et al., 1978; Smith and Curtis, 1979; 
Wiggins et at., 1975). Po is a member of the immunoglobulin (1g) superfamily and 
the extracellular N-terminus shows structural similarities to some cell adhesion 
molecules (Lemke et at., 1988). The N-terminus may contribute to the formation of 
the myelin intraperiod line by hydrophobic and electrostatic interactions. The C- 
terminus cytoplasmic domain is basic and may promote the formation of the major 
dense line through interactions with acidic lipids in the plasma membrane (Garbay 
et at., 2000). Thus Po is involved in the compaction of the myelin sheath 
Particularly through homophilic interactions in its extracellular domain (Filbin et 
at., 1990). 
Recent evidence shows that Po mRNA is detectable in rats in a population of 
migrating neural crest cells at Eli, with preferential localisation to those neural 
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crest cells neighbouring motor axons growing from the neural tube, which are 
likely to be prospective Schwarm cells (Lee et al., 1997). Po mRNA was also 
detectable in Schwane cell precursors at E14 and just prior to myelination in both 
prospective myelin forming and non-myelin forming Schwann cells. Expression of 
Po is elevated postnatally in actively myelinating Schwann cells, before decreasing 
to basal levels after myelination is complete. The basal levels of Po protein and 
mRNA in non-myelin forming Schwann cells neonatally is down-regulated and is 
undetectable in mature non-myelin forming Schwann cells (Lee et al., 1997). 
Transection of unmyelinated nerve fibres and loss of axonal contact restores basal 
Po expression in non-myelin forming Schwann cells, consistent with a Po-inhibitory 
signal in mature unmyelinated nerve fibres. 
Peripheral nerve myelin 22 kl)a (PMP22) is a small myelin glycoprotein of 22 kDa 
that includes complex glycosylation sites and constitutes 2 to 5% of myelin 
(Kitamura et al., 1976; Pareek et al., 1993). The PMP22 protein contains four 
transmembrane domains (Manfioletti et al., 1990; Suter et al., 1992a) that resemble 
domains in proteolipid protein (PLP) IDM20, and in the connexin subunits of gap 
junctions (Lemke, 1993). PMP22 may serve a similar function in PNS myelin as Po, 
as it contains carbohydrate residues that mediate adhesion (Pareek et al., 1993; 
Snipes et al., 1992). PMP22 is not restricted to the PNS and has been detected at 
low levels in the lung, brain and gut (Hagedorn et al., 1999; Parmantier et al., 
1995). Mutations in the PMP22 gene result in a variety of peripheral neuropathies 
such as those seen in Trembler and Trembler-J mice caused by mutations in one of 
the transmembrane domains (Suter et al., 1992a; Suter et al., 1992b). These mice 
suffer from hypomyelination and persistent Schwane cell proliferation. Similar 
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point mutations in the PMP22 gene have also been linked to CMT 1A (Charcot- 
Marie-Tooth) disease in humans in which there is a severe deficiency of myelin 
(Naef and Suter, 1998; Valentijn et al., 1992). Mutations in the PMP22 gene result 
in arrest of Schwann cell differentiation at the premyelinating stage (Sereda et al., 
1996). Thus PMP22 may play a role in the development of Schwarm cells and their 
transition to myelin forming Schwann cells as well as maintaining a compact 
myelin sheath. 
MAG is a glycosylated myelin protein that is expressed in both the PNS and CNS. 
There are two isoforms of the MAG protein, small MAG (S-MAG) is the 67 kDa 
isoform that is predominant in Schwann cells and large MAG (L-MAG) is the 72 
kDa isoform that is more widely expressed in the CNS (Frail and Braun, 1984; 
Trapp et al., 1989). MAG is a member of the Ig superfamily and has a large N- 
terminus extracellular domain that includes five Ig-like domains and, a short 
transmembrane domain and either a 46 (S-MAG) or 90 (L-MAG) amino acid C- 
terminus cytoplasmic domain (Salzer et al., 1987). Expression of MAG is limited in 
the PNS and it constitutes only 0.1% of total myelin protein (Figlewicz et al., 
1981). It is located on the paranodal loops, both externally and internally at the 
mesaxon and at the Schmidt-Lanterman clefts (Martini and Schachner, 1988; 
Stemberger et at., 1979; Trapp et al., 1989; Trapp and Quarles, 1984; Trapp and 
Quarles, 1982; Trapp et al., 1984b). The role of MAG in intermembrane spacing 
prevents the exclusion of the Schwann cell cytoplasm at the Schmidt-Lanterman 
clefts. MAG is also capable of regulating neunte outgrowth in an inhibitory manner 
(McKerracher et al., 1994; Mukhopadhyay et al., 1994). MAG can also mediate 
myelin-axonal signalling, recent evidence suggests that MAG may regulate the 
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calibre of myelinated axons ensuring that they are viable for myelination. Mice 
with a null mutation in the MAG gene have reduced axonal calibres and reduced 
spacing between neurofilaments (Yin et al., 1998). 
MBP's are a group of small highly basic proteins (about 25% of the residues), the 
four that have been detected in the PNS are 14,17,18.5 and 21.5 kDa and all are 
generated from a single gene by alternative splicing of the primary transcript (de 
Ferra et al., 1985; Gilbert et al., 1982; Greenfield et al., 1980; Mentaberry et al., 
1986; Takahashi et al., 1985). The MBP proteins make up about 5 to 15% of the 
proteins found in myelin (Benjamins and Morell, 1978) and are thought to play a 
similar role to the Po protein, in maintaining the integrity of the major dense lines 
and in compaction of the myelin sheath. The localisation of MBP to the major 
dense lines, is consistent with this role (Omlin et al., 1982). Loss of both Po and 
MBP expression results in absence of major dense lines and uncompacted myelin. 
Loss of only Po results in only partial compaction of the myelin sheath and loss of 
MBP only, in shiverer mice, results in normal compaction in the PNS but no 
compaction of CNS myelin (Martini et al., 1995; Privat et al., 1979). Thus MBP 
can partially compensate for the loss of Po in the PNS, but as Po is exclusively 
expressed in the PNS it can only compensate for the loss of MBP expression in the 
PNS, leaving CNS myelin uncompacted. 
The PLP myelin protein is a 30 kDa protein that constitutes 50% of CNS myelin 
where it is thought to play a role in maintaining the intraperiod line, probably by 
promoting the apposition of the outer leaflets of the plasma membrane (Boison et 
al., 1995; Duncan et al., 1987). The gene encoding PLP also produces DM20 
through alternative splicing. Loss of PLP/DM20 expression in the CNS results in a 
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variety of phenotypes such as compacted myelin with axonal swelling and 
degeneration (Griffiths et al., 1998), in other cases there is widespread 
hypomyelination and oligodendrocyte death (Griffiths et al., 1995). PLP has four 
transmembrane domains and a large extracellular domain, DM20 is identical except 
for the loss of 35 amino acids (Nave et al., 1987). PLP/DM20 constitutes only 
about 1% of myelin proteins in the PNS; its localisation and role here are not yet 
clearly defined. Some have argued that they are expressed in the Schwann cell 
cytoplasm outside of the myelin sheath (Griffiths et al., 1989; Puckett et al., 1987). 
More recently PLP/DM20 has been detected in the compact myelin sheath, 
incorporated into the Schwann cell plasma membrane (Agrawal and Agrawal, 
1991; Garbem et al., 1997). Individuals with null mutations in which PLP is not 
expressed rather than misexpressed show PNS abnormalities such as demyelinating 
peripheral neuropathy consistent with a role for PLP/DM20 in the development and 
maintenance of the myelin sheath in the PNS (Garbern et al., 1997). 
P2 is a basic 14.8 kDa myelin protein that is found only in the cytoplasmic side of 
compact myelin membranes (Hahn et al., 1987; London, 1971; Trapp et al., 1984a). 
The level of P2 expression varies from species to species and may be as little as 1% 
of PNS myelin proteins in mice and rats or as much as 12 % in human and bovine 
nerves (Garbay et al., 2000; Greenfield et al., 1982). It is thought that P2 is involved 
in fatty acid uptake and transport and its role as a lipid carrier suggests that it may 
be involved in myelin assembly and maintenance. CNPase (2', 3'-cyclic nucleotide 
3'-phosphodiesterase) constitutes only 0.5% of total PNS myelin proteins 
(Uyemura et al., 1972). A single gene encodes both CNPasel, a 46 kDa protein, 
and CNPase2, a 48 kDa protein (Douglas and Thompson, 1993; Gravel et al., 
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1994). CNPase is a cytoplasmic myelin protein that has been detected at the 
paranodal loops, the outer mesaxon and in the Schmidt-Lanterman clefts (Trapp et 
al., 1988a; Yoshino et al., 1985). Its exact physiological function is unclear, but 
CNPase interacts with oligodendrocyte membranes and with the actin cytoskeleton 
and may therefore be able to modulate glial cell morphology (De Angelis and 
Braun, 1996; Gravel et al., 1996). 
1.5.9: The node of Ranvier 
Specialised proteins are expressed at the nodes of Ranvier that may be involved in 
its formation or stabilisation. Epithelial cadherin (E-cadherin) is an adhesive 
glycoprotein in Schwann cells and is expressed only in uncompacted myelin, at the 
Schmidt-Lanterman clefts and in the paranodal loops (Fannon et al., 1995). The 
cytoplasmic C-terminus domain of E-cadherin forms complexes with cytoskeletal 
proteins such as F-actin to regulate the architecture of the Schwann cell 
cytoplasmic network at the paranodes and Schmidt-Lanterman clefts. 
Periaxin is a myelin protein expressed exclusively by myelin forming Schwarm 
cells at the paranodal (periaxonal) loops of the nodes of Ranvier and constitutes 5% 
of myelin proteins (Gillespie et al., 1994). Large periaxin (L-periaxin) is a 147 kDa 
protein expressed in the plasma membrane of myelinating Schwann cells at the 
paranodes while the 16 kDa small periaxin (S-periaxin) is expressed diffusely 
throughout the paranodal cytoplasm (Dytrych et al., 1998; Gillespie et al., 1994). 
Periaxin expression is first detected before other myelin proteins at the Schwann 
cell membrane apposing the axon as the Schwann cells and peaks postnatally 
during active myelination, when expression of periaxin becomes concentrated to 
the Schwann cell membrane apposing the basal lamina (Scherer et al., 1995). 
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Periaxin expression is also increased during active remyelination following injury. 
Contactin-associated protein (Caspr; also known as paranodin) is a neurexin family 
integral membrane protein of 190 kDa expressed by neurons. Although initially 
expressed throughout the axon, Caspr becomes concentrated at the paranodal loops 
of mature myelinated fibres (Einheber et al., 1997). Casprl is connected with the 
axonal cytoskeletal by proteins such as spectrin binding to protein 4.1. A large 
extracellular domain binds contactin, regulating the colocalisation of contactin and 
Casprl to the paranodal loops (Menegoz et al., 1997; Peles et al., 1997; Rios et al., 
2000). The 155 kDa isoform of neurofascin is a glial component of the paranodal 
loops that also binds Casprl (Tait et al., 2000). The complex of contactin, Casprl, 
protein 4.1 and neurofascin mediates interactions between the paranodal loops of 
the Schwann cell and the axonal cytoskeleton at the nodes of Ranvier. 
The juxtaparanode, located under the compact myelin sheath neighbouring the 
paranode, is rich in K+ channels. Caspr2, is colocalised with delayed rectifier K+ 
channels in the juxtaparanodal region (Poliak et al., 1999). Caspr2 associates 
through a PDZ-binding domain in the cytoplasmic C-terminus region with the 
Kvl. 1, Kvl. 2 and Kvß2 channel subunits by binding to the C-terminus domain of 
the KK channels' a subunits (Poliak et al., 1999). Clusters of Na+ channels at the 
nodes of Ranvier are anchored by ankyrin G, an axonal cytoskeletal protein with a 
480 kDa and a 270 kDa unit. Thus Casprs and associated proteins such as contactin 
and neurofascins mediate specialisation of both the nodal, paranodal and 
juxtaparanodal regions of myelinated axons. 
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1.6: Peripheral nerve regeneration 
1.6.1: Wallerian degeneration 
Wallerian degeneration describes the processes following crush or transection 
injury to nerves. The regenerative process itself involves recapitulation of many 
developmental processes in peripheral nerves. Upon injury to the nerve the axons in 
the distal stump that have become isolated from the neuronal cell body begin to 
disintegrate within 24 hours, this is followed by fragmentation of the myelin sheath. 
In the PNS early invasion by macrophages facilitates regeneration by clearing the 
debris (Beuche and Friede, 1984; Franzen et al., 1998). Schwann cells persist in 
degenerating nerves and help to clear the debris created by axonolysis and 
myelinolysis over a period of weeks along with the macrophages and possibly 
fibroblasts (Weinberg and Spencer, 1978). Mice in which macrophage recruitment 
is delayed undergo very slow Wallerian degeneration but are still able to regenerate 
(Lunn et al., 1989), as Schwann cells are also able to clear the myelin debris 
(Fernandez-Valle et al., 1995). 
1.6.2: The bands of Büngner 
Schwann cells align themselves along the endoneurial basal lamina tubes known as 
bands of Büngner that remain intact following crush injury. Fibroblasts and 
perineurial cells also invade the bands of Büngner, which serve as guides for axons 
between the proximal and distal stumps in regenerating nerves (Anderson et al., 
1991; Hall, 1986b; Hall, 1989; Weinberg and Spencer, 1978; Williams et al., 1983). 
The bands of Büngner are more likely to remain aligned following crush injury and 
this is probably why regeneration following crush is usually more successful than 
following transection. These Schwann cell lined basal lamina tubes are the 
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exclusive conduits for successful axonal regeneration in vivo (Nathaniel and Pease, 
1963) and the presence of both the basal lamina and Schwarm cells is vital for 
axonal regeneration in the PNS. 
Expression of laminin chains, such as the al, a2, ßl and yl chains, is upregulated 
in Schwann cells when axonal contact is lost (Doyu et al., 1993; Masaki et al., 
2000; Tona et al., 1993). The ability of regenerating axons in the bands of Biingner 
to interact with laminin-2 is particularly important in mediating neunte outgrowth 
during regeneration. Antibody blockade of laminin-2 activity is more inhibitory to 
neunte outgrowth on denervated nerve substrates than on intact nerve substrates 
(Agius and Cochard, 1998; Anton et al., 1994a). Other ECM molecules such as 
fibronectin and chondroitin sulphate are also upregulated following peripheral 
nerve injury (Tona et al., 1993; Vogelezang et al., 1999). The levels of protein and 
mRNA of F-spondin, an ECM molecule normally expressed by Schwarm cells 
when sensory and motor neurons are projecting to their peripheral targets, is 
upregulated in Schwann cells distal to the site of injury (Burstyn-Cohen et al., 
1998; Klar et al., 1992). Moreover antibody blockade of F-spondin in axotomised 
nerves inhibits neurite outgrowth. However the bands of Büngner alone are not 
sufficient for axonal regeneration, many of the ECM molecules upregulated in the 
basal lamina of regenerating nerves are in fact produced by Schwann cells. Axons 
extending from the proximal stump in regenerating nerves are always accompanied 
by migrating Schwann cells, without which axonal regeneration is substantially 
delayed and less widespread (Feneley et al., 1991; Hall, 1986a; Rodriguez et al., 
2000). 
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1.6.3: Schwann cell migration and proliferation 
Both myelin forming and non-myelin forming Schwann cells enter a proliferative 
stage within a couple of days of axonal and myelin fragmentation following injury 
and loss of axonal contact (Clemence et al., 1989). This proliferative stage closely 
follows macrophage infiltration and these cells may induce mitogenic activity in 
Schwann cells. Lysosomal processing of myelin membranes by macrophages 
induces the production of a mitogenic factor for Schwann cells by the macrophages 
(Baichwal et al., 1988). However Schwarm cells involved in clearing the myelin 
debris are able to proliferate without the presence of macrophages and their 
mitogenic factors (Fernandez-Valle et al., 1995). The proliferative activity of 
Schwann cells in regenerating nerves suggests that these Schwann cells may not be 
terminally differentiated. Loss of axonal contact in degenerating nerves leads to 
dedifferentiaton of Schwann cells and alters the phenotype of terminally 
differentiated Schwann cells to one similar to that of non-myelin forming or 
immature Schwann cells (Mirsky and Jessen, 1996). Expression of myelin proteins 
and of mRNA for proteins such as Po, MBP and MAG is substantially reduced in 
these Schwann cells (Lemke and Chao, 1988; Trapp et al., 1988b; Willison et al., 
1988). 
Fluid conditioned by cells in regenerating nerves contains biologically active 
factors that promote Schwann cell adhesion, migration and proliferation (Le Beau 
et al., 1988). Thus cells in regenerating nerves differentiate into a state in which 
they produce factors conducive to a vital aspect of regeneration. Adhesion may be 
mediated by laminins and other ECM molecules produced by Schwann cells as well 
as by upregulated levels of N-cadherin, NCAM and Ll in Schwann cells that have 
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dedifferentiated to an immature/ non-myelin forming phenotype (Fu and Gordon, 
1997). Expression levels of some growth factors such as NGF, CNTF and IGFs that 
are normally expressed in developing Schwann cells are also elevated following 
injury to the nerve (Fu and Gordon, 1997; Lemke and Chao, 1988). CNTF is a 
survival factor for motor neurons and its elevated expression during regeneration 
probably helps to support the survival of motor axons as they sprout towards their 
peripheral targets. IGFs act as autocrine survival factors for immature Schwann 
cells and elevated expression of this growth factor probably helps to support the 
survival of Schwann cells that have dedifferentiated upon loss of axonal contact 
after injury. 
Nerve injury also results in induction of expression of the low affinity p75 
neurotrophin receptor in Schwann cells in the bands of Büngner distal to the lesion 
and in Schwann cells proximally at the actual site of the lesion (Funakoshi et al., 
1993; Taniuchi et al., 1986; Taniuchi et al., 1988). This receptor is normally only 
expressed by Schwann cell precursors, immature and non-myelin forming Schwann 
cells (Jessen et al., 1994; Jessen and Mirsky, 1991), but Schwann cells 
dedifferentiate in regenerating nerves and consequently re-express the receptor. 
Moreover once axons had regenerated into the area of p75 positive Schwarm cells 
and had established contacts with the Schwann cells, expression of the receptor was 
down-regulated (Taniuchi et al., 1988). In vitro NGF promotes Schwane cell 
migration, a prerequisite for successful axonal regeneration (Anton et al., 1994b), 
but it is not known whether NGF-mediated Schwann cell migration is a major 
factor in regeneration in vivo. mRNA for the high affinity NGF receptor, TrkA, was 
not detectable in any part of both intact nerves and in lesioned nerves over a3 week 
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time period (Funakoshi et al., 1993), suggesting that any NGF-mediated promotion 
of neunte outgrowth and Schwane cell migration is mediated by the p75 receptor. 
Schwane cell survival in the distal nerve stumps is substantially higher 24 hours 
after axotomy in mice lacking the p75 receptor than in wild type mice, consistent 
with NGF-mediated activation of p75 receptors in regulating Schwann cell 
apoptosis (Syroid et al., 2000). This difference in apoptotic Schwann cell death in 
p75 deficient mice is developmentally regulated and occurs only postnatally and in 
regenerating nerves and was not observed in E15 immature Schwann cells. 
Schwann cell numbers and proliferation may also be regulated during Wallerian 
degeneration by interactions of neuregulins with their ErbB2 receptors. The ErbB2 
and ErbB3 receptors are expressed in mature Schwann cells and phosphorylation 
and activation of the ErbB2 receptor occurs in Schwane cells during Wallerian 
degeneration at a time corresponding to Schwane cell proliferative activity (Kwon 
et al., 1997). Moreover addition of exogenous neuregulins can inhibit Schwane cell 
apoptosis in vivo following axotomy (Grinspan et al., 1996; Syroid et al., 1996). 
Control of Schwann cell numbers in regenerating nerves is a necessary prerequisite 
to remyelination. Myelin forming Schwane cells need to re-establish contact with 
individual axons before induction of myelin genes and myelination can proceed. 
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1.7: Aims of the project 
The dy/dy mouse exhibits myelination abnormalities and is severely deficient in 
laminin-2. This project aimed to use this mutant mouse to test the hypothesis that 
laminin-2 regulates several aspects of Schwarm cell behaviour and interactions 
between Schwann cells and axons, including regulation of Schwann cell 
morphology and myelination. I have investigated the ultrastructure of intact mutant 
nerves and investigated the expression of laminin-2 in myogenic and neural tissues 
of the dy/dy mouse. I have used sciatic nerve transection and crush injuries to 
determine the role of laminin-2 in axon sprouting and remyelination in vivo during 
regeneration. I have used cryoculture to determine the extent to which laminin-2 
acts as a substrate for Schwann cell migration. Explant cultures of mutant DRGs 
determined the role of laminin-2 in regulating the intrinsic motility of Schwann 
cells and cultures of dissociated Schwann cells were used to investigate the role of 
laminin-2 in several aspects of Schwann cell behaviour, particularly morphology. 
Finally Schwann cell-neuron co-cultures were used to investigate what role 
Schwann cell-mediated laminin-2 expression plays in neunte outgrowth. These 
techniques helped to clarify the role of laminin-2 in regulating Schwann cell 
behaviour. 
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Chapter 2: Materials and Methods 
Table 2.1: Antibodies: Table showing primary antibodies used for 
immunohistochemical, immunocytochemical and immunoblotting analysis: 
Antibody Antigen Host animal Source 
Clone 4H8-2 Laminin a2 chain Rat Alexis 
300 kDa fragment 
Clone 403 Laminin a2 chain Rabbit Gift of L. Sorokin 
G1-3 domain 
Paulsson a2 Laminin a2 chain Rabbit Gift of M. Paulsson 
chain 300 kDa fragment 
EHS-laminin Laminin-1 Rabbit Sigma 
heterotrimer 
PGP 9.5 Protein gene product Rabbit Biogenesis 
9.5 (PGP 9.5) 
Clone 2H3 155 kDa Mouse Developmental Studies 
Neurofilament protein Hybridoma Bank 
S100 S100 Schwann cell Rabbit Dako 
cytoplasmic protein 
GAP-43 GAP-43 Rabbit Gift of G. Wilkin 
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2.1: Animals 
Heterozygous 129/ReJ dy/dy mice from Jackson Laboratories (USA) were bred 
using brother/sister matings. Each litter usually had a penetrance of 1 in 3 to 1 in 4 
mutant mice Homozygous dystrophic mice were distinguishable from their 
heterozygous and homozygous unaffected littermates at 2-3 weeks of age. At this 
point they were distinguishably smaller in size and had begun to exhibit hind-limb 
paralysis, which manifested itself as dragging of the hindlimbs. In addition 
dystrophic mice often had convulsions of the head and arched backs. The eye area 
of dystrophic mice was usually scabby and the eyes often only half-open. dy/dy 
mice normally die of respiratory failure by 6 months of age, but I did not maintain 
them beyond 3 months of age at which point they are severely dystrophic. 
Homozygous and heterozygous unaffected mice were indistinguishable. Animals 
were killed at 0.5-2 months of age by asphyxiation in CO2. 
2.2: Immunohistochemistry of sections 
2.2.1: Fresh frozen sections 
The sciatic nerves, cardiac muscle and thigh skeletal muscles were removed from 4 
severely ataxic P45-55 dy/dy mice and four of their unaffected littermates for 
immunohistochemistry. The tissues were immediately embedded in Optimum 
Cutting Temperature compound (OCT; BDH-Merck, UK) and snap frozen in liquid 
nitrogen. Cryosections 7-8 µm thick were cut on a Bright OTF/AS/D cryostat (UK) 
and 4-6 sections were collected onto each polysine pre-treated slide (BDH-Merck). 
Sections were allowed to dry onto the slides and then immunostained immediately. 
Fresh-frozen sections of skeletal and cardiac muscle and of sciatic nerve in the 
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longitudinal plane were first immunostained with a rat monoclonal antibody raised 
against laminin a2 chain isolated from mouse heart (clone 4H8-2; Alexis, UK) 
diluted 1: 100 in antibody diluent. Section were alternatively stained with a rabbit 
polyclonal antibody to mouse a2 chain G1-3 domain (clone 403; gift of Dr L 
Sorokin, University of Erlangen-Nürnberg, Erlangen, Germany) diluted 1: 200 in 
antibody diluent. Antibody diluent was made up of 10% MEM (Modified Eagle's 
Medium; Gibco Brl, UK), 1.35% 1M N-[2-Hydroxyethyl]piperazine-N'-[2-ethane- 
sulphonic acid] (HEPES; Sigma, UK), 10% fetal calf serum (FCS), 0.1% sodium 
azide (Sigma) and 1.35% of a 7.5% sodium bicarbonate solution (Gibco Brl). 
Incubation with the primary antibody was for 1-2 hours at room temperature (all 
antibody staining was carried out at room temperature). The antibody was then 
removed and the slides were rinsed in three 10 minute washes of phospate buffered 
saline (PBS; Sigma), followed by a rinse in double distilled water (DDW). Sections 
were then fixed for 15 minutes in 4% paraformaldehyde (TAAB, UK) and rinsed in 
PBS and DDW as above. The 4H8-2 rat monoclonal antibody was visualised with a 
tetramethyl rhodamine isothiocyanate (TRITC) -conjugated goat anti-rat IgG 
(Jackson Immunoresearch Laboratories Inc., USA) diluted 1: 100. The clone 403 
rabbit anti-a2 chain antibody was visualised with a Cy3-conjugated goat anti-rabbit 
IgG (1: 100; Amersham, UK). Sections were incubated in both these conjugate for 
45 minutes. The conjugates were removed and the slides washed in PBS and DDW 
as above. 
For double immunostaining of laminin a2 chain with laminin-1, sections were then 
incubated with a rabbit polyclonal antibody to EHS-laminin (1: 100; Sigma; UK) for 
1-2 hours. The rabbit anti-EHS-laminin antibody was rinsed off with PBS and 
115 
DDW as above and the sections incubated in donkey anti-rabbit IgG (1: 100; 
Amersham) for 45 minutes, washed in PBS and DDW and visualised by incubating 
the sections in Streptavidin fluorescein (1: 100; Amersham) for 45 minutes. The 
slides were rinsed in PBS and DDW and post-fixed for 3 minutes in methanol 
(BDH-Merck) at -20 °C. The slides were rinsed in PBS and DDW and the 
coverslips mounted in glycerol (BDH-Merck) containing 2.5% 1,4-diazobicyclo- 
(2,2,2)-octane (DABCO; Sigma) to inhibit fading of fluorescence. 
Immunofluorescence was observed using a Zeiss Axioskop microscope equipped 
with epifluorescence optics (Germany) and digitised images taken under a x20 and 
a x40 objective using a Spot 2 cooled CCD camera (Diagnostic Instruments, 
Sterling Heights, MI, USA). 
2.2.2: Fixed tissues (transected nerves) 
Transected dy/dy and unaffected sciatic nerves (see chapter 2.4.1) were removed 
two weeks after injury and immediately placed in 4% paraformaldehyde for 4 hours 
at room +4°C. The paraformaldehyde was removed and the nerves washed in three 
rinses of PBS. The nerves were then left in 1M sucrose (BDH-Merck) in PBS 
solution overnight or until the nerves had sunk to the bottom of the solution. After 
three rinses in PBS, the nerves were embedded in OCT and the distal to proximal 
orientation noted. The sciatic nerves were then snap frozen at -70°C in liquid 
nitrogen. 7-8 µm thick sections were cut in the longitudinal plane on a Bright 
cryostat and 4 sections were collected onto each polysine pre-treated slide in the 
same proximal to distal orientation. 
Sections were incubated in one of two axonal markers; a rabbit polyclonal antibody 
to PGP 9.5 (1: 400; Biogenesis, UK) or a mouse monoclonal antibody to the 155- 
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kDa neurofilament (clone 2H3; 1: 2000; Developmental Studies Hybridoma Bank, 
USA). Sections were incubated in primary antibody for 1-2 hours at room 
temperature. The antibodies were removed and the slides washed in three, ten 
minute, washes of PBS and one, ten minute, wash of DDW. The PGP 9.5 antibody 
was visualised with a Cy3-conjugated goat anti-rabbit IgG (1: 100) and the 2H3 
antibody was visualised with a Cy3-conjugated goat anti-mouse IgG (1: 100; 
Amersham). Sections were incubated in conjugates for 45 minutes and the slides 
were then rinsed in PBS and DDW as above. Sections were post-fixed for 3 
minutes in methanol at -20 °C and rinsed in PBS and DDW. Coverslips were 
mounted in glycerol containing DABCO. Immunofluorescence was observed using 
a Zeiss Axioskop microscope and digitised images taken under a x40 objective 
using a Spot 2 cooled CCD camera. 
2.2.3: Polyester wax embedded tissues 
Sciatic nerves were removed from 11 severely ataxic P45-55 dy/dy mice and 13 of 
their unaffected littermates. The sciatic nerves were left in 4% paraformaldehyde 
overnight and then placed in PBS for 24 hours. The sciatic nerves were then 
dehydrated in graded concentrations of industrial methylated spirit (IMS; BDH- 
Merck) as below: 







The sciatic nerves were then infiltrated with graded concentrations of polyester wax 
(400 polyethylene glycol distearate; Aldrich, UK) at 40°C as described below: 
Ratio: Time (hours) 
100%IMS: wax 
50: 50 1 
25: 75 1 
100% wax 1 
100% wax 1 
The nerves were then embedded in 100% polyester wax in preparation for 
sectioning on a microtome. 7-8 µm thick sections were cut on a microtome using 
Teflon-coated glass knives. Ribbons of sections were cut, a drop of 5% gelatin was 
placed on an uncoated glass slide (BDH-Merck) and 4 sections from the ribbon 
were then placed on the gelatin to mount them on the slides. The sections were 
allowed to dry onto the slides and then could be stored at +4°C until needed. 
Sections had to undergo dewaxing before immunostaining could be carried out. 
Sections were left to equilibrate for 30 minutes at room temperature and then 
dewaxed in graded concentrations of IMS, DDW and PBS as described below: 
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Solution Time (minutes) 
100% IMS 5 
100% IMS 3 
90% IMS 3 
70% IMS 3 
50% IMS 3 
DDW 3 
PBS 3 
Sections were incubated in a rabbit polyclonal antibody to the Schwann cell 
cytoplasmic protein, S100 (1: 400; DAKO, UK) for 1-2 hours at room temperature. 
The antibody was washed off with three ten-minute rinses of PBS, followed by a 
rinse in DDW. The sections were then incubated in fluorescein isothiocyanate 
(FITC) -conjugated goat anti-rabbit IgG (1: 100; Sigma) for 45 minutes to visualise 
S100 immunoreactivity. The slides were washed as above and the sections double 
immunostained with an axonal marker. Sections were incubated in clone 2H3 
mouse monoclonal antibody to the 155-kDa neurofilament protein (1: 2000) for 1-2 
hours at room temperature. Slides were then washed in PBS and DDW as above 
and incubated with a Cy3-conjugated goat anti-mouse IgG for 45 minutes (1: 100). 
The slides were then rinsed in PBS and DDW and the sections post-fixed in 
methanol at -20°C for 3 minutes. Sections were rinsed in PBS and DDW and 
coverslips mounted in DABCO in glycerol. 
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2.2.3.1: Analysis of Schwann cell morphology and numbers 
Polyester wax embedded sections of sciatic nerves from 11 dy/dy mice and 13 
unaffected littermates that had been double immunostained with S 100 and 2H3 
were viewed using a Zeiss Axioskop microscope equipped with epifluorescence 
optics under a x20 and a x40 objective. Digitised images were taken a using a Spot 
2 cooled CCD camera. These images were analysed for Schwann cell morphology 
and numbers. S100 immunoreactive Schwann cells were classified as either round 
or ellipsoid (elongated) in morphology and the number of each was counted on 
each section. The number of round and ellipsoid Schwann cells were expressed as a 
percentage for each nerve analysed and the average percentage of each in dy/dy and 
unaffected sciatic nerves calculated. Digitised images were also used to calculate 
the total number of S 100 immunoreactive Schwarm cells per mm. All the Schwann 
cells in each digitised image were counted and the length of nerve in which they 
were contained was calculated using the Optimas image analysis programme 
(Optimas v. 6, Media Cybernetics, Silver Spring, MD, USA). The Student's t-test 
(0.05% significance level) was used to compare the number of Schwarm cells per 
unit of length of nerve. Statistical analysis was carried out using Microsoft Excel 
(v. 6, USA) in all experiments. 
2.3: Western Blotting 
2.3.1: Preparation of SDS-PA GE gels 
Samples were subjected to electrophoresis on a denaturing 5% SDS-PAGE gel with 
a 4% stacking gel (Laemmli, 1970). Briefly, a 30 ml solution of resolving gel was 
made up using 5 ml of a 30% acrylamide solution (Ultrapure Protogel; National 
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Diagnostics, Atlanta, GA., USA), 7.5 ml resolving gel buffer (1.5M Trizma 
Hydrochloride, pH8.8; Sigma), 300 µl of 10% sodium dodecyl sulphate (SDS; 
BDH-Merck), 150 µl of 10% (Sigma), 15 µl of N, N, N', N'-tetramethyl- 
ethylenediamine (TEMED; Biorad) and made up to 30ml with 17 ml DDW. A 15 
ml solution of 4% stacking gel was made up with 2 ml of 30% acrylamide, 3.75 ml 
of stacking gel buffer (0.5M Trizma Hydrochloride; pH 6.8), 150 Al of 10% SDS, 
7.5 µl of TEMED, 150 µl of ammonium persulphate and 9 ml of DDW. 
2.3.2: Preparation of Samples 
Skeletal muscle, dorsal roots and sciatic nerves were removed from 6 severely 
ataxic P30-P50 dy/dy mice and 5 unaffected littermates and frozen in liquid 
nitrogen. Tissues were homogenised in 50-300 µl of lysis buffer, depending on the 
quantity of the tissue. The lysis buffer contained 0.05M Trizma Hydrochloride (pH 
6.8), 4M urea (BDH-Merck), 1% SDS, 0.1% each of PMSF phenylmethylsulphonyl 
fluoride (PMSF; Sigma), 3-[3-cholamidopropyl imethylammonio]-1-propane- 
sulphonate (CHAPS; Sigma), nonylphenoxy polyethoxy ethanol (NP-40; Sigma) 
and Triton X100 (Sigma). 
The total amount of protein was determined using BCA Protein Assay Reagent 
(Pierce, Ill, USA) and each sample made up to a protein concentration of 2 mg/ml 
with lysis buffer. Laminin-2 (human placental merosin; Gibco Brl) standards were 
diluted to a concentration of 0.25 mg/ml in lysis buffer. Before use tissue 
homogenates and standards were mixed at a ratio of 2: 1 tissue homogenate: x3 
treatment buffer (0.75 M Trizma Hydrochloride, 30% glycerol, 15% mercapthanol 
[Biorad], 15% SDS and bromophenol blue [Sigma]) and denatured at 100°C for 3 
minutes. 20 µl of each sample and the standard were loaded onto each gel 5% gel 
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along with a molecular weight marker (Rainbow marker; Amersham). Samples 
were run through the stacking gel at 60V and through to the end of the resolving gel 
at 100V. Once the dye front had reached the bottom of the gel, proteins were 
transferred for immunoblotting. 
2.3.3: Immunoblotting 
Gels were blotted onto millipore polyvinylidene difluoride (PVDF; Sigma) 
membranes at 300 mAmps for 2 hours. Membranes were then blocked for 1 hour in 
blocking buffer made up from 5% powdered milk (Marvel; UK) in TBS 
(triethanolamine buffered saline; 0.15M sodium chloride [BDH-Merck] and 0.05M 
Trizma Hydrochloride). Membranes were incubated overnight at room temperature 
in either a rabbit polyclonal antibody against the 300 kDa fragment of laminin a2 
isolated from mouse heart (1: 100; gift of Dr M Paulsson, University of Cologne, 
Cologne, Germany) (Paulsson and Saladin, 1989) or a rabbit polyclonal antibody 
against EHS-laminin (1: 100; Sigma); both antibodies were diluted in blocking 
buffer. The primary antibody was removed and membranes were washed three 
times in 10 minute washes of TBS. Membranes were incubated for 2 hours in 
peroxidase-conjugated goat anti-rabbit IgG (1: 500 in blocking buffer; Sigma). 
Membranes were washed in TBS as above and the immunostaining visualised with 
0.6% 4-chloro-l-napthol (Sigma). Immunoblots were photographed and black and 
white photographs were taken and scanned and imported as Adobe Photoshop 5.5 
files. 
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2.4: Sciatic nerve lesions 
2.4.1: Sciatic nerve transection 
Three severely ataxic dy/dy mice aged 6 weeks and three unaffected littermates 
were anaesthetised with a mixture of Hypnorm (fentanyl citrate and fluanisone) and 
Hypnovel (midazolam). Under a dissecting microscope the left sciatic nerve was 
exposed and transected at midthigh using a pair of fine scissors. The wounds were 
closed and the animals allowed to recover for a period of 2 weeks. At this time the 
mice were killed by asphyxiation in CO2 and a lcm length of transected nerve 
removed and fixed in 4% paraformaldehyde. Cryosections of transected nerve were 
immunostained with axonal markers (see chapter 2.2.2) to determine the extent of 
axonal sprouting. 
2.4.2: Sciatic nerve crush injury 
Eleven severely ataxic dy/dy mice and 4 unaffected littermates were anaesthetised 
as in 2.4.1. Under a dissecting microscope, the left sciatic nerve was exposed and 
crushed at midthigh with a pair of fine forceps. The wounds were closed and the 
mice allowed to recover for periods of 2,4 and 6 weeks. At these post-operative 
times mice were killed by asphyxiation in CO2 and a 1cm length of crushed sciatic 
nerve was removed from each mouse. Contralateral nerves were also removed from 
some dy/dy mice for investigation of the ultrastructure of intact dy/dy sciatic nerve. 
Lesioned and intact sciatic nerves were processed for semi-thin sectioning and 
electron microscopy. 
2.4.3: Preparation of tissues for semi-thin sectioning and electron microscopy 
One centimetre lengths of intact and crushed nerves were removed from dy/dy and 
unaffected mice and stretched lightly across a small piece of card and immersion- 
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fixed in 2.5% gluteraldehyde in PBS for 4 hours at +4°C. Specimens were washed 
in PBS and post-fixed in 1% Os04 for 90 minutes at +4°C and then dehydrated 
through graded ethanol and embedded in TAAB resin. Each nerve was cut into 
2mm blocks in a proximodistal sequence before embedding for sectioning. Intact 
nerves were prepared for longitudinal sectioning, lesioned nerves were embedded 
for transverse sectioning such that the site of the crush was consistently within 
block 2. 
2.4.4: Semi-thin sectioning and quantitative assessment of remyelination 
One micrometre thick semi-thin sections were cut from each block and stained with 
1% toluidine blue to screen appropriate sections for qualitative electron 
microscopic analysis and for quantitative light microscopy. The total number of 
myelinated axons in transverse sections of each proximal and distal nerve stump in 
unaffected and dy/dy mice was counted approximately 0.4cm from the crush site. 
Myelinated axons were counted using a x100 objective on a Zeiss Axioskop 
microscope and the average numbers of myelinated axons in these sites at each time 
point compared. Student's t-tests (5% significance level) were used to compare 
remyelination at the 2 week time point only. 
2.4.5: Electron microscopy 
Ultra-thin sections of intact nerves were cut in the longitudinal plane and of each 
distal stump in lesioned nerves, approximately 0.2-0.4 cm distal to the crush site, in 
the transverse plane. The ultra-thin sections were collected onto copper grids and 
contrasted with uranyl acetate and lead citrate. Ultra-thin sections were viewed with 
a Hitachi H-7000 transmission electron microscope. 
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2.5: Schwann cell migration assays 
2.5.1: Cryoculture 
The cryoculture technique has been used previously to assay neurite outgrowth and 
Schwann cell migration in vitro (Anton et al., 1995; Anton et al., 1994a; Anton et 
al., 1994b; Shewan et al., 1995). Cryosections of peripheral nerve were used as 
substrates for Schwann cell migration in in vitro studies. This technique provides a 
physiologically relevant substrate for studying the factors involved in Schwann cell 
migration but without the added complexity of interactions with other cell types 
and with trophic factors. Thus ECM molecules and cell surface molecules are 
included in the substrate while diffusable factors are excluded. 
2.5.2: Homologous cryoculture assay 
Intact sciatic nerves were removed from adult Wistar rats that had been killed by 
asphyxiation in CO2 and immediately mounted onto slices of rat liver and fresh- 
frozen in liquid nitrogen. Cryostat sections of rat sciatic nerve, 7-8 µm thick, were 
cut in the longitudinal plane and collected onto each sterile poly-L-lysine-coated 
(PLL; 2 mg/ml; Sigma) 13mm diameter round glass coverslip (BDH-Merck). 
Briefly, coverslips were prepared by placing coverslips in a 10 cm diameter petri 
dish (Nunc; UK) and washing with sterile DDW, coverslips were then incubated in 
20 ml of sterile PLL solution for 2 hours at room temperature. The PLL was 
drained off and the coverslips allowed to dry under sterile conditions in a tissue 
culture hood. Coverslips containing 3-4 cryostat sections were stored at -70°C in 
preparation for cryoculture. 
Intact DRG explants were prepared from P3 Wistar rats. The DRGs were removed 
and placed in warmed Ham's F-12 medium (Gibco) and trimmed free of attached 
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roots under a dissecting microscope. Trimmed DRGs were incubated with 2 ml of 
0.025% trypsin (Sigma) in calcium- and magnesium-free Hanks buffered salt 
solution (CMF; Gibco Brl) containing 50 µl of 1.25% collagenase (Sigma) for 20 
minutes. They were next washed in Ham's F-12 medium and then incubated in 
trypsin inhibitor DNAase (TID) for 20 minutes. Briefly, TID was prepared with 50 
µg/ml of DNAse (Type I; Sigma), 250 µg/ml of soybean trypsin inhibitor (Type II; 
Sigma), 3 mg/ml bovine serum albumin (BSA; Sigma) and 0.038% magnesium 
sulphate (BDH-Merck). The DRGs were washed again in Ham's F-12 medium and 
then explanted onto cryosections. Coverslips containing rat sciatic nerve 
cryosections were placed at the base of a well in a 4-well culture plate (Nunc) and a 
DRG placed carefully on each section under a dissecting microscope, taking care 
not to disrupt the nerve section. DRG explants were allowed to stick to the nerve 
sections by incubating in a small amount (less than 50 µl) of Dulbecco's modified 
Eagle's medium (DMEM; Gibco Brl) containing 10% FCS and 100 ng/ml of NGF 
(Promega, UK). Once the explant had stuck to the cryosection the culture medium 
was topped up to 500 µl. Cultures were maintained for either 24 (n = 74), 40 (n 
=120) or 65 (n = 99) hours in a humidified CO2 incubator (Jouan; UK) at 37°C in 
7.5% CO2 before labelling (2.5.4). 
2.5.3: Heterologous cryoculture: Rat DRG explants on mouse sciatic nerve 
cryosections 
Intact sciatic nerves were removed from severely ataxic P45-P55 dy/dy mice and 
their unaffected littermates and mounted onto slices of rat liver and frozen in liquid 
nitrogen. Seven to 8 µm thick cryosections of nerve were cut and collected as in 
2.5.2. P3 rat DRG explants were prepared and plated onto dy/dy (n = 71; proximal, 
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n= 20; distal, n= 51) and unaffected (n = 51; proximal, n= 37, distal, n= 49) 
mouse sciatic nerve cryosections as above (chapter 2.5.2). DRG explants were 
incubated for 40 hours before labelling (chapter 2.5.5) in an incubator at 37°C in a 
humidified atmosphere with 7.5% CO2 in 500 µl DMEM containing 10% FCS and 
100 ng/ml of NGF. 
To assess the effect of laminin-2 on Schwann cell migration on dy/dy sciatic nerve 
substrates, heterologous cryocultures were carried out on laminin-2 pre-treated 
nerve sections. dy/dy (n = 6) and unaffected (n = 7) sciatic nerve cryosections were 
prepared as above, but in each experiment half of the coverslips containing sections 
of unaffected (n = 5) or dy/dy (n = 14) sciatic nerve were preincubated with 10 
pg/ml of human placental merosin (laminin-2) in culture medium for 2 hours prior 
to plating of the explant. Rat E19 DRG explants were used in these experiments; 
these were prepared using the same method as in 2.5.2 but incubation time in 
0.025% trypsin and in TID was shortened to 15 minutes each. E19 DRGs were 
plated onto laminin-2 preincubated and untreated dy/dy and unaffected sciatic nerve 
cryosections as above and cultures were incubated in DMEM containing 10% FCS 
and 100 ng/ml of NGF in an incubator at 37°C in a humidified atmosphere with 
7.5% CO2 in 500 µl for 40 hours before labelling. 
2.5.4: Migration of dy/dy Schwann cells 
Intact DRG were prepared from ataxic P16-P20 dy/dy (n = 7) mice and their 
unaffected (n = 8) littermates and prepared as in 2.5.2 except that incubation time in 
0.025% trypsin in CMF containing 50µl of 1.25% collagenase and in TID was 
increased to 30 minutes each. 13 mm diameter round coverslips that had been 
precoated in PLL and then incubated in 10 µg/ml of laminin-1 (EHS-laminin; 
127 
Sigma) were placed in a 4-well plate and one DRG explant was positioned in the 
centre of each laminin-1 preincubated coverslip. Cultures were then incubated for 
40 hours in DMEM culture medium with 10% FCS containing 100 ng/ml of NGF 
in an incubator at 37°C in a humidified atmosphere with 7.5% C02. 
2.5.5: Analysis and Quantification of Schwann cell migration 
In order to analyse Schwann cell migration from DRG explants the cell tracker dye, 
5-chloromethylfluorescein diacetate (CMFDA; Molecular Probes, Eugene, OR, 
USA) was used. CMFDA is membrane permeable and is taken up by living cells 
where cytoplasmic esterases cleave the acetate groups to produce a fluorescent 
product. The CMFDA was added to cultures at 4 µM and incubation continued for 
45 minutes. Explants were then washed three times in Ham's F-12 medium and 
fixed in 4% paraformaldehyde. 
Both DRG neurons extending neuntes and migrating Schwann cells take up 
CMFDA in explant cultures and cryocultures but it labels Schwann cells with much 
greater intensity than neuntes. Schwarm cells are also distinguishable from 
CMFDA-labelled neuntes by morphology. To further distinguish between the two, 
some explant cultures and cryocultures were double-labelled with an antibody to 
GAP-43 a marker for growing neuntes after paraformaldehyde fixation. Cells in the 
cultures were first permeabilised by incubation with methanol at -20°C for 3 
minutes, rinsed in PBS and incubated with a rabbit polyclonal antibody to GAP-43 
(1: 1000; gift of Dr G Wilkin, Imperial College, London, UK) at room temperature 
for 1-2 hours. The primary antibody was rinsed off in three washes of PBS and the 
coverslips incubated in Cy3-conjugated goat anti-rabbit IgG (1: 100) for 45 minutes 
and then rinsed in three washes of PBS. CMFDA-labelled and CMFDA/GAP-43 
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double-labelled explants were mounted in DABCO in glycerol. 
CMFDA-labelled cells were analysed using a Zeiss Axioskop microscope equipped 
with epifluorescence optics using x10, x20 and x40 objectives. Digitised images 
were captured with a Spot 2 cooled CCD camera. The distance migrated by 
Schwann cells was determined as the distance from the centre of the DRG explant 
to the leading edge of migrating Schwann cells. Measurements were taken using 
Optimas v. 6. Statistical analysis was carried out using Microsoft Excel; the 
correlation coefficient was calculated for the distances migrated at the three time 
points in the homologous cryoculture system. Student's t-tests were used to 
compare migration from P3 rat DRG explants on dy/dy and unaffected mouse 
sciatic nerve substrates (1% significance level), from E19 rat DRG explants on 
laminin-2 treated and untreated mutant and unaffected substrates (5% significance 
level) and to compare migration of P16-20 dy/dy and unaffected Schwann cells 
(0.1% significance level). 
2.6: Sciatic nerve cultures containing dissociated Schwann cells 
2.6.1: Sciatic nerve dissociation 
Sciatic nerve cell cultures consisting largely of Schwane cells were prepared from 
the sciatic nerves of ataxic P 16-20 dy/dy mice and their unaffected littermates using 
a method adapted from the chapter on Schwann cell culture (p223) by Louise 
Morgan in "Neural Cell Culture" (edited by J. Cohen and G. P. Wilkin, 1995, 
OUP). Sciatic nerves were dissected out from near the vertebral column to their 
point of bifurcation in the hind-limbs and then cut approximately in half such that 
each unit length of sciatic nerve was 1 cm. Dissected sciatic nerves were placed in 
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cold MEM buffered with 25 mM HEPES. The nerves were then cleaned of any 
attached muscle or fat and desheathed, using a pair of forceps to pull away the 
epineurial sheath. The nerves were then chopped into 1 mm pieces and incubated at 
37°C for 45 minutes in an enzyme solution containing 1.25 mg/ml trypsin and 2 
mg/ml collagenase in CMF (250 pl per cm of nerve). The nerves were subsequently 
triturated in TID (125 µl per cm of nerve) 15-20 times (through a P-1000 Gilson 
pipette tip) to prepare a single cell suspension. 
The cell suspension was centrifuged for 5 minutes at 500 rpm (revolutions per 
minute). The supernatant was removed and the cell pellet resuspended in DMEM 
with 10% FCS (about 100 µl of culture medium per cm of nerve) containing 5 
µg/ml of insulin (Sigma) and 1 mM of glutamine (Gibco Brl). 100 µl of cell 
suspension was plated onto each PLL-precoated 13mm round coverslip that had 
been incubated at 37°C for at least 2 hours in 10 gg/ml of either laminin-1, laminin- 
2 or fibronectin (Sigma) in a 4-well culture plate. When cells had adhered to the 
coverslip at around 1-2 hours after plating, the medium in each well was topped up 
to 500 µl. Cultures were maintained for a period of 2 hours to 40 hours in a 
humidified CO2 incubator at 37 °C containing 7.5% CO2 before fixation and 
immunostaining. At least 4 animals were used for each time point and each 
substratum (see figs. 6.2,6.4,6.7). 
2.6.2: Immunocytochemistry, analysis and quantification of dissociated Schwann 
cells 
Dissociated Schwann cells were examined in vitro at 3 time points before fixation. 
Live cultures were observed at 3,16 and 40 hours after plating using a Nikon 
DIAPHOT-TMD inverted microscope (Japan) with a x20 and a x40 objective. 
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Digitised images were captured at these time points using a CCD camera (Model 
FA87; Grundig, Germany). 
Cultures of sciatic nerve containing Schwann cells were fixed and immunostained 
at 3 and 40 hour timepoints using the rabbit polyclonal antibody against the S 100 
(1: 400) Schwann cell cytoplasmic protein. Cultures were fixed at room temperature 
in 4% paraformaldehyde for 15 minutes and then rinsed 3 times in PBS followed by 
permeabilisation for 3 minutes in methanol at -20°C and further washes in PBS. 
Coverslips were then incubated for 1-2 hours in the primary antibody at room 
temperature. After rinsing in PBS cultures were incubated in Cy3-conjugated goat 
anti-rabbit IgG (1: 100) for 30-45 minutes and rinsed. For double immunostaining 
of Schwann cells for S 100 and the laminin a2 chain, cultures were first incubated, 
unfixed, for 1 hour at room temperature in rat monoclonal antibody against laminin 
a2 (1: 100; clone 4H8-2), then washed in prewarmed MEM medium before fixation 
for 15 minutes in 4% paraformaldehyde followed by rinsing in PBS and 
permeabilisation in methanol at -20°C for 3 minutes. S 100 staining was then carried 
out as above, the S100 staining was then visualised with Cy3-conjugated goat anti- 
rabbit IgG as above and the a2 chain staining by incubation with biotinylated anti- 
rat IgG (1: 100; Sigma) for 30-45 minutes followed by incubation in Streptavidin 
flourescein (1: 100) for 30-45 minutes. Cultures were mounted in DABCO in 
glycerol. 
Fluorescence immunostained Schwann cells were viewed under a x20 and x40 
objective on a Zeiss Axioskop microscope equipped with epifluorescence and 
digitised images taken using a Spot 2 cooled CCD camera. The numbers of S 100 
immunopositive Schwann cells on laminin-1, laminin-2 and fibronectin substrates 
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in cultures fixed at 3 hours and 40 hours after plating was counted manually and the 
numbers of dy/dy and unaffected Schwann cells compared using Student's t-tests 
(5% significance level at 3 hours and 0.5% significance level at 40 hours). Numbers 
of bipolar (2 or less processes) or multipolar (more than 2 processes) were also 
counted manually in cultures of dy/dy and unaffected Schwann cells on laminin-1 
and laminin-2 substrates at 40 hours. The percentage of multipolar cells was 
calculated in each culture and Student's t-tests were used to compare the numbers 
of dy/dy and unaffected multipolar Schwann cells (0.1% significance level) and the 
numbers of multipolar dy/dy Schwann cells on laminin-1 and laminin-2 substrates 
(5% significance level). 
2.7: Schwann cell-neuron co-cultures 
2.7.1: Preparation of dissociated Schwann cells as a culture substratum 
Dissociated suspensions of sciatic nerve cells were prepared as described above 
from P16-20 dy/dy mice and their unaffected littermates (chapter 2.6.1), but pellets 
of unaffected and or dy/dy sciatic nerve cells were resuspended to a final 
concentration of 30,000 in modified Bottenstein and Sato's culture medium (BSF- 
2; 100 µg/ml transferrin [Sigma], 3 mg/ml BSA, 2% FCS, 6 µg/ml progesterone 
[Sigma], 16 µg/ml each of putrescine [Sigma] and sodium selenite [Sigma] and 100 
pg/ml insulin all in 94% Ham's F-12 medium) supplemented with 1mM glutamine. 
These cell suspensions were plated onto laminin-1/PLL pre-coated 13 mm round 
glass coverslips, prepared as described above, in a 4-well culture plate. Cultures 
were maintained in a humidified incubator containing 5% C02, at 37°C for 48 
hours until confluent, before the addition of dissociated DRG neurons. 
132 
2.7.2: Dissociated DRG neurons 
DRG neurons were prepared from the DRGs of 4-6 week old dy/dy mice and their 
unaffected littermates (Gavazzi et al., 1999). DRGs were removed and attached 
roots trimmed in Ham's F-12 medium. DRGs underwent enzymic dissociation in 
0.0125% collagenase in BSF-2 for 1.5 hours in a humidified CO2 incubator at 37°C 
containing 5% CO2. The DRGs were removed from solution by means of a broken 
glass pasteur pipette and washed by being placed in a 20 ml Universal tube 
(Sterilin, UK) with 10 ml of Ham's F-12 such that the DRGs sunk to the bottom of 
the tube. Most of this solution was then removed carefully, leaving a moist plaque 
of DRGs at the bottom of the tube. Using a cut Gilson P-1000 pipette tip the DRGs 
were mechanically triturated 10-15 times in 500 µl of BSF-2. The top layer of the 
suspension was removed and floated gently over 2 ml of 15% BSA in a 10 ml 
conical centrifuge tube (Sterilin). A further 500 µl of BSF-2 was added to the 
remainder of the DRG plaque in the Universal tube and DRGs were again 
mechanically triturated 10-15 times through a P-1000 Gilson pipette tip. The 
remainder of the suspension was added to the cell suspension floating over the BSA 
in the centrifuge tube. The cell suspension was spun at 600 rpm for 7 minutes. The 
supernatant was removed carefully and the pelleted neurons resuspended in 100 µl 
of TID. The suspensions of dy/dy or unaffected DRG neurons were then diluted to a 
final concentration of 2-2,500 cells/ ml in BSF-2 containing 100 ng/ml NGF and 
1mM glutamine before plating on pre-established confluent cultures of dy/dy or 
unaffected Schwann cells. In each experiment half of the Schwann cell cultures 
were pre-incubated for 2 hours in culture medium supplemented with 10 µg/ml of 
laminin-2 before the addition of neurons. Co-cultures were maintained for a further 
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18-20 hours in a humidified CO2 incubator at 37°C containing 5% CO2 before 
fixation and inununostaining. At least 26 DRG neurons were assessed under each 
condition (see fig. 7.2). 
2.7.2: Immunocytochemistry and quantification ofSchwann cell-neuron co-cultures 
Schwann cell-neuron co-cultures were labelled with an antibody to GAP-43, and 
antigen expressed in growing neuntes. Co-cultures were firstly fixed at room 
temperature in 4% paraformaldehyde for 15 minutes, followed by rinses in PBS and 
permeabilisation with methanol at -20°C for 3 minutes and further rinses in PBS. 
Co-cultures were then incubated in a rabbit polyclonal antibody to GAP-43 
(1: 1000) for 1-2 hours, followed by rinsing in PBS. The primary antibody was then 
visualised by incubating the cultures in Cy3-conjugated goat anti-rabbit IgG 
(1: 100) for 30-45 minutes followed by further rinses in PBS. Coverslips were then 
mounted in DABCO in glycerol. 
Fluorescence immunostained co-cultures were viewed on a Zeiss Axioskop 
microscope equipped with epifluorescence and digitised images taken using a Spot 
2 cooled CCD camera under a x20 objective. Digitised images were taken only of 
DRG neurons in co-cultures that were observed to be growing in direct contact with 
recognisable Schwane cells. The number of processes projecting from the cell 
bodies of the DRG neurons and the number of process endings were counted from 
digitised images. The branching frequency and thus branching complexity was 
computed as the ratio of processes stemming from their cell bodies to the number 
of process endings (Butt et al., 1994). Student's t-tests were used to compare 
branching complexity of DRG neurons on laminin-2-treated and untreated dy/dy 
and unaffected Schwann cells at the 1% and 5% significance levels. 
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Chapter 3: The dy/dy mouse: Morphological abnormalities in 
sciatic nerves and expression of laminin a2 protein in myogenic 
and non-myogenic tissues 
3.1: Introduction 
The dy/dy mutation is a spontaneous mutation, resulting in an inherited myopathy 
in mice. In the earliest description by Michelson and colleagues in 1955, clear signs 
of atrophy and degeneration of skeletal muscle fibres were identified but no neural 
abnormalities were reported. Using electron microscopy, Bradley and Jenkison 
(1973) first identified extensive abnormalities in the PNS. dy/dy peripheral nerves 
contained large areas of bare, "amyelinated" axons, directly apposed and 
unensheathed by Schwann cells or myelin and displayed abnormally elongated 
nodes of Ranvier. Dorsal and ventral roots, cranial nerves and portions of sciatic 
nerve proximal to the spinal cord were all affected (Biscoe et al., 1974; Bradley et 
al., 1977; Bradley and Jenkison, 1973). 
The primary defect in these mice was first characterised as a "genetic deficiency of 
the basal lamina" in skeletal muscle and peripheral nerves by Madrid and 
colleagues (1975). Myelinated fibres appeared to have a patchy basal lamina and 
amyelinated fibres were completely devoid of basal lamina. These neural 
abnormalities were shown to result in slowed conduction velocities, abnormal, 
spontaneous propagation of impulses mid-axon and "cross-talk" of impulses 
between apposing naked axons (Carbonetto, 1977; Rasminsky, 1978). In the first 
part of this chapter I have described further detailed electron microscopy that we 
have carried out to determine the ultrastructure of dy/dy peripheral nerves and a 
novel immunohistochemical analysis, revealing more details of the abnormal axon- 
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Schwann cell relationships. 
Detailed molecular characterisation of the defect in dy/dy mouse basal lamina was 
first described by Arahata and colleagues (1993), who showed a severe reduction in 
both the laminin a2 chain protein and in mRNA transcripts of the lama2 gene in 
skeletal muscle, peripheral nerves and cardiac muscle (Arahata, 1993; Sunada et al., 
1994; Xu et al., 1994a). These previous investigations into laminin a2 chain protein 
expression in dy/dy mice, used a variety of polyclonal antibodies raised against 
different fragments of the laminin a2 chain. These included antibodies raised 
against recombinant peptides, affinity purified antibodies against both the 300 kDa 
N-terminus domain and the C-terminus G-domain of the laminin a2 chain and 
against G-domain synthetic peptides (Ehrig et al., 1990; Paulsson et at., 1991; 
Sunada et al., 1994; Xu et al., 1994a; Xu et at., 1994b). However none of these 
studies used antibodies against native mouse laminin a2 chain. So to further 
analyse the cause of the histological abnormalities seen in dy/dy peripheral nerves 
in relation to patterns of laminin a2 chain expression in muscle and neural tissue, I 
used antibodies to the native protein to re-assess the expression of the laminin a2 
chain in dy/dy mice. I have employed two different antibodies, one a rabbit 
polyclonal antibody for immunohistochemistry and the other a rat monoclonal 
antibody for immunoblotting, both raised against mouse whole heart merosin rather 
than synthetic peptides (Paulsson and Saladin, 1989; Schuler and Sorokin, 1995). 
Our use of novel antibodies raised against native a2 antigens, revealed strikingly 
different expression patterns of the laminin a2 chain in dy/dy skeletal muscle to 
those published previously (Sewry et at., 1998). 
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3.2: Results 
3.2.1: The interaction of Schwann cells with axons is disturbed in dy/dy sciatic 
nerves 
3.2.1.1: Ul tras tru ctu re 
Electron micrographs of dy/dy sciatic nerves sectioned in the longitudinal plane 
(fig. 3.1) showed the abnormalities characteristic of the mutant PNS initially 
observed by Bradley and Jenkison (1973). Patches of amyelinated sciatic nerve 
were observed where myelinated fibres had lost their myelin sheath (fig. 3.1a). 
Many axons with patchy myelin sheaths were not fully ensheathed by Schwann 
cells and some unmyelinated axons completely lacked any contact or ensheathment 
by Schwane cells. Naked axons were thus often directly apposed with no separation 
by Schwann cell cytoplasm. These bundles of naked axons are also found apposed 
to axons that are partially myelinated (fig. 3.1b). The nodes of Ranvier, normally 
short gaps of less than 1µm (Rios et al., 2000) in Schwane cell ensheathment and 
myelination, that allow for saltatory conduction of action potentials were often 
abnormally long in dy/dy sciatic nerves (fig. 3.1c) (Bradley et al., 1977). The 
endoneurial basal lamina is frequently patchy and fails to completely surround 
Schwane cells ensheathing the axons (fig. 3.1 c). 
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Figure 3.1: Intact dy/dy sciatic nerves show abnormalities of Schwann cell 
ensheathment and myelination. Electron micrographs of longitudinal sections of 
intact dy/dy sciatic nerves. (a) The axon (A) is incompletely ensheathed by a Schwann 
cell (SC) and partially myelinated (thin arrow), but the myelin sheath (MS) does not 
ensheath the whole axon. The lack of membrane loops where the myelin sheath 
terminates distinguishes this portion of the axon as being amyelinated rather than 
containing a node of Ranvier. (b) In this portion of nerve there is a partially myelinated 
axon (thin arrows), apposed by a group of naked axons (thick arrow) which are not 
ensheathed by Schwann cells. (c) The axon is myelinated but has an elongated node of 
Ranvier clearly seen by the paranodal membrane loops (PL) formed by the expansion 
of the myelin sheath (thin arrows). The endoneurial basal lamina in this region is 
patchy (arrowhead). Some axons are not properly ensheathed by Schwann cells and are 
directly apposed (thick arrow). Magnification: (a, b) x7500, (c) x22500. Scale bar: (a, 
b) = 2.4 µm, (c) = 7.2 µm. 
Sciatic nerves processed and prepared for electron microscopy by the Electron 



















Immunohistochemical analysis of dy/dy mice also showed abnormalities in both 
axonal and Schwann cell morphology in the PNS. Sciatic nerves from severely 
ataxic P45-P55 dy/dy mice were immunostained with an antibody against S 100, a 
Schwann cell cytoplasmic protein. Quantification showed that a significantly 
greater (p<0.0005) number of Schwann cells per unit length of nerve were to be 
found in dy/dy compared to unaffected nerves (table 3.1; fig. 3.2 c, d). Thus in 
longitudinal sections of unaffected sciatic nerve, there were 20.28 ± 1.44 (mean ± 
s. e. m., n= 13) S100-positive Schwann cells per mm of nerve compared with 30.57 
± 1.99 (n = 11) Schwann cells per mm of dy/dy nerve. 
In addition, Schwann cells in dy/dy sciatic nerves often displayed a different 
morphology to those in unaffected nerves and an apparently looser association with 
axons. Double-staining with antibodies to both S 100 and 2H3, an antibody against 
high molecular weight neurofilament, showed that in unaffected nerves Schwann 
cells were generally ellipsoid in shape and appeared to be closely aligned with 
axons as indicated by the neurofilament staining (fig. 3.2a, c, e). In contrast, the 
Schwann cells in dy/dy sciatic nerves appeared rounder and exhibited a looser 
association with 2H3-labelled axons (fig. 3.2b, d, f). A semi-quantitative analysis 
showed that 46.3% of dy/dy Schwann cells were ellipsoid whereas 81.4% of 
unaffected Schwann cells were ellipsoid. Moreover neurofilament staining 
appeared to be less extensive in mutant nerves (fig. 3.2a, b); this difference was 
more apparent in the sciatic nerves of older dy/dy mice (data not shown). 
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Figure 3.2: dy/dy sciatic nerve shows morphological differences to unaffected 
nerves. Polyester wax embedded unaffected (ua) (a, c, e) and dy/dy (b, d, f) sciatic 
nerves were cut into 8 µm thick sections and double-labelled with antibodies to the 
Schwann cell cytoplasmic protein, S100 (green) and with 2H3 against the 165 KDa 
neurofilament protein (red) and observed at a magnification of x40 (a-d) and x100 (e 
and f). (a) In unaffected nerves immunostaining with the 2H3 antibody showed that the 
nerve contained many long, straight neurofilaments (arrowhead) and the axons neatly 
aligned. (b) Neurofilament staining in dy/dy sciatic nerves is patchy (arrowhead) and 
less extensive and the axons do not appear to be neatly aligned with each other. (c) 
Schwann cells in unaffected sciatic nerves are usually ellipsoid in shape (arrow). (d) In 
dy/dy nerves there are far more Schwann cells and in addition a substantial proportion 
of them are rounded rather than ellipsoid (arrow). (e, f) Double-staining shows that the 
largely ellipsoid Schwann cells in unaffected nerves all seem to be closely aligned with 
axons (arrow) and in dy/dy nerves many of the rounded Schwann cells are not aligned 








Table 3.1: Quantification of Schwann cell numbers per unit length in 
unaffected and dy/dy sciatic nerves. Sections of sciatic nerve were immunostained 
with an antibody to the cytoplasmic protein S100. The number of S100 
immunoreactive cells were counted in digitised fluorescent images of unaffected (n 
= 13) and dy/dy (n = 11) sciatic nerves and the length of nerve in which these cells 
were contained was calculated to determine the number of Schwann cells per mm 
of nerve. The difference in the number of S 100 immunoreactive cells was highly 
significant (p<0.0005). 
Unaffected sciatic nerves dy/dy sciatic nerves 
Average number of Schwann 20.28 30.57 
cells/mm 
Number of nerves analysed 13 11 
(n) 
Standard deviation 6.62 5.20 
(t) 
Standard error of the mean 1.44 1.99 
(t) 
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3.2.2 Immunoblotting of d)/dy mouse tissues shows a differential expression 
pattern of the laminin a2 chain in peripheral nerve, cardiac muscle and 
skeletal muscle 
Immunoblotting of tissue extracts with the antibody to EHS-laminin/laminin-1 
revealed intense staining at approximately 400 kDa equivalent to that of the a1 
chain, staining at a 220 kDa band indicated the presence of the PI chain. The 
human placental merosin standard used is not a pure source of laminin-2 and 
contains detectable levels of the laminin al chain. There was comparable staining 
intensity for the a1 chain, and for the 01 chain in skeletal muscle and in neural 
tissues of dy/dy and unaffected mice (figs 3.3b, 3.4b, 3.5b). Thus the ß1 chain that 
is also normally constituents of the laminin-2 heterotrimer, is not down-regulated in 
dy/dy tissue. 
Immunoblotting of the same samples with an antibody specific to the laminin a2 
chain (Paulsson and Saladin, 1989) however, showed differences in the expression 
of this constituent of the laminin-2 heterotrimer. The antibody used recognises a 
300 kDa proteolytic fragment of the laminin a2 chain protein. As expected, 
samples of dorsal roots, sciatic nerve, cardiac and skeletal muscle from unaffected 
mice showed strong expression of the laminin a2 chain with a sharp, intensely 
stained band at 300 kDa. A few bands at approximately 220 kDa and below 
probably represent degradation products (Paulsson et al., 1991), as the antibody 
does not detect the ß1 and yl chains in laminin-2 standards (figs. 3.3a, 3.4a, 3.5a). 
The dy/dy mice analysed for expression of the laminin a2 chain were used only 
when they had begun to show advanced symptoms typical of dy/dy mice. Thus all 
mice classified as mutants in this study displayed advanced hind-limb paralysis. In 
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previous reports, using different antibodies, negligible levels of laminin a2 protein 
were detected by Western blotting in either peripheral nerves or skeletal muscles 
from dy/dy mice (Arahata, 1993; Sunada et al., 1994; Xu et al., 1994a). In contrast, 
in our experiments expression of the 300 kDa a2 chain band by dy/dy mouse 
tissues in western blots was substantially reduced only in nerve tissue. In dy/dy 
skeletal muscle, a strong 300 kDa band was clearly visible (fig. 3.6a) and almost as 
intense as the level in skeletal muscle from unaffected mice (the limited availability 
of the non-commercial antibody used for immunoblotting meant a2 chain 
expression in cardiac muscle could only be analysed immunohistochemically; see 
below). In contrast, sciatic nerves and dorsal roots in dy/dy mice appeared not to 
express significant quantities of the laminin a2 chain. Staining at 300 kDa in the 
peripheral nerves of dy/dy mice appeared to be negligible (fig. 3.4a, 3.5a), 
suggesting a complete absence or severe deficiency of the laminin a2 chain, in 
agreement with previous studies using different antibodies. 
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Figure 3.3: The laminin a2 chain is weakly expressed in the sciatic nerves of dy/dy 
mice. 2mg/ml of homogenised unpurified sciatic nerve proteins from dy/dy and 
unaffected (ua) mice were run on 5% SDS-PAGE gels, blotted onto PVDF membranes 
and stained with either a rabbit polyclonal antibody to the laminin a2 chain (a) or a 
rabbit polyclonal antibody against laminin-1 (b). (a) A 300 kDa a2 chain was clearly 
seen in lanes containing the human placental merosin standard (m) and unaffected 
sciatic nerve, as well as a degradation product at 220 kDa. In dy/dy sciatic nerves the 
staining intensity of the a2 chain is greatly reduced and the chain is barely detectable. 
(b) The al and ß1 chains were detected at 400 and 220 kDa respectively with a 
degradation product with a lower molecular weight than 220 kDa. There is no decrease 
in the expression of these chains in dy/dy sciatic nerves. (r = rainbow marker, A= 220 
kDa marker on rainbow marker, B= 97.4 kDa marker on rainbow marker, green arrow 
= origin, blue arrow = dye front, *= degradation products). 
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Figure 3.4: The laminin a2 chain is weakly expressed in the dorsal roots of dy/dy 
mice. 2mg/ml of homogenised unpurified dorsal root proteins from dy/dy and 
unaffected (ua) mice were run on 5% SDS-PAGE gels, blotted onto PVDF membranes 
and stained with either a rabbit polyclonal antibody to the laminin a2 chain (a) or a 
rabbit polyclonal antibody against laminin-1 (b). (a) There was strong expression of a 
300 kDa a2 chain band in the lanes containing the dorsal roots of unaffected mice and 
in the lane containing the human placental merosin standard (m), as well as the 
degradation product at 220 kDa. In lanes containing dy/dy dorsal roots, expression of 
the laminin a2 chain was negligible. (b) The aland ßl chains can be seen at 400 and 
220 kDa respectively. The staining intensity is comparable in lanes containing the 
human placental merosin standard. (r = rainbow marker [molecular weights as before], 
green arrow = origin, blue arrow = dye front, *= degradation products). 
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3.4: Dorsal roots 
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Figure 3.5: The laminin a2 chain is strongly expressed in dj/týy skeletal muscle. 
2nng/ml of unpurified homogenised skeletal muscle proteins from unaffected (ua) 
and c4v/c4v mice were run on 5% SDS-PAGE gels, blotted with PVDF membranes 
and stained with either a rabbit polyclonal antibody against the laminin a2 chain (a) 
or a rabbit polyclonal antibody against laminin-1 (b). (a) There is strong expression 
of the a2 chain at 300 kDa and a degradation product at 220 kDa in both unaffected 
and dy/tlv skeletal muscles and in the human placental merosin standard (m). There 
does not seem to be a substantial decrease in the staining intensity of the a2 chain 
hands in the skeletal muscle of dv/dy mice as there is in peripheral nerves. (b) The 
a1 and III chains are equally well expressed at 400 and 220 kDa, respectively, in 
the skeletal muscle of dy/dy and unaffected mice. (r = rainbow marker [molecular 
weights as before], green arrow = origin, blue arrow = dye front, *= degradation 
products). 
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3.5: Skeletal muscle 
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3.2.3: Immunohistochemical analysis also shows differential expression of the 
laminin a2 chain in dv/dy peripheral nerves, cardiac muscle and skeletal 
muscle 
The rat monoclonal antibody 4H8 used for immunohistochemical analysis, like the 
rabbit polyclonal antibody used above, was raised against mouse heart laminin and 
recognises a 300 kDa fragment of the laminin a2 chain (Schuler and Sorokin, 
1995). Skeletal and cardiac muscle and sciatic nerve from both dy/dy and 
unaffected mice, stained with an antibody against EHS-laminin (fig. 3.6c, d, 3.7c, 
d, 3.8c, d), are all strongly immunopositive, indicating that the ß1 and yl chain are 
present at comparable levels in mutant and unaffected tissue. However, staining 
with the a2 chain-specific antibody (4H8-2) showed that whilst levels of a2 were 
expressed at negligible levels in dy/dy peripheral nerves (fig. 3.6a, b), the intensity 
of immunostaining in skeletal muscle was comparable in both mutants and controls 
and was not substantially reduced in dy/dy cardiac muscle (fig. 3.7a, b, 3.8a, b). 
Wherever the laminin a2 chain was expressed, it co-localised with EHS-laminin 
immunoreactivity (fig. 3.6e, f, 3.7e, f, 3.8e, f). 
Another antibody to laminin a2 chain, (clone 403; gift of L. Sorokin) was obtained 
to try and clarify the results of these experiments. This antibody was raised in rabbit 
against the C-terminus G1-3 domain of mouse laminin a2 chain. However, it was 
found that in skeletal and cardiac muscle and in sciatic nerve, immunoreactivity 
was of comparable intensity in all tissues from unaffected (fig. 3.6g, 3.7g, 3.8g) and 
dy/dy (fig. 3.6h, 3.7h, 3.8h) mice. Thus two principal antibodies used for the 
detection of the a2 chain in immunoblotting and in immunohistochemistry, 
corresponded in their ability to detect significant expression of the laminin a2 chain 
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in dy/dy skeletal and cardiac muscle but not in peripheral nerves. 
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Figure 3.6: Laminin a2 chain immunoreactivity is not detected in dy/dy sciatic 
nerve with clone 4H8 monoclonal antibody. Fresh frozen, 8 µm cryosections of 
sciatic nerve from unaffected (ua) (a, c, e) and dy/dy (b, d, f) mice were double 
immunostained with antibodies to the laminin a2 chain (a2; clone 4118) and to EHS- 
laminin (lnl) and visualised with fluorescein and rhodamine conjugates, respectively, 
at x40 magnification. Sections were also immunostained with an antibody to the 
laminin a2 chain, clone 403, and visualised with a rhodamine conjugate (g, h). (a) The 
endoneurium in the sciatic nerves of unaffected (ua) mice appears to express high 
levels of the laminin a2 chain (arrowhead). (b) The endoneurium in the sciatic nerves 
of dy/dy mice appears to be completely devoid of the laminin a2 chain and no 
immunoreactivity could be detected. (c) The endoneurium of unaffected sciatic nerves 
was strongly immunoreactive for EHS-laminin (arrow), consistent with expression of 
all or some of al, ßl and yl chains. (d) The endoneurium in dy/dy sciatic nerves is 
also strongly immunoreactive for EHS-laminin (arrow). Although the staining intensity 
is comparable to that seen in unaffected nerves, the pattern of staining is less organised 
than in unaffected nerves where clear bands of endoneurium are visible. (e) Double- 
staining shows that in unaffected nerves the laminin a2 chain co-localises with all or 
some of al, ßl and yl chains. (t) Double-labelling of dy/dy sciatic nerve shows only 
EHS-laminin immunoreactivity with no co-localisation with the laminin a2 chain. (g) 
The endoneurial basal lamina of sciatic nerves in unaffected mice is strongly 
immunoreactive (arrowhead) with the clone 403 antibody against the mouse G-domain 
of the mouse laminin a2 chain. (h) The endoneurial basal lamina of dy/dy sciatic 
nerves (arrowhead) is also strongly immunoreactive with the 403 antibody. Scale bar 







Figure 3.7: Laminin a2 chain immunoreactivity is detected at low levels in the 
cardiac muscle of dy/dy mice with 4H8 antibody. Fresh frozen, 8 µm cryosections of 
cardiac muscle from unaffected (ua) (a, c, e) and dy/dy (b, d, f) mice were double 
immunostained with antibodies to the laminin a2 chain (a2; clone 4H8) and to EHS- 
laminin (lnl) and visualised with fluorescein and rhodamine conjugates, respectively, 
at x40 magnification. Sections were also immunostained with an antibody to the 
laminin a2 chain, clone 403, and visualised with a rhodamine conjugate (g, h). (a) 
Laminin a2 chain is strongly expressed (arrowhead) in the basal lamina surrounding 
cardiac muscle fibres in unaffected mice. (b) In the cardiac muscle of dy/dy laminin a2 
chain immunoreactivity is very weak (arrowhead). (c) Immunoreactivity for the 
al/ßl/y1 chains recognised by the antibody against EHS-laminin is strong in cardiac 
muscle from unaffected mice (arrow). (d) The cardiac muscle of dy/dy mice is 
immunoreactive for the al/3l/y1 chains but staining intensity is weaker than in the 
cardiac muscle of unaffected mice (arrow). (e) The laminin a2 chain co-localises with 
the al/ßl/y1 chains in the cardiac muscle of unaffected mice. (f) Although 
immunoreactivity is substantially weaker for both the anti-EHS-laminin and the anti- 
laminin a2 chain antibodies, co-localisation is still observed in the cardiac muscle of 
dy/dy mice. (g) Strong immunoreactivity is observed in the basal lamina of cardiac 
muscle (arrowhead) stained with clone 403 antibody against the G-domain of the 
mouse laminin a2 chain in unaffected mice. (h) dy/dy cardiac muscle basal lamina is 




Figure 3.8: Laminin a2 chain immunoreactivity is slightly reduced in the skeletal 
muscle of the dy/dy mouse with 4H8 antibody. Fresh frozen, 8 µm cryosections of 
skeletal muscle from unaffected (ua) (a, c, e) and dy/dy (b, d, f) mice were double 
immunostained with antibodies to the laminin a2 chain (a2; clone 4118) and to EHS- 
laminin (ln1) and visualised with fluorescein and rhodamine conjugates, respectively, 
at x40 magnification. Sections were also immunostained with an antibody to the 
laminin a2 chain, clone 403, and visualised with a rhodamine conjugate (g, h). (a) The 
skeletal muscle basal lamina of unaffected mice is strongly immunoreactive for the 
laminin a2 chain (arrowhead). (b) Although the staining intensity appears slightly 
weaker than in unaffected mice, the skeletal muscle basal lamina of dy/dy mice is still 
quite strongly immunoreactive for the laminin a2 chain (arrowhead) and there does not 
appear to be a very substantial reduction in expression. (c) The skeletal muscle basal 
lamina is strongly immunoreactive for the al/ß1/y1 chains (arrows) in unaffected 
mice. (d) The skeletal muscle basal lamina of dy/dy mice appears to be strongly 
immunoreactive for the laminin a1/p1/y1 chains (arrow). (e) Expression of the laminin 
al/(31/y1 chains co-localises with laminin a2 chain expression in the skeletal muscle 
basal lamina of unaffected mice. (f) The laminin a2 chain and al/ß1/yl chains also co- 
localise in the skeletal muscle basal lamina of dy/dy mice. (g) The skeletal muscle 
basal lamina of unaffected mice is strongly immunoreactive (arrowhead) with the clone 
403 antibody against the G-domain of mouse laminin a2 chain. (h) The 403 antibody 
is also strongly immunoreactive in the basal lamina of the skeletal muscle (arrowhead) 








3.3.1: Morphological differences in the peripheral nerves of dv/dv mice 
The laminin a2 chain affected in dy/dy mice and in humans with merosin-deficient 
CMD is pleiotropic, being expressed in both myogenic and neural tissues. In 
contrast, the mutation in humans with DMD and in mdx mice, affects the gene that 
encodes dystrophin, a component of the DAG receptor complex. Dystrophin is 
widely expressed in muscle, but another cytoskeletal protein, utrophin, serves the 
same function in Schwann cells (Hoffman et al., 1987; Ohlendieck and Campbell, 
1991). This mutation results in a dystrophy that is primarily myogenic, without 
extensive neural abnormalities and is a less severe dystrophy than in dy/dy mice or 
humans with merosin-deficient CMD. 
Thus the discovery of neural abnormalities in dy/dy mice raised the possibility that 
these may contribute to severity of the dystrophy (Banker et al., 1979). Schwann 
cells have a major role in axonal guidance and survival as evidenced in mutant 
mice with targeted deletions of the ErbB2 or ErbB3 neuregulin receptors which are 
deficient in Schwann cells and suffer from apoptotic death of neurons and 
defasciculation (Morris et al., 1999; Riethmacher et al., 1997; Woldeyesus et al., 
1999). Schwann cells are also involved in the development and regeneration of 
NMJs (Love and Thompson, 1998; Son and Thompson, 1995a; Son and Thompson, 
1995b; Son et al., 1996; Trachtenberg and Thompson, 1997; Trachtenberg and 
Thompson, 1996). Schwann cell abnormalities, for instance invasion of the synaptic 
cleft by Schwann cell processes in mice lacking the laminin-11 heterotrimer (Patton 
et al., 1998), result in loss of synapses and consequent loss of neuromuscular 
transmission. It is therefore possible that the neural abnormalities in dy/dy mice also 
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affect the ability of nerves to innervate and conduct impulses to skeletal muscles. 
The main neural target of the mutation in dy/dy mice are the Schwann cells and the 
data in this chapter provides additional evidence for a major neurogenic component 
to the resulting dystrophy. 
Previous ultrastructural studies had shown that patchy endoneurial basal lamina, 
hypomyelination and abnormally wide nodes of Ranvier were common in the spinal 
roots and peripheral nerves of dy/dy mice (Bradley et al., 1977; Bradley and 
Jenkison, 1973; Bradley and Jenkison, 1975; Madrid et al., 1975). Our electron 
microscopical studies confirmed these abnormalities in the intact sciatic nerves of 
the dy/dy mouse. Immunohistochemical studies further showed that the deficiency 
in the laminin a2 chain was associated with substantial changes in the organisation 
of dy/dy sciatic nerves. 
Thus S100 positive cells were significantly more numerous in dy/dy sciatic nerves 
as shown by a 56% increase in the number of immunoreactive cells per unit length 
of nerve (see table 3.1). Also, whilst the vast majority of Schwann cells in 
unaffected nerves appeared to have the ellipsoid morphology characteristic of 
Schwann cells that have associated with and elongated along axons, in dy/dy nerves 
almost half the Schwann cells were rounded in shape. Furthermore double 
immunostaining of Schwann cells and axons showed a lack of close alignment in 
dy/dy nerves. Analysis of ultrastructure (fig. 3.1) confirmed that dy/dy Schwann 
cells often only loosely contacted axons. This failure to elongate and align with the 
axon would lead to the more rounded morphology of dy/dy Schwann cells, since it 
would expose less Schwann cell surface membrane to axons. In addition electron 
micrographs showed that some dy/dy Schwann cells extended processes to several 
162 
axons, which would account for the abnormal morphology revealed in S 100 
immunohistochemistry of dy/dy nerves. The extension of multiple processes could 
contribute to the apparent increase in the density of S 100 positive cells in dy/dy 
sciatic nerves. These rounded and densely packed areas of S 100 immunoreactivity 
in dy/dy nerves may in some cases represent Schwarm cell processes. 
Several in vitro studies have shown that the deposition of basal lamina leads to 
changes in Schwann cell morphology linked to their terminal differentiation and 
axonal ensheathment. In cultures with neurons, addition of exogenous basal lamina 
led to longitudinal spreading of the Schwann cells along the nerve fibres. This was 
a basal lamina and not a nerve-dependent phenomen, as the removal of neurons 
from the culture did not prevent the Schwann cells from elongating (Carey et al., 
1986). Similarly, in co-cultures with fibroblasts, elaboration of the basal lamina 
results in the elongation of the Schwann cells and alignment with respect to each 
other (Obremski et al., 1993b). The patchy basal lamina observed in dy/dy nerves is 
probably insufficient to support this differentiation and elongation of Schwann cells 
and may account for the morphology of S 100 positive cells in mutant nerves. 
Thus for those Schwann cells that are able to differentiate in dy/dy nerves, contact 
with basal lamina is essential for normal Schwann cell-axon interactions. When 
suspended nerve fascicles were grown in vitro in the absence of basal lamina, 
clusters of Schwann cells extended processes to more than one axon (Bunge and 
Bunge, 1978). Few Schwann cells actually ensheathed the axons and there was no 
myelin formation, abnormalities reminiscent of those found in dy/dy mice. Addition 
of ECM constituents resulted in Schwann cell ensheathment of both small and large 
diameter axons and myelination of the latter (Bunge and Bunge, 1978). 
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Furthermore control of Schwann cell differentiation and basal lamina formation can 
be triggered by ascorbic acid in co-cultures of axons and Schwann cells, suggesting 
that myelination could be regulated by the ability of Schwann cells to form basal 
lamina (Eldridge et al., 1989; Eldridge et al., 1987). 
The endoneurial basal lamina in dy/dy nerves may be insufficient for normal 
development of Schwane cells and myelination of axons on two counts; firstly its 
scarcity means that few Schwann cells are in intimate contact with the basal lamina 
and secondly the composition of the basal lamina that is present is abnormal. The 
endoneurial basal lamina in adult dy/dy nerves contains abnormally high levels of 
laminin a4 chain, which is not normally found there (Patton et al., 1997). The a4 
chain could, in principle, heterotrimerise in the endoneurial basal lamina with the 
ßl and yl chains normally associated with the a2 chain, but evidently this cannot 
compensate structurally or functionally for the absence of laminin a2 chain in the 
mutant. Thus ectopic upregulation of the a4 chain in dy/dy endoneurium is unable 
to fully compensate for laminin a2 chain in inducing Schwann cell ensheathment 
and myelination in the mutant nerves. 
I have observed abnormalities of Schwann cell ensheathment and morphology in 
the sciatic nerves of dy/dy mice, which may disrupt the ability of nerves innervating 
skeletal muscles to transmit impulses. Abnormalities have also been observed at the 
NMJ in dy/dy mice, which may interfere with synaptic transmission. The post- 
synaptic area per nerve terminal, post-synaptic membrane length and the post- 
synaptic area per nerve terminal area are all significantly less in dy/dy mice. The 
junctional folds were less complex and Schwann cell cytoplasm was seen to extend 
into the synaptic cleft (Banker et al., 1979; Desaki et al., 1995; Law et al., 1983). 
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This latter abnormality has been more recently observed in transgenic mice lacking 
the laminin-11 heterotrimer ((x5f32y1) which like laminin-4 (a2ß2y1) is normally 
expressed in synaptic basal lamina (Patton et al., 1998). This is consistent with a 
role for specific laminin chains in controlling Schwann cell process extension. 
However these abnormalities at the NMJ do not appear to be severe enough to 
significantly affect neuromuscular transmission in dy/dy mice as defined by 
spontaneous transmitter release rather than evoked transmitter release. The failure 
rate for neuromuscular transmission in dy/dy mice of 2% was equivalent to that 
seen in normal mice (Carbonetto, 1977). Conduction velocity is however lower in 
dy/dy nerves (Rasminsky et al., 1978). This lowered conduction velocity arises as a 
result of two of the neural abnormalities that we have observed. Firstly, large axons 
that are normally myelinated throughout their lengths to aid conduction are either 
not myelinated or have long amyelinated patches (fig. 3.1a, b). Secondly, the 
widened nodes of Ranvier in myelinated mutant nerves (fig. 3.1c) compromise the 
saltatory conduction that occurs from node to node. An abnormally high frequency 
of giant spontaneous potentials has been noted in dy/dy peripheral nerves and 
ectopic generation of impulses also arises mid-nerve due to "cross-talk" between 
apposing, naked axons unsheathed by Schwann cells (fig. 3.1b) (Carbonetto, 1977; 
Rasminsky, 1978). If conduction to the muscle is compromised or the axon itself 
degenerates, the muscle fibre would become functionally denervated and may begin 
to atrophy. Denervation of dy/dy skeletal muscle produces certain mechanical 
changes on muscle weight, contraction time and twitch and tetanus relaxations that 
suggest that some mechanical alterations seen in dy/dy skeletal muscle arise 
neurogenically (Zeman and Sandow, 1979). 
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Early observations on axoplasmic flow of proteins determined that slow axonal 
transport is decreased and fast axonal transport was increased in the nerves of dy/dy 
mice (Bradley and Jaros, 1973; Komiya and Austin, 1974). However this is not 
necessarily indicative of axonal degeneration and may simply be due to a higher 
turnover of protein in dy/dy peripheral nerves. The rate of axonal transport of 
choline acetyltransferase activity is reduced in dy/dy sciatic nerves (Jablecki and 
Brimijoin, 1974). This may indicate a reduction in the activity of motorneurons in 
dy/dy mice as a result of either axonal degeneration or of muscle necrosis. 
Nicotinic receptors in both dy/dy and mdx mouse skeletal muscle show reduced 
sensitivity to the agonistic effects of acetylcholine; in dystrophic muscle synaptic 
transmission may be altered as a result of phosphorylation of one of the nicotinic 
receptor subunits. However spontaneous opening of nicotinic receptors without 
impulse conduction is a common feature of dy/dy but not mdx mouse skeletal 
muscle and is suggestive of an inability to downregulate the activity of this receptor 
(Franco-Obregon and Lansman, 1995). The fact that spontaneous activity is unique 
to dy/dy mice suggests that the pathogenesis in dy/dy skeletal muscle differs from 
that of mdx skeletal muscle. Severe neuronal abnormalities in dy/dy mice may result 
in more profound alterations in activity at the NMJ compared to mdx mice. The 
spontaneous activity is a feature characteristic of undifferentiated myoblasts, which 
may be present in dy/dy skeletal muscle either as a result of retarded development 
or due to regeneration of focal lesions in dy/dy skeletal muscle (Ringelmann et al., 
1999). These focal lesions may be either a direct consequence of the dystrophy in 
the muscles or due to denervation as a result of the neural abnormalities in dy/dy 
mice. 
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Mice with targeted deletions in which the ErbB2 neuregulin receptor is deficient, 
are able to form acetylcholine receptors at the NMJ, probably due to activation of 
alternate ErbB3 and ErbB4 receptors (Lin et al., 2000; Woldeyesus et al., 1999). 
However an absence of Schwann cells means that the unensheathed motor axons 
innervating skeletal muscles degenerate and defasciculate, generating both pre and 
post-synaptic abnormalities. The motor nerve terminals are not ensheathed by 
Schwann cells at all in ErbB2-1 mice and post-synaptically there is a deficiency or 
absence of junctional folds (Lin et al., 2000). Poor junctional folding is also seen at 
the NMJ of dy/dy mice and is a feature of developing and regenerating muscle 
fibres (Banker et al., 1979; Desaki et al., 1995; Law et al., 1983). Thus 
neuromuscular and skeletal muscle abnormalities could be generated purely as a 
result of motor axon degeneration caused by lack of Schwann cell ensheathment. 
With the recent construction of several different lines of laminin a2 null mutant 
mice, it has been possible to further test the neurogenic aspect of a2-chain-deficient 
dystrophies (Kuang et al., 1998b; Miyagoe et al., 1997). In these null mutants it was 
evident that laminin-2 was necessary for the repair and maintenance of skeletal 
muscle (Kuang et al., 1998a; Kuang et al., 1998b; Kuang et al., 1999). However 
insertion of a human laminin a2 chain transgene under a muscle-specific creatine 
kinase promoter improved muscle morphology and integrity but the mice were still 
left with the progressive lameness of the hind-limbs consistent with a major 
neurogenic contribution in the dystrophy (Kuang et al., 1998b). It is clear therefore, 
that both neurogenic and myogenic pathology contribute to the dystrophy in a2- 
deficient mice. 
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3.3.2: Differential expression of the laminin a2 chain in skeletal muscle and 
neural tissue suggests the existence of tissue-specific variants of the a2 chain 
When the basal lamina deficiency in dy/dy mice was initially identified, it appeared 
that expression of the laminin a2 chain protein was negligible in skeletal and 
cardiac muscles and peripheral nerves. Moreover these early studies also found that 
levels of lama2 gene mRNA were also substantially reduced and barely detectable 
in some cases in skeletal and cardiac muscles (Arahata, 1993; Sunada et al., 1994; 
Xu et al., 1994a). In this chapter I have shown that in fact, myogenic dy/dy tissues 
continue to express laminin a2 chain, while expression in neural tissue is negligible 
(Sewry et al., 1998) and this has been confirmed recently both 
immunohistochemically and at the mRNA level (Ringelmann et al., 1999; Sorokin 
et al., 2000). These findings suggest that a laminin a2 chain variant exists. 
We found that laminin a2 chain immunoreactive protein expression was negligible 
in the peripheral nerves of dy/dy mice, but was detected at low levels in cardiac 
muscle and at apparently close to normal levels in skeletal muscle. In this study, I 
used a rabbit polyclonal antibody for immunoblotting (Paulsson and Saladin, 1989) 
and a rat monoclonal antibody for immunostaining (Schuler and Sorokin, 1995), 
both raised against mouse heart laminin; both recognise the 300 kDa N-terminus 
fragment of the laminin a2 chain. In the first study to attribute the cause of the 
muscular dystrophy in dy/dy mice to a deficiency of the laminin a2 chain (Arahata, 
1993), rabbit polyclonal antibodies against the C-terminus segment of the human 
a2 chain and against the N-terminus segment of mouse a2 chain were used. 
Immunoblotting and immunohistochemistry both showed that laminin a2 chain 
immunoreactivity was negligible in cardiac and skeletal muscle and peripheral 
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nerves. In addition, electron microscopy showed that the skeletal muscle basal 
laminae were thinner and discontinuous in dy/dy mice (Arahata, 1993). Other 
previous studies used antibodies raised against the C-terminus and N-terminus 
fragments of the laminin a2 chain, synthetic peptides and recombinant proteins, 
and also showed a substantial deficiency of the laminin a2 chain protein in mutant 
skeletal and cardiac muscle and peripheral nerves (Sunada et al., 1994; Xu et al., 
1994a). 
My study concurs with previous work in showing that laminin a2 chain protein 
expression is severely deficient or absent in dy/dy peripheral nerves but provides 
conflicting evidence that laminin a2 chain protein may be expressed at substantial 
levels in myogenic tissues of dy/dy mice (Sewry et al., 1998). The differences 
between laminin a2 chain immunoreactive protein expression in dy/dy myogenic 
tissue in this study compared to previous work could simply reflect a variation in 
the epitopes recognised by the different antibodies used. This is unlikely however, 
as my study used two different antibodies, albeit both raised against a2 chain 
protein of mouse heart laminin. Furthermore two recently published studies have 
also shown that the laminin a2 chain protein is detectable in dy/dy myogenic tissues 
such as skeletal and cardiac muscle but not in non-myogenic tissues such as 
peripheral nerves and lung (Ringelmann et al., 1999; Sorokin et al., 2000). One of 
the antibodies used in these two published studies is the 4H8 antibody that I have 
used to analyse a2 chain protein expression immunohistochemically. It is possible 
that mouse heart laminin, against which these antibodies were raised, contains a 
variant form of the laminin a2 chain protein. Antibodies raised against heart 
laminin may recognise epitopes that do not exist on the primary variant of the 
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laminin a2 chain that was found to be deficient in both the myogenic and non- 
myogenic tissues of dy/dy mice. Thus the antibodies used in my experiments appear 
to recognise variant laminin a2 chain, which is expressed in all tissues in 
unaffected mice and is substantially down-regulated in all except myogenic tissues 
in dy/dy mice. 
The idea that a variant of the laminin a2 chain exists in mice is supported by the 
recent identification of a variant laminin a2 chain in patients with the human 
equivalent of the dy/dy muscular dystrophy, merosin-deficient CMD (Pegoraro et 
al., 1998; Pegoraro et al., 2000). A mutation in exon 31 of the lama2 gene resulted 
in an expressed variant of the laminin a2 chain that may fail to assemble a laminin- 
2 heterotrimer. The inability of this variant a2 chain to incorporate a heterotrimer 
means that any basal laminae in these patients that would normally express the a2 
chain are not formed properly. Immunostaining and immunoblotting by myself and 
in previous studies show that both variants of the a2 chain are expressed in 
unaffected and dy/dy mice (Arahata, 1993; Ringelmann et al., 1999; Sewry et al., 
1998; Sorokin et al., 2000; Sunada et al., 1994; Xu et al., 1994a), rather than as a 
consequence of mutations in the lama2 chain gene as in seen in subjects with CMD 
by Pegoraro and her colleagues (2000). There is at least one example of a laminin a 
chain with expressed variants. The lama3 gene has been shown to encode more 
than one isoform of the laminin a3 chain. Initially a shorter, truncated isoform, 
laminin a3A was identified (Aberdam et al., 1994; Rousselle et al., 1991), a longer 
isoform, the laminin a3B also exists (Miner et al., 1997). This raises the possibility 
that other laminin chains such as the a2 chain may have more than one variant in 
normal tissues. 
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dy/dy mice may seem at odds with earlier observations that showed a marked 
reduction in the lama2 mRNA encoding the protein. The lama2 gene mRNA was 
not detectable in skeletal muscle by Northern blotting in affected mice, however 
amplification of the mRNA signal with RT-PCR showed that detectable levels of 
lama2 mRNA were expressed in skeletal and cardiac muscle but at significantly 
reduced levels (Arahata, 1993; Xu et al., 1994a). Also Ringelmann and colleagues 
(1999) have recently reported that reduced but clearly detectable lama2 mRNA 
expression in dy/dy skeletal muscle but not in non-myogenic tissues using Northern 
blot analysis, without the benefit of RT-PCR amplification. The cDNA probes used 
in these studies detected different sequences in the lama2 mRNA, Xu and 
colleagues (1994) used probes that recognised 3' sequences in what would translate 
to the N-terminus domain of the protein whereas Ringelmann and colleagues 
(1999) used cDNA probes that recognised sequences in the 5' region. These 
findings indicate that the particular sequence of lama2 mRNA may be more stable 
in the myogenic than non-myogenic tissues of dy/dy mice or that more is generated 
than in non-myogenic tissues. Although there is no conclusive evidence, an 
alternative explanation for continued high-level expression of a2 chain protein and 
mRNA in myogenic tissues of dy/dy mice is that differentially spliced variants of 
the a2 chain exist. 
Despite the finding that a possible variant of the laminin a2 chain is expressed at 
clearly detectable levels in the skeletal muscles of dy/dy mice they still suffer from 
a severe myopathy and the skeletal muscle basal laminae are discontinuous 
(Arahata, 1993). Neurogenic myopathy in dy/dy and merosin-deficient CMD 
skeletal muscle as a result of neural abnormalities may heighten the severity of the 
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myogenic myopathy compared to other muscular dystrophies where the PNS 
remains largely unaffected. The antibodies I have used may also detect an 
alternative variant that is expressed but functionally ineffective in dy/dy myogenic 
tissues. Although the dy/dy locus is known to map to the same region of mouse 
chromosome 10 as the lama2 gene (Sunada et al., 1994), the exact site of the 
mutation is unknown and the locus may encompass more than one site in the a2 
chain. This could result in the absence of one isoform in non-myogenic tissues but 
continued low-level expression in myogenic tissues. 
The mutation in dy2j/y2dj mouse and in some humans with merosin-deficient CMD, 
leads to the production of an altered but still detectable laminin a2 chain that is 
unable to heterotrimerise in skeletal muscle (Colognato and Yurchenco, 1999; 
Pegoraro et al., 1998; Pegoraro et al., 2000). It is possible that the variant I have 
detected fails to heterotrimerise and so the basal laminae of myogenic tissues in 
dy/dy mice are abnormal despite detectable expression of a laminin a2 chain. If so, 
then processing skeletal muscle in a native gel without denaturing the heterotrimer 
may reveal whether the a2 chain variant in dy/dy myogenic tissue is incorporated 
into a heterotrimer. In fact in this chapter I have shown that an antibody against the 
G1 to G3 C-terminus domains of the laminin a2 chain detects expression of this a2 
chain fragment in skeletal and cardiac muscle and sciatic nerves. Thus in skeletal 
and cardiac muscle an a2 chain isoform may be expressed that is truncated rather 
than deleted but which is not able to incorporate into a basal lamina. 
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Chapter 4: The response of dy/dy sciatic nerves to injury 
4.1: Introduction 
It is thought that many of the processes involved in the development of the 
peripheral nervous system are recapitulated during regeneration following injury to 
the nerve. The absence of laminin-2 in the PNS of dy/dy mice results in the 
extensive abnormalities that have been described in chapter 3. To investigate how 
and why these may arise and to understand the role of laminin-2 in aspects of 
regeneration in the PNS, dy/dy mice underwent crush or transection of the sciatic 
nerve. 
By transecting the sciatic nerves of dy/dy and unaffected mice and leaving a 0.5mm 
gap between the severed ends, it was possible to investigate the importance of 
laminin-2 in vivo in regulating the ability of axons to sprout across this gap to the 
distal stump. The bands of Büngner are endoneurial basal lamina tubes that are 
aligned with migrating Schwann cells and form between the distal and proximal 
stumps of regenerating nerves to provide a conduit for axons (Anderson et al., 
1991; Hall, 1986b; Hall, 1989; Williams et al., 1983). Transection of the nerve 
severs the endoneurial basal lamina tubes that form the bands of Büngner. Thus 
regeneration following transection requires the formation of new basal lamina 
tubes, an obstacle to regeneration in unaffected transected nerves but an even 
greater challenge for laminin-2-deficient mice. Axonal sprouting into the distal 
stump was observed in transected dy/dy nerves, but appeared to be less extensive 
than in unaffected nerves. 
Crushing rather than transecting peripheral nerves leaves the endoneurial basal 
lamina tubes largely intact and therefore presents less of a challenge for 
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regenerating axons. dy/dy sciatic nerves were crushed to investigate the initiation 
and maintenance of Schwann cell interactions with axons that had sprouted into the 
distal stump. In a previous study partial and complete crush to the severely 
hypomyelinated dorsal roots of dy/dy mice resulted in increased numbers of 
Schwann cells and more extensive myelination within 1 month of injury (Stirling, 
1975b). Another previous study investigated longer-term regeneration in spinal 
roots and peroneal nerves of dy/dy mice 6 weeks following crush injury, which 
appeared to result in increased Schwann cell basal lamina coverage (Bray et al., 
1983). I found that Schwann cell ensheathment of axons following crush was 
abnormal and incomplete in dy/dy nerves and that remyelination was both delayed 
and less extensive when it did occur. 
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4.2: Results 
4.2.1: Axonal regeneration occurs following transection of dv/dy sciatic nerve, 
but is less extensive than in unaffected nerves 
The sciatic nerves of dy/dy and unaffected mice were transected, leaving a small 
gap of less than 0.5 mm between the severed ends of the nerve to investigate the 
consequences of a severe reduction in laminin a2 chain on axonal regeneration in 
vivo. Previous experiments have shown that laminin-2 promotes neunte outgrowth 
in vitro (Engvall et al., 1992) and that blocking laminin-2/4 activity has an 
inhibitory affect on neunte outgrowth in regenerating nerves both in vitro and in 
vivo (Agius and Cochard, 1998; Anton et al., 1994a). If the basal lamina tubes, the 
bands of Büngner were unable to re-form in dy/dy mice, this might prohibit axonal 
regeneration. 
Regenerating sciatic nerves were removed 2 weeks post-transection such that each 
length of nerve contained the lesion site and approximately 0.5 cm of nerve from 
either side of the lesion site. 7-8 µm thick sections of regenerating nerve were 
stained with antibodies against two axonal markers, a 165 KDa intermediate 
neurofilament protein (2H3) and PGP 9.5. The proximal stumps of transected 
nerves in dy/dy and unaffected mice were immunopositive for both 2H3 (not 
shown) and PGP 9.5 (fig. 4.1a, b), although staining appeared to be patchier in the 
dy/dy mice. The difference in axonal staining between the proximal stumps of 
transected dy/dy and control nerves was equivalent to that seen between mature 
intact dy/dy and control nerves (fig. 3.2). 
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Figure 4.1: Very few axons grow into the distal stump in dy/dy sciatic nerves 
following transection. Sciatic nerves of unaffected (ua) and dy/dy mice were 
transected, removed two weeks post-transection, fixed and immunostained with 
an antibody against PGP 9.5, an axonal marker (arrows). (a) The proximal (prox) 
stump in unaffected nerves appears to be full of PGP 9.5 immunoreactive axons. 
(b) There were few immunoreactive axons (arrow) in the proximal stump of tran 
-sected dy/dy sciatic nerves. (c) In unaffected nerves there is substantial growth 
of axons through the gap left by the transection. (d) There are very few axons in 
the gap between the two cut ends of the transected dy/dy sciatic nerves. (e) There 
is widespread axonal outgrowth into the distal stump of the transected sciatic ner 
-ves of unaffected mice. (f) Axonal outgrowth into the distal stump of transected 
dy/dy sciatic nerves is still sparse two weeks post-lesion. Scale bar = 50 µm. 
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ua dy/dy 
By two weeks post-transection, it was possible to see macroscopically that the gap 
between the severed ends of the nerve in both dy/dy and control nerves had been 
bridged and the lesion site was marked by a swollen, discoloured area. The lesion 
site was immunoreactive for both PGP 9.5 and 2H3 in unaffected and mutant 
transected nerves although immunoreactivity for these axonal markers appeared far 
less extensive in transected dy/dy nerves (fig 4.1c, d). The immunoreactivity 
indicated that a few axons were able to sprout through the lesion site in dy/dy 
nerves. By two weeks post-transection immnuonreactivity was also detectable in 
the distal stump of transected mutant and unaffected nerves. Although there was 
extensive axonal sprouting into the distal stump in the transected nerves of 
unaffected mice only a very limited amount of axonal inununoreactivity was 
detectable in transected dy/dy nerves (fig. 4.1 e, f). 
4.2.2: Remyelination is delayed, aberrant and less extensive in the sciatic 
nerves of dy/dy mice following crush injury 
Transection of dy/dy sciatic nerves showed that some axons are capable of 
sprouting into the distal stump, even when there is a severe deficiency of laminin-2. 
To investigate what role laminin-2 has in other regenerative and by implication 
developmental processes sciatic nerve crushes were carried out. Axonal sprouting 
into the distal stump is usually more successful following crush and therefore 
presents a better model for establishing the role of laminin-2 in mediating 
interactions between axons and Schwann cells. 
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Figure 4.2: 1 week post-crush the distal stumps of both unaffected and dy/dy sciatic 
nerves have undergone Wallerian degeneration. Light micrographs of toluidine blue- 
stained 1 µm transverse resin sections 1 week post-crush. (a) In the proximal stump of 
unaffected nerves the myelinated axons remain intact. (b) The proximal stumps of crushed 
dy/dy sciatic nerves also remain intact, but there appear to be fewer myelinated axons. (c) 0.4 
cm distal to the crush the unaffected nerve has undergone Wallerian degeneration and there 
are no myelinated axons. (d) The nerve 0.4 cm distal to the crush in dy/dy mice also 
undergoes what appears to be normal Wallerian degeneration. Magnification x40. Scale bar = 
40 µm. 
Sciatic nerves were crushed by Professor Susan Standring, processed, stained and sectioned 
into semi-thin sections by the Electron Microscopy unit at Guy's hospital and photographed 
by Yael Uziyel. 
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As expected one week post-crush the proximal stump of dy/dy and unaffected 
nerves appeared to be intact and there was no sign of axonal degeneration (fig. 4.2a, 
b). Wallerian degeneration was evident in the distal stumps of both dy/dy and 
unaffected crushed sciatic nerves, which had a similar appearance (fig. 4.2c, d), 
both were undergoing axonolysis and myelinolysis with degeneration of axons and 
myelin« Differences in regeneration between dy/dy and control nerves became 
apparent however two weeks post crush. Significantly fewer axons were myelinated 
in the distal stump of crushed dy/dy nerves than in control nerves (fig. 4.3a, p<0.05; 
fig. 4.4). Quantification of toluidine-blue stained semi-thin sections at 2 weeks 
showed that axons in approximately 14.9% of the bands of Btingner in dy/dy mice 
were thinly remyelinated whereas in unaffected mice approximately 63.6% of 
axons in the bands of Büngner contained myelinated axons. Electron micrographs 
revealed severe abnormalities in the distal stumps of dy/dy nerves. The endoneurial 
basal lamina surrounding axon-Schwann cell units was patchy; bundles of axons 
were often incompletely ensheathed by Schwann cell processes and were directly in 
contact with the basal lamina (fig. 4.5). In some cases axons shared Schwann cells 
or several Schwann cells would surround an axon and there were few axons that 
were completely ensheathed by one Schwann cell and encased in basal lamina as 
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Figure 4.3: Remyelination following sciatic nerve crush is delayed and less 
extensive in the distal stump of dy/dy mice. The number of myelinated axons 
was quantified in the proximal (prox) and distal (dis) stumps of crushed 41/dv 
and unaffected (ua) sciatic nerves at 2,4 and 6 weeks post-crush. (a) At two 
weeks post-crush, there is a significant (*, p<0.05) difference in the number 
of myelinated axons in the distal stump of unaffected and clv/dv mice (ua = 1, 
dy/dy = 3). The proportion of myelin axons in the distal stump relative to the 
proximal stump is 14.9% in dy/dy nerves and 63.6% in unaffected nerves. (b) 
At 4 weeks there is an increase in the proportion of myelinated axons in the 
distal stump of dy/dy sciatic nerves to 47.9%, but this is still substantially less 
than in unaffected nerves at 61.3% (ua = 1, dy/dy = 2). (c) At 6 weeks post- 
crush remyelination is almost complete in unaffected nerves (85.1 %), but in 
the distal stump of dy/dy nerves the proportion of myelinated axons (52.7%) 
was not substantially more than at 4 weeks (ua = 1, dy/dy = 2). Mean ± s. c. m. 
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Figure 4.4: Semi-thin sections of dy/dy sciatic nerves show that remyelination appears to 
be delayed 2 weeks post-crush. Light micrographs of toluidine blue-stained 1 µm resin 
sections of the distal stumps of sciatic nerves 0.4 cm distal to the crush. (a) In a transverse 
section of unaffected nerve, there are many myelinated axons visible. (b) Typically, there are 
no myelinated axons visible in transverse sections of dy/dy sciatic nerve. (c) Myelinated 
axons (thin arrow) are clearly visible in longitudinal sections of unaffected nerves 2 weeks 
post-crush. (d) Although Schwann cells are present (thin arrow), there is little evidence of 
remyelination in longitudinal sections of dy/dy sciatic nerve. Magnification x40. Scale bar = 
40 µm. 
Sciatic nerves were crushed by Professor Susan Standring, processed, stained and sectioned 
into semi-thin sections by the Electron Microscopy unit at Guy's hospital and photographed 
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Figure 4.5: Flectron micrographs 5110 W that 2 weeks post-crush, remyclination in the 
distal S 111 ip of d /d1' sciatic nerves is delayed and abnormal. Electron micrographs of 
IIan. ýýeis sect oils od iiistaI stumps of srialir nerves 0.4 cm to crush, 2 weeks post-crush. (a) 
III unalIcrted nerves renlwlinatiou is widespread (thin arrows) and individual myclinated 
axons are each cunllplctcly ensllratlied by one Schwann cell (thick arrow). (h) In dr/u 
nerve,, the regenerating axons are not remyelinatcd and the associations between the axons 
and Scllwann cell's are abnormal. schwane Cells extend processes that surround but CIO not 
completely ensllrath several axons and many axons are in direct contact with the basal 
lamina (thick au o s). (c) In dl/dt nerves, the axon has a very thin, uncompacted myelin 
slieatll (thin arnl\ý )' but the Schwalm cell cllshcathing it also extends processes towards 
neighbouring unnlyclinated axons (thick arrows). The basal lamina in these regenerating 
nerve, is patchy (arrowhead). (d) Axons that are rcmyclinated in ch/di, sciatic nerves have a 
very thin myelin sheath, which usually remains uncompacted (thin arrows). (e) In 
regenerating (/i di sciatic nerves, the basal lamina is patchy (arrowhead) and many large 
diameter axons are ha rdIy or inronlhlctcly ensheathedl by Schwane cells (thick arrows). 
Magnification: (a, h) x6250, (c) x12500, (d) x15000, (c) x17500. Scale bar: (a, b) =2 pun, (c) 
Illlu, (d) 4.8' pill, (c) 5.0 pill. 
Sciatic nerves were crushed by Professur Susan Standring, processed liar electron microscopy 
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The deficit in dy/dy sciatic nerves also appears to have long-term consequences for 
nerve regeneration following crush injury. The proportion of myelinated axons in 
the distal stump relative to the proximal stump increased in dy/dy nerves but a 
substantial difference persisted in the number of remyelinated axons relative to 
unaffected mice for four (unaffected mice = 61.3% and dy/dy mice = 47.9% 
remyelinated) and six weeks (unaffected mice = 85.1%, dy/dy mice = 52.7% 
remyelinated) post-crush (fig. 4.3b, c; fig 4.6). In addition axon-Schwann cell 
relationships in regenerating dy/dy sciatic nerves were still clearly abnormal. Those 
axons that were ensheathed by Schwann cells could often be seen to form 
uncompacted myelin sheaths (fig. 4.7). At the six week timepoint many of the 
abnormalities observed in uninjured dy/dy nerves had become apparent in the 
regenerated nerves including patchy, discontinuous basal lamina around the axon- 
Schwann cell units, unensheathed axons and an abnormally high proportion of 
axons remained unmyelinated. 
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Figure 4.6: Semi-thin sections show that remyelination is still less extensive in dy/dy 
sciatic nerves 4 to 6 weeks post-crush Light micrographs of toluidine blue-stained 
transverse 1 µm resin sections of the distal stumps of sciatic nerves, 0.4 cm distal to the 
crush, 4 and 6 weeks post-crush. (a) In unaffected nerves, remyelination is extensive 4 weeks 
post-crush (thin arrow). (b) 4 weeks post-crush the distal stump of dy/dy nerves has begun to 
undergo some remyelination (thin arrow), but this is very limited. (c) 6 weeks post-crush 
remyelination in the unaffected nerves appears to be almost complete (thin arrow). (d) 6 
weeks post-crush remyelination (thin arrow) in dy/dy sciatic nerves is more extensive than at 
4 weeks but is still less widespread than at 4 weeks (b). Magnification x40. Scale bar = 40 
µm. 
Sciatic nerves were crushed by Professor Susan Standring, processed, stained and sectioned 
into semi-thin sections by the Electron Microscopy unit at Guy's hospital and photographed 
by Yael Uziyel. 
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Figure 4.7: Electron micrographs show that rem-yelination is still less extensive and 
abnormal in dj/dyy sciatic nerves 4 weeks post-crush. Electron micrographs of' transverse 
sections of distal stumps of t y/dy sciatic nerves, 0.4 cm distal to the crush site, 4 weeks post- 
crush. (a) Some axons remain unmyelinated in regenerating dy/dy nerves. The basal lamina is 
patchy (arrowhead) and axons are incompletely ensheathed by Schwann cells that extend 
processes towards more than one axon, exposing some axons directly to basal lamina. (b) In 
remyclinated axons, the myelin sheath remains uncompacted (thin arrow). Magnification: (a) 
x25000, (b) x17500. Scale bar: (a) =8 µm, (b) = 5.6 µm. 
Sciatic nerves were crushed by Professor Susan Standring, processed for electron microscopy 
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4.3.1: Axon sprouting following transection is less extensive in the dy/dy mouse 
Two weeks after a transection injury, the distal stumps of the cut sciatic nerves in 
both unaffected and dy/dy mice were immunopositive for the axonal marker PGP 
9.5 meaning that axons had bridged the gap in both. However it was clear that 
axonal sprouting was far less extensive in the dy/dy sciatic nerves than in the 
unaffected nerves. This suggests that axons in the proximal stump of dy/dy nerves 
were surrounded by an environment less conducive to axonal sprouting. 
Under normal circumstances, nerve regeneration following transection in the PNS 
is successful, as long as the gap between the two cut ends of the nerve is not too 
great. In this case the gap was only 0.5mm which was sufficiently small for the 
transected nerves in unaffected mice to successfully bridge the gap. Regenerating 
axons use the bands of Büngner and the Schwann cells aligned along these 
endoneurial basal lamina tubes to help guide them from the proximal to the distal 
stump. The severe deficit of laminin a2 chain in dy/dy mice means that they are 
incapable of forming a structurally intact endoneurial basal lamina and 
consequently Schwann cells are not able to interact normally with axons (Arahata, 
1993; Bradley and Jenkison, 1973; Bradley and Jenkison, 1975; Madrid et al., 
1975; Sunada et al., 1994; Xu et al., 1994a). This would most likely impair their 
ability to form bands of Biingner to use as conduits for the growing axons during 
regeneration. 
Northern blot analysis of mRNA levels has shown that during regeneration 
proliferating Schwann cells in contact with axons produce increased quantities of 
the gene transcripts encoding lamin ßl and yl chains but not al chain (Doyu et al., 
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1993). Schwann cells are however capable of producing the laminin a2 chain 
(Hsiao et al., 1993). Recent evidence suggests that the laminin a2 chain protein is 
induced and maintained by Schwann cell contact with regenerating axons, thus 
inununoreactivity was down-regulated during degeneration but was progressively 
upregulated during the process of regeneration (Masaki et al., 2000). Intense 
laminin immunoreactivity is detectable in the bands of Büngner 7-10 days after 
nerve crush or transection when axons have begun to extend towards the distal 
stump (Kuecherer-Ehret et al., 1990; Tona et al., 1993). 
The migrating and proliferating Schwann cells help to create the bands of Büngner 
by the induction of laminin chain production during regeneration. The laminin 
chains detected so far during regeneration, the a2, ß1 and y1 chains, constitute the 
laminin-2 heterotrimer and it is therefore likely that the predominant or exclusive 
heterotrimer found in the bands of Büngner is laminin-2 (Doyu et al., 1993; Masaki 
et al., 2000). Blockade of laminin-2 activity both in vivo and in vitro has been 
shown to inhibit neunte outgrowth following Wallerian degeneration (Agius and 
Cochard, 1998; Anton et al., 1994a). Axonal regeneration in the PNS of dy/dy mice 
is most probably directly restricted by poorly formed bands of Büngner. Vacated 
endoneurial basal lamina tubes are discontinuous in dy/dy nerves and Schwann cell 
contact with axons during regeneration would not be able to induce adequate 
production and deposition of the laminin a2 chain by Schwann cells. 
It is also likely that the activity of Schwann cells distally and in the bands of 
Büngner affects axon outgrowth. Transection of the sciatic nerve results in 
increased expression of the low affinity neurotrophin receptor, p75, in Schwann 
cells in the bands of Büngner (Taniuchi et al., 1986; Taniuchi et al., 1988). Once 
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the axons had extended through the bands of Büngner towards the distal stump, 
expression of the receptor was down- regulated. In DRG's neuronal expression of 
the p75 receptor is down-regulated while glial expression is upregulated following 
sciatic nerve transection (Zhou et al., 1996). When Schwann cells loose axonal 
contact, for instance following transection, they begin to dedifferentiate; immature 
and non-myelin-forming Schwann cells are known to express the p75 receptor, 
whereas mature myelin-forming Schwann cells do not (Jessen and Mirsky, 1991). 
In vitro Schwann cells migrate more rapidly on denervated NGF-rich sciatic nerve 
substrates than on NGF-poor intact substrates and blocking antibodies to both NGF 
and the p75 receptor partially inhibit Schwann cell migration (Anton et al., 1994b). 
Thus both the Schwann cell and its surrounding environment are in a state 
conducive to Schwane cell migration during regeneration. Moreover laminin-2 may 
play a role in regulating Schwane cell migration. Blockade of laminin-2 activity on 
denervated sciatic nerve substrates in vitro almost halves the rate of Schwann cell 
migration (Anton et al., 1994a). The lack of laminin-2 in the bands of Büngner of 
regenerating dy/dy nerves means that Schwann cell migration is probably 
compromised. 
A deficit in Schwann cell migration may be a factor in the poor axonal sprouting 
observed in the transected nerves of dy/dy mice. During regeneration axons are 
always accompanied by migrating Schwann cells and axon outgrowth appears to be 
dependent on the active participation of proliferating and migrating Schwann cells 
(Feneley et al., 1991; Hall, 1986a; Hall, 1986b). In fact there is some evidence that 
Schwann cells may be leading axons during regeneration. When the cut end of a 
nerve was transplanted onto a soleus muscle, the axons and Schwann cells emerged 
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together from the cut end of the nerve and the axons were associated with Schwann 
cells along their entire lengths (Son and Thompson, 1995b). Usually the axons and 
Schwann cells were co-extensive but in some cases the tips of the Schwann cell 
processes were seen to be ahead while the axons appeared to be navigating along 
the Schwann cell processes. Moreover Schwann cell extension limits the rate of 
axonal regeneration; axons grew faster along pre-established Schwann cell 
processes than when Schwann cells accompanied them in their growth (Son and 
Thompson, 1995b). It is less clear whether this is the case during development, 
when neural crest is ablated in stage 13 chick embryos, thereby removing Schwann 
cells or Schwann cell precursors, motor axons will not grow into the forelimb 
(Noakes et al., 1988). If this is true then it would suggest that the motor axons were 
guided by the Schwann cells. However the HNK-1 antibody marker used by 
Noakes does not reliably distinguish between axons and Schwann cells and at this 
developmental stage it would be difficult to distinguish their leading processes 
morphologically. 
Following transection the existing basal lamina tubes are destroyed. Even if the gap 
between the two cut ends of the nerve is relatively short, this presents a major 
obstacle to axonal regeneration and especially so in the dy/dy mice that are unable 
to produce one of the major constituents of the endoneurial basal lamina tubes. 
Laminin-2 has been shown to promote both neunte outgrowth in vitro and in vivo 
during regeneration and Schwarm cell migration (Anton et al., 1994a; Cho et al., 
1998; Cohen and Johnson, 1991; Engvall et al., 1992). The deficiency of a 
molecule capable of promoting two aspects of the regenerative process, axonal 
outgrowth and Schwann cell migration, means that axonal sprouting is poor in 
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transected dy/dy peripheral nerves. 
4.3.2: Regeneration and remyelination is delayed and abnormal in dy/dy 
sciatic nerves following crush iniury 
As in transection, crush injury results in Wallerian degeneration but subsequent 
regeneration is usually more successful as the basal lamina tubes remain intact and 
Schwann cells are not required to migrate as extensively. Thus crushing the sciatic 
nerves of dy/dy mice resulted in more extensive axonal regeneration and allowed us 
to investigate in more detail axon-Schwann cell interactions in the absence of 
laminin-2. In previous studies, crush injuries to the peripheral nerves of dy/dy or 
dy2j/dy22 were shown to result in improvements in the extent of Schwann cell 
ensheathment, myelination and basal lamina coverage compared to the intact nerve 
(Bray et al., 1983; Stirling, 1975b). Our findings show that in fact the 
morphological abnormalities observed in intact dy/dy peripheral nerves are 
recapitulated in regenerating nerves. Although the degenerative process appeared to 
proceed normally in dy/dy nerves, mutant mice were unable to remyelinate the 
axons at a comparable rate and as efficiently. The electron micrographs showed that 
although axons were present in the distal stumps of dy/dy nerves at two weeks post- 
crush, only 14.9% of the axons in the bands of Biingner were myelinated compared 
to 63.6% in unaffected nerves. Differences in the extent of remyelination persisted 
up to the last time point examined, at 6 weeks post-crush 85.1% of axons were 
remyelinated in unaffected nerves compared with 52.7% in mutant nerves. In 
addition, axonal ensheathment by dy/dy Schwann cells was abnormal and in many 
cases incomplete (Uziyel et al., 2000), allowing frequent direct apposition of axons. 
Also myelination in the dy/dy nerves was abnormal; the myelin sheath was often 
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uncompacted and frequently extended to neighbouring axons. 
Despite the establishment of some axonal contact by Schwann cells in regenerating 
dy/dy peripheral nerves following crush injury dy/dy Schwane cells cannot be 
induced to produce the a2 chain. Unaffected Schwane cells in regenerating nerves 
are induced to produce the a2, ßl and yl chains necessary to form the laminin-2 
heterotrimer (Doyu et al., 1993; Masaki et al., 2000). The production of basal 
lamina is a requirement for Schwann cell-axon interactions prior to Schwann cell 
differentiation and myelination (Carey et al., 1986; Eldridge et al., 1989). Schwann 
cell contact with the basal lamina causes the Schwann cells to cease proliferating; 
the Schwann cells then differentiate and undergo a change in morphology, 
elongating and ensheathing and aligning themselves along the axon and eventually 
producing myelin (Carey et al., 1986; Obremski and Bunge, 1995; Obremski et al., 
1993a; Obremski et al., 1993b). Suspended nerve fascicles sometimes form in long- 
term cultures of sensory ganglia explants. When Schwann cells in these cultures are 
deprived of contact with the ECM these fascicles begin to exhibit Schwann cell 
abnormalities resembling those seen in dy/dy mice including instances of 
incomplete ensheathment of axons (Bunge and Bunge, 1978). Recently, 
myelination was shown to occur in vitro in co-cultures of Schwann cells and DRG 
neurons in the absence of a basal lamina (Podratz et al., 1998), but at a much 
reduced rate and extent, reminiscent of the dy/dy mouse in vivo. 
In the regenerating nerves of dy/dy mice some axons grew along the outer aspects 
of the Schwann cells in the bands of Büngner in direct contact with the basal lamina 
(fig. 4.5,4.7). Without direct contact with the basal lamina or exposure only to 
patchy, laminin-2 deficient basal lamina Schwann cells in the dy/dy mice were not 
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able to differentiate fully and ensheathe the axons adequately. In fact the bundles of 
completely unensheathed axons and the loose ensheathment of other axons by 
Schwann cells in regenerating dy/dy nerves sometimes resembled an embryonic 
phenotype and recapitulated the abnormalities seen in the intact nerves (Bradley 
and Jenkison, 1973; Uziyel et al., 2000). 
These findings are consistent with a specific role for laminin-2 in determining the 
polarity of differentiated Schwann cells in vivo. It has been clear for some time that 
basal lamina induces Schwann cell differentiation and elongation in vitro (Carey et 
al., 1986; Obremski and Bunge, 1995; Obremski et al., 1993a; Obremski et al., 
1993b). The abnormal morphology of dy/dy Schwann cells both in vivo and in vitro 
(Uziyel et al., 2000) (see chapter 6.2.6) suggests that it is the laminin a2 chain 
component of the endoneurial basal lamina that specifically regulates this aspect of 
their morphology. This is also true of terminal Schwann cells; abnormal Schwann 
cell process extension into the synaptic cleft has been observed at the NMJ of dy/dy 
mice (Banker et al., 1979). The synaptic basal lamina normally contains laminin-4, 
an a2 chain-containing laminin. Its absence in the synaptic basal lamina of dy/dy 
mice may account for the abnormal polarity of dy/dy terminal Schwann cells. 
Regulation of Schwann cell polarity is not exclusive to a2 chain laminins as 
inappropriate extension of terminal Schwann cell processes into the synaptic cleft 
has also been observed in mice deficient in the synaptic laminin, laminin-11 (Patton 
et al., 1998). Thus it appears that specific laminin heterotrimers actively control the 
polarity of Schwann cells and constrain process extension. 
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Chapter 5: The role of laminin-2 in Schwann cell migration 
5.1: Introduction 
During both development and regeneration Schwann cell migration is an important 
process in establishing a normally functioning peripheral nerve. Schwann cell 
precursors are generated from neural crest cells at around E14-15 in rats and E12- 
13 in mice (Jessen and Mirsky, 1999). During development these precursors co- 
migrate with the growth cones extended by embryonic peripheral axons. As they 
begin to differentiate into immature Schwann cells at around E17 in rats and E15 in 
mice, they migrate further along the nerve bundles, extend cytoplasmic processes 
and begin to subdivide the nerve into smaller bundles (Ziskind-Conhaim, 1988). 
This results in each axon being individually enwrapped by a Schwann cell, prior to 
myelination during the first few postnatal weeks. Whilst it has been claimed that 
during development Schwann cells appear to precede the axonal growth cones, the 
antibody marker used was not Schwann cell-specific (Noakes and Bennett, 1987; 
Noakes et al., 1988). There is stronger in vivo evidence that Schwann cells can 
migrate and extend processes ahead of growth cones during regeneration (Son and 
Thompson, 1995b). 
Schwann cell migration following injury to peripheral nerves is of particular 
importance in establishing a conduit for regenerating axons. Regenerating axons 
extending from the proximal stump of the injured nerve along the bands of Biingner 
are always accompanied by migrating Schwann cells (Feneley et al., 1991). Thus 
basal lamina tubes alone are not sufficient to support axonal regeneration, neuntes 
are rarely seen to extend towards the distal stump in regenerating nerves if 
Schwann cells are not present or are prevented from proliferating and migrating 
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(Feneley et al., 1991; Hall, 1986a; Hall, 1986b). 
Schwann cell migration in vitro has been shown to be promoted by a variety of 
ECM molecules and by molecules expressed by the Schwann cells themselves. 
Fibronectin, laminin-1 and laminin-2 have been shown to promote integrin- 
mediated Schwann cell migration (Milner et al., 1997). Migrating Schwann cells in 
regenerating nerves align themselves along the bands of Büngner. These 
endoneurial basal lamina tubes are rich in laminin-2. Blocking of laminin-2 activity 
in vitro on denervated sciatic nerve substrates inhibits both neunte outgrowth and 
Schwann cell migration (Anton et al., 1994a). Other ECM molecules influence 
migration of CNS cells in vitro too; vitronectin promotes astrocyte migration and 
both fibronectin and laminin-2 promote the migration of oligodendrocyte precursor 
cells whereas tenascin-C inhibits the migration of these precursors (Frost et al., 
1996; Kiernan et al., 1996; Milner et al., 1999). The Schwarm cell surface 
membrane protein CD9 promotes Schwane cell migration on intact nerve substrates 
in cryoculture (Anton et al., 1995). 
Schwane cell migration has been studied long-term in vivo following injury to the 
nerve but in vitro techniques such as those used to study molecules involved in 
Schwane cell, oligodendrocyte and astrocyte migration provide a more accessible 
method to assay migration. Cryoculture involves the use of unfixed tissue sections 
such as peripheral nerves, as substrates for cell migration. In sections of intact 
peripheral nerves the basal lamina is exposed as well as the cell membranes of 
Schwane cells and of axons. It has been widely used to assay both Schwane cell 
migration and neunte outgrowth on intact and denervated peripheral nerve 
substrates and usually involves the use of blocking antibodies to determine the role 
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of specific molecules in these processes (Agius and Cochard, 1998; Anton et al., 
1995; Anton et al., 1994a; Anton et al., 1994b). Sections of intact sciatic nerve 
provide a substrate that includes Schwann cells and axons and the molecules they 
express as well as the basal lamina and its molecular components. Sections of intact 
dy/dy peripheral nerves are lacking in the laminin-2 component of the endoneurial 
basal lamina and as such provide a means to investigate the extent to which 
laminin-2 is involved as a substrate for Schwann cell migration (see chapter 6.2.4 
for its role in regulating the intrinsic motility of Schwann cells). 
Neonatal rat DRG explants were plated onto cryosections of sciatic nerve and the 
extent of Schwann cell migration was visualised by labelling DRG explants with 
the CMFDA cell tracker dye. CMFDA is taken up by growing neuntes but 
predominately by migrating Schwann cells; it is membrane permeable and diffuses 
into living cells where the chloromethyl moieties react with intracellular thiols and 
the acetate groups are cleaved by cytoplasmic esterases to produce a fluorescent 
product. This fluorescence could then be visualised on an Axioskop microscope 
with epifluorescence optics. I firstly determined that the rate of Schwann cell 
migration in the cryoculture assay was linear over an extended period of time in 
vitro and that it compared favourably with rates of Schwann cell migration 
measured in vivo. The cyroculture migration assay showed that intact laminin-2- 
deficient dy/dy sciatic nerves are significantly less efficient as a substrate for 
Schwann cell migration. Moreover a normal rate of migration could be restored by 
pre-treating dy/dy sciatic nerve substrates with exogenous laminin-2. 
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5.2: Results 
5.2.1: Measurement of rat Schwann cell migration in vitro 
The rate of Schwann cell migration from rat neonatal DRG explants in cryoculture 
for periods up to 65 hours was initially determined using sections of homologous 
normal adult rat sciatic nerve as a substrate (fig. 5.1 a). These experiments allowed 
me to validate the cryoculture system and to determine: 
a) Whether the rate of Schwann cell migration remained constant over extended 
periods in vitro. 
b) Whether the rate of Schwann cell migration in cryoculture and in vivo were 
comparable. 
The distance migrated by CMFDA-labelled rat Schwann cells was measured from 
digitised images and defined as the distance from the central point of the explant to 
fluorescent-labelled cells at the leading edge of the outgrowth zone (fig. 5.1a). 
Schwann cells were distinguishable by their morphology and in some of the 
cryoculture experiments axons were counterstained with an antibody to GAP-43 to 
help distinguish between neuntes and Schwann cells (not shown). The rate of 
Schwann cell migration in these cryoculture experiments measured at three time 
points was found to be linear (correlation coefficient = 0.996) (fig. 5.1b). The 
average rate of Schwann cell migration of 22 µm/hour in homologous rat 
cryoculture experiments, compared well with reported rates of migration in 
regenerating nerves in vivo of approximately 10-30 pm/hour (Anderson et al., 1991; 
Daniloff, 1991; Feneley et al., 1991). However some component of the Schwann 
cell migration measured in these and consequent Schwann cell migration assays in 
























Figure 5.1: Rat Schwann cells migrate from DRG explants for up to 65 
hours at a linear rate on cryosections of rat sciatic nerve. (a) Neonatal 
rat DRG's were plated onto sections of rat sciatic nerve. After 24,40 and 60 
hours the living Schwarm cells were labelled with a cell tracker dye, CMFDA. 
The explants were fixed and the distance migrated determined as the distance 
from the centre of the explant to the leading edge of the migrating Schwann 
cells. (b) Graph of the distance the Schwann cells migrated at 24 hours (n = 74), 
40 hours (n = 120) and 65 hours (n = 99). The correlation coefficient of 0.996 is 
consistent with a linear rate of migration over 65 hours of 22 µm/hour. Mean 
± s. e. m. This experimental paradigm was carried out at least 10 times. 
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5.2.2: Rat Schwann cell migration is slower on dy/dy sciatic nerve substrates 
A heterologous cryoculture system allows for species-specific labelling or 
manipulation of cells and molecules in the cryoculture. Modification of the 
cryoculture technique to a heterologous system such that P3 rat DRG explants were 
plated onto sections of normal mouse sciatic nerve resulted in a rate of migration 
comparable to that seen in homologous cryoculture experiments. P3 rat DRG 
explants were plated onto sections of sciatic nerve from either unaffected or dy/dy 
mice. In previous experiments where the effect of laminin-2 on Schwann cell 
migration has been measured using blocking antibodies, the activity of other 
laminin chains or heterotrimers may also have been blocked (Anton et al., 1994a). 
It was found that Schwann cell migration was significantly reduced (p<0.01) on the 
dy/dy sciatic nerve substrates (fig. 5.2,5.3a). Schwann cells migrated 1148.1 µm 
over a 40 hour time period (28.7 gm/hour) on unaffected nerve substrates and 961.5 
µm on dy/dy nerve substrates (24 µm/hr), a reduction in the rate of migration of 
16.4%. 
The myelination abnormality in dy/dy mice is more severe proximal to the spinal 
cord. The reasons for this are unclear but may be due to a greater deficit of laminin- 
2 in proximal nerves. I therefore investigated whether the rate of Schwann cell 
migration was more affected on sections of dy/dy sciatic nerve proximal to the 
spinal cord. Although the average rate of migration on sections of dy/dy sciatic 




Figure 5.2: Rat Schwann cells migrated at a reduced rate on 4y/4v sciatic 
nerve substrates. Neonatal rat DRG explants were placed on sections of' 
unaffected (ua) and dy/dy sciatic nerves. After 40 hours they were stained 
with the cell tracker dye CMFDA, fixed and the distance migrated measured 
at the leading edge of the Schwann cells (arrowheads). (a) Schwann cells mig 
-rating on an unaffected mouse sciatic nerve substrate. The underlying nerve 
is just visible (arrow). (b) Schwann cell migration on a dy/dy mouse sciatic 
nerve substrate is substantially less than on unaffected nerve substrates. 
Magnification x 10. Scale bar = 250 µm. 
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Figure 5.3: The rate of Schwann cell migration is significantly reduced on dy/dy 
mouse sciatic nerve substrates from portions of sciatic nerve both distal and 
proximal to the spinal cord. Neonatal rat DRG explants were initially plated on 
random portions of dy/dy or unaffected (ua) sciatic nerve (a), then in subsequent 
experiments on cryosections cut from portions of sciatic nerve either distal or proximal 
to the spinal cord (b). The explants were stained with the cell tracker dye CMFDA and 
fixed after 40 hours in vitro. The distance migrated by Schwann cells was assessed 
using digitised images. (a) Schwann cell migration was significantly reduced on 
random portions of dy/dy sciatic nerve (*, p<0.01). Schwann cells migrated 961.5 ± 
15.5 µm on dy/dy sciatic nerve substrates, a 16.4% reduction compared to migration on 
unaffected sciatic nerve substrates, which averaged 1148.1 ± 21 µm. (b) Schwann cell 
migration was significantly reduced on proximal portions (**, p<0.01) of dy/dy sciatic 
nerve compared to unaffected nerve. Migration was 853.2 ± 25.7 µm on proximal 
dy/dy sciatic nerves and 985.9 ± 25.7 µm, a reduction of 13.5%. Migration was also 
significantly reduced on distal portions of dy/dy sciatic nerve (***, p<0.01) by 14.2% 
compared to Schwann cell migration on distal portions of unaffected sciatic nerve. 
Schwann cells migrated 1033 ± 16.6 µm on distal portions of unaffected nerve and 
886.5 ± 18.3 µm on distal portions of dy/dy sciatic nerves. There was no significant 
difference between the reduction in Schwann cell migration on distal and on proximal 
portions of dy/dy sciatic nerve. Mean ± s. e. m. Schwann cell migration assay 
experiments were carried out at least 10 times on random sections of nerve and at least 
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on sections of distal nerve (22.16 µm/hr), this difference was not statistically 
significant. In fact, Schwann cells also migrated marginally faster on distal (25.83 
pm/hr) than on proximal unaffected nerves (24.65 µm/hr) (fig. 5.3b). Moreover the 
rate of Schwann cell migration on dy/dy nerves was significantly less on both distal 
and proximal sections of nerves (p<0.01). 
5.2.3: The reduced rate of rat Schwann cell migration on dr/dy sciatic nerves is 
compensated by exogenous laminin-2 
To determine whether the above reduction in the rate of migration is a direct 
consequence of the lack of laminin-2 in dy/dy sciatic nerves, Schwann cell 
migration from E19 rat DRG explants was compared on sections of dy/dy and 
unaffected nerves with and without the addition of exogenous laminin-2 (fig. 5.4, 
5.5). Exogenous laminin-2 raised the rate of migration on dy/dy sciatic nerve 
substrates to 24.92 µm/hr, to the level of the unaffected nerve. 
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Figure 5.4: The deficit in the rate of Schwann cell migration on dy/dy sciatic nerve 
substrates is compensated by exogenous laminin-2. E19 rat DRG explants were 
plated onto cryosections of dy/dy or unaffected (ua) sciatic nerve, some of which had 
had exogenous laminin-2 added. Schwann cell migration was observed after 40 hours 
using CMFDA cell tracker dye. (a) Schwann cells migrating on an unaffected nerve 
substrate. The distance migrated by Schwann cells on the nerve substrate from the 
centre of the explant to the leading edge of the Schwann cells (arrowheads) was 
measured. (b) Schwann cells do not appear to migrate as far on dy/dy sciatic nerves as 
on unaffected nerves (arrowheads). (c) Addition of exogenous laminin-2 (In-2) does 
not appear to affect the distance migrated on unaffected nerve substrates (arrowhead). 
(d) Addition of exogenous laminin-2 enhances Schwann cell migration on dy/dy sciatic 
nerves so that it appears that Schwann cells at the leading edge (arrowheads) have 
migrated as far as they would on an unaffected nerve substrate. Scale bar = 250 µm. 
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Figure 5.5: The significant deficit in the rate of Schwann cell migration 
on dy/dy sciatic nerves can be rectified with the addition of exogenous 
laminin-2. Schwann cells migrating on dy/dy and unaffected (ua) sciatic 
nerve substrates with or without additional exogenous laminin-2 were 
visualised with the cell tracker dye CMFDA and the distance migrated at 
the leading edge of the Schwann cells was measured. There was a signifi- 
cant (*, p<0.05) decrease in the distance migrated on dv/dy (n = 6) compared 
to unaffected (n = 7) sciatic nerve substrates in control conditions when no 
exogenous laminin-2 was present. Addition of exogenous laminin-2 resulted 
in increased Schwann cell migration on dy/dy (n = 14) sciatic nerve substrates 
but not on unaffected (n = 5) nerve substrates, such that there was no longer 
any significant difference in the distance migrated on the different sciatic 





5.3.1: The rate of Schwann cell migration in crvoculture corresponds well with 
the rate of migration in vivo 
Schwann cell migration is an important aspect of both development and 
regeneration in the PNS. To establish whether the cryoculture technique employing 
sciatic nerve sections as a substrate for Schwann cell migration reflected rates of 
Schwann cell migration in vivo, migration assays were initially undertaken using 
neonatal rat DRG explants plated onto rat sciatic nerve sections. Schwann cell 
migration in cryoculture was measured at three time points over 65 hours and found 
to maintain a constant rate of 22 pm/hour. This was comparable to rates observed in 
several studies of Schwann cell migration in vivo during regeneration, but in these 
migration assays Schwann cell division is probably a factor in the distance of 
Schwann cells from the explant. 
Evacuated muscle grafts have been shown to provide as effective a substrate as 
nerve grafts for bridging substantial gaps between nerve stumps following 
transection (Feneley et al., 1991). The skeletal muscle provides a basal lamina 
substrate rich in the laminin-2 heterotrimer (Leivo and Engvall, 1988) to support 
Schwann cell migration and axonal outgrowth in regenerating nerves. Schwann 
cells migrated mostly along the basal lamina tubes left by the evacuated myofibrils 
at a rate equivalent to approximately 20 µm/hour over a period of 20 days (Feneley 
et al., 1991). In another in vivo assay, Fluoro-Gold labelled rat sciatic nerve 
Schwann cells were transplanted into severed rat sciatic nerves and were found to 
have migrated up to 30mm in 120 days, a rate of approximately 10 pm/hour 
(Daniloff, 1991). Schwann cells free to migrate along tibial nerve grafts without 
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accompanying axons migrated mostly along the inside of the existing basal lamina 
tubes and formed columns resembling the bands of Biingner. These Schwann cells 
migrated about 8.5mm in 6 to 8 weeks, corresponding to a rate of 8 µm/hour, half 
the rate observed when accompanied by axons (Anderson et al., 1991). Thus the 
rates of Schwann cell migration I observed in vitro using cryoculture appeared to 
closely reflect rates measured in vivo. 
5.3.2: The rate of Schwann cell migration in vitro is reduced on laminin-2 
deficient dv/dy sciatic nerve substrates but can be restored using exogenous 
laminin-2 
The endoneurial basal lamina is particularly important for guiding Schwann cell 
migration during regeneration. Using the laminin-2-deficient sciatic nerves of dy/dy 
mice as a substrate in cryoculture provided a useful means to assess its specific 
contribution to Schwann cell migration. The severe deficiency of laminin-2 and the 
patchy basal lamina covering found in the peripheral nerves of dy/dy mice did not 
lead to a substantial deficit of Schwann cell migration in vitro. However there was a 
significant (16.4%) reduction in the distance migrated by the Schwann cells from 
the neonatal rat DRG explants on dy/dy nerves relative to unaffected nerves. The 
fact that addition of exogenous laminin-2 corrects the deficit in Schwann cell 
migration on dy/dy sciatic nerves is consistent with the lack of laminin-2 in the 
endoneurial basal lamina of dy/dy mice being primarily responsible for the deficit. 
Although the PNS abnormalities in the dy/dy mouse are more severe proximal to 
the spinal cord, in the spinal nerve roots and proximal portions of the sciatic nerve 
(Bradley and Jenkison, 1973; Bradley and Jenkison, 1975), it is not clear whether 
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this is due to a more severe deficiency of the laminin a2 chain. The reduction in 
Schwann cell migration was marginally greater on proximal portions of dy/dy 
sciatic nerve than distal portions in cryoculture, but not significantly so. 
In a previous cryoculture study, Schwann cell migration was assayed from DRG 
explants plated onto untreated denervated nerve substrates and denervated nerve 
substrates treated with laminin-2 function-blocking antibodies (Anton et al., 
1994a). Migration on nerve substrates treated with the antibody was substantially 
reduced by almost 40%. This reduction is considerably more than the reduction in 
the rate of migration I observed on dy/dy nerves and could be accounted for in 
several ways. Firstly, it is possible that there is a low amount of laminin-2 
expressed in dy/dy endoneurial basal lamina, whereas the antibody would globally 
block all laminin-2. Secondly, exogenous expression of other laminin chains such 
as the a4 chain in the endoneurium of dy/dy mice may partially compensate for the 
absence of the a2 chain (Patton et al., 1997). Thirdly, whereas laminin a2 is 
specifically absent in dy/dy nerves, the ARM-1 antibody may inhibit other 
associated laminin chains and consequently inhibit the ability of other laminins 
such as laminin-1 in the perineurial basal lamina to promote Schwann cell 
migration in cryoculture. Finally and probably most importantly, the sciatic nerves 
used by Anton and her colleagues (1994a) in their study were taken from 
predegenerated nerves whereas dy/dy nerves were not. Intact nerve sections contain 
axons and Schwann cells but denervated sections do not. DRG neurons extend 
neuntes preferentially onto denervated adult nerve substrates in cryoculture (Bedi et 
al., 1992) and it seems that denervated substrates are also more conducive to 
Schwann cell migration. In intact nerves CSPG's mask the activity of laminin-2 in 
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the endoneurial basal lamina but in regenerating nerves this masking is removed, 
probably as a result of the activity of matrix metalloproteinases (MMPs) such as 
MMP-2 and 9 (Ferguson and Muir, 2000). The greater acess to laminin-2 combined 
the acellular nature of predegenerated nerves may allow laminin-2 to play a greater 
role in Schwann cell migration during regeneration. 
It is certainly clear that neither the ARM-1 treated denervated nerves nor the use of 
dy/dy nerves as substratum in vitro resulted in complete blockade of Schwann cell 
migration. Although laminin-2 is an important factor in Schwann cell migration, it 
must work in conjunction with other molecules. When silicon chambers used to 
bridge a5 mm gap in severed rat sciatic nerves were filled with solutions of NGF, 
fibronectin, laminin or a combination of laminin and fibronectin, it was found that 
all these factors promoted Schwann cell migration, but that the synergistic activity 
of the fibronectin/laminin combination was particularly effective (Bailey et al., 
1993). The effectiveness of a combination of ECM molecules in promoting 
Schwann cell migration is most likely related to their ability to activate different 
Schwann cell integrin receptors. Laminins mediate Schwann cell migration through 
ß1 heterodimers, laminin-1 through a6ß1 and laminin-2 through alßl or a2ß1, 
whereas Schwann cell migration on fibronectin is mediated primarily through avß8 
integrin (Milner et al., 1997). Thus it is likely that in vivo, different combinations of 
ECM molecules and growth factors may act to promote Schwann cell migration by 
activating different receptor combinations. 
Blocking NGF activity with antibodies in cryoculture on sections of denervated 
sciatic nerve also partially inhibits Schwann cell migration and NGF pre-treatment 
of denervated sections promotes Schwann cell migration (Anton et al., 1994b). 
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Expression of both NGF and its receptors is raised in Schwann cells during 
development and regeneration (Bandtlow et al., 1987; DiStefano and Johnson, 
1988; Heumann et al., 1987; Taniuchi et al., 1988), which is consistent with NGF 
being one of several contributory factors that promote Schwann cell migration 
during these processes. Another possible factor may be CD9, a Schwann cell 
surface membrane glycoprotein that is also found on embryonic sensory, motor and 
sympathetic neurons. CD9 is a tetraspan protein that is co-localised with and can 
associate with the a3, a6 and ß1 Schwann cell integrins (Hadjiargyrou et al., 
1996). In the adult, Schwann cell CD9 mRNA is down-regulated in degenerating 
nerves and then subsequently re-expressed in regenerating nerves upon axonal 
contact (Banerjee and Patterson, 1995). In a cryoculture assay in which migrating 
Schwann cells were exposed to an antibody against CD9, Schwann cell migration 
was promoted (Anton et al., 1995), consistent with a role for CD9 in negative 
regulation of Schwann cell migration. 
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Chapter 6: The influence of laminin-2 on Schwann cell properties 
in vitro 
6.1: Introduction 
In this chapter I have used in vitro techniques to examine the effect of laminin-2 on 
intrinsic Schwann cell properties. In development, Schwann cells are derived from 
pluripotent neural crest cells (Le Douarin and Smith, 1988) and induced towards 
the glial lineage by GGF (Shah et al., 1994) when crest cells first encounter 
growing axons (Loring and Erickson, 1987; Rickmann et al., 1985). Schwann cell 
precursors are first generated at around E12-13 in mice (E14-15 in rats) (Dong et 
al., 1999). These precursors differ substantially from mature Schwann cells in 
several respects. Precursors die by apoptosis in the absence of axonal support in 
vitro whereas immature and mature Schwann cells are self-supporting and survive 
through autocrine loops (Dong et al., 1999; Jessen et al., 1994). In addition there 
are morphological differences between precursors and Schwann cells in vitro; 
precursors have a flattened, multipolar morphology and extensive cell-cell contacts 
whereas Schwann cells are normally bi- or tripolar. Precursors are also far more 
motile than Schwann cells (Dong et al., 1999; Jessen et al., 1994). Rat Schwann 
cells show a mitogenic response to FGF's whereas their precursors do not (Jessen et 
al., 1994). In contrast FGF-2 is mitogenic for mouse Schwann cell precursors, this 
may be due to FGF-2 playing a role in the generation of immature Schwann cells 
(Dong et al., 1999). 
Immature Schwann cells are generated from Schwarm cell precursors at around 
E14-15 in mice (E16-17 in rats) and display some of the characteristics of mature 
Schwann cells. Immature Schwann cells can generate three Schwann cell 
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phenotypes; myelin forming Schwann cells that ensheath and myelinate larger 
diameter axons in a one to one manner (Webster, 1971; Windebank et at., 1985), 
non-myelin forming Schwann cells that ensheath several smaller diameter axons 
within their grooves but do not myelinate and terminal Schwann cells that ensheath 
the axon at the motor endplate. The morphology and mitogenic response to FGF's 
of immature Schwann cells is the same as that of mature Schwann cells (Dong et 
al., 1999; Jessen et al., 1994). In addition, the Schwann cell cytoplasmic protein, 
S 100, expressed at very low levels or not all in Schwann cell precursors becomes 
strongly expressed in immature and all mature Schwann cells. Immature rat 
Schwann cells express many of the same molecular markers as those expressed by 
mature non-myelin forming Schwane cells, this includes the low affinity 
neurotrophin receptor, p75, GFAP, N-CAM and L1 (Jessen and Mirsky, 1991). 
The final stage of differentiation to non-myelin-forming or myelin-forming 
Schwane cells occurs in the first postnatal weeks in rodents and is thought to be 
regulated by axonal signalling but the exact mechanism is not clear. Non-myelin 
forming Schwane cells express the same molecular markers as immature Schwane 
cells but myelin forming Schwane cells begin to express myelin proteins such as 
Po, MAG, PLP, MBP, CNPase and PLP instead and proceed to myelinate the axon 
(Jessen and Mirsky, 1991). When axonal contact is lost, for instance following 
nerve transection, Schwann cells are able to dedifferentiate to an immature 
Schwann cell phenotype. 
Cultures of dissociated sciatic nerve cells were carried out in order to compare the 
intrinsic properties of isolated dy/dy and unaffected Schwann cells and to 
investigate how the abnormalities observed in vivo may have arisen. The number of 
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Schwann cells extracted per unit length of dy/dy sciatic nerves was far greater than 
in unaffected nerves and after 40 hours in vitro a far higher proportion of dy/dy 
Schwann cells were found to have survived. The increased rate of survival 
suggested that dy/dy Schwane cells were either proliferating more or undergoing 
apoptotic death less than unaffected Schwann cells in vitro. Previous studies had 
found that in adult dy/dy peripheral nerves, many undifferentiated Schwane cells 
continued to proliferate (Perkins et al., 1981; Perkins et al., 1980). Observations of 
living cultures showed that while dy/dy Schwane cells extend processes within 2 
hours in vitro unaffected Schwane cells are much slower to do so. Increased 
Schwann cell migration from dy/dy DRG explants on laminin-1 in vitro showed 
that laminin-2 has an effect on intrinsic Schwann cell motility as well as promoting 
Schwann cell migration as a substratum (chapter 5.2.2). 
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6.2: Results 
6.2.1: dv/dv Schwann cells do not express the laminin a2 chain in sciatic nerve 
cultures 
Cultures of sciatic nerve cells consisting predominately of Schwann cells were 
fixed after 40 hours in vitro. Double immunostaining was carried out using 
antibodies against the Schwann cell cytoplasmic protein, S 100 and against the 
laminin a2 chain to determine whether dy/dy Schwann cells were capable of 
expressing laminin a2 in vitro. Schwann cells from both unaffected and dy/dy mice 
expressed the S 100 protein intracellularly (fig. 6.1). The laminin a2 chain was 
expressed in a punctate pattern on the surface of unaffected S 100 immunoreactive 
Schwane cells and was also found to be deposited on the laminin-1-coated glass 
coverslips (fig. 6.1a). Expression of the laminin a2 chain on the surface of dy/dy 
Schwane cells was not observed, nor did there appear to be any deposition on the 
glass coverslips (fig. 6.1b). Thus it appears that cultured dy/dy Schwane cells, like 
their in vivo counterparts, are unable to synthesise laminin a2 chain protein. 
6.2.2: Dissociation of dv/dy sciatic nerves results in increased numbers of 
Schwann cells in vitro that rapidly extend cytoplasmic processes 
Cultures of sciatic nerve cells from P15-20 mice were examined 2-3 hours after 
plating under a phase contrast microscope and following immunostaining with the 
antibody to S 100, to determine any differences in the morphology of dy/dy and 
unaffected Schwann cells when initially dissociated. Each coverslip was plated with 
cells from an lcm length of sciatic nerve (this was considered to be "half a sciatic 
nerve" from the vertebral column to the point of bifurcation in the hind- limbs). 
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Figure 6.1: dy/dy Schwann cells do not express the laminin a2 chain in vitro. After 
40 hours in vitro dy/dy and unaffected (ua) Schwann cells were double-labelled with 
antibodies against the laminin a2 chain (green) and S100 (red), a Schwann cell marker. 
(a) In cultures of unaffected sciatic nerves cells, the laminin a2 chain is strongly 
expressed on the surface of Schwann cells and is deposited on to the coverslip as well 
(arrows). The cultures are immunoreactive for both S100 and the a2 chain. (b) The 
Schwann cells in cultures of dy/dy sciatic nerve cells do not appear to express any 
laminin a2 chain at all, and cultures of dy/dy sciatic nerve cells are immunoreactive for 
S 100 only. Magnification = x40. Scale bar = 50 µm. 
Dissociated Schwann cells were double immunostained in this manner in at least 10 
experiments. 
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Laminin a2 chain and 5100 
Schwann cells from unaffected and dy/dy mice were plated onto laminin-1 pre- 
coated coverslips, fixed after 3 hours in vitro and immunostained with the S 100 
antibody. There was a significant difference (p<0.05) in the yield of Schwann cells 
from unaffected sciatic nerves and dy/dy nerves. Whilst each coverslip was plated 
with cells derived from the same length of nerve, almost twice as many S 100 
immunoreactive Schwann cells were obtained from dy/dy sciatic nerve (4434 ± 
864) as from nerves of unaffected mice (2657 ± 695) (fig. 6.2). Thus, it appears that 
dy/dy sciatic nerves either contain a greater number of Schwann cells per unit 
length or they are better able to survive the dissociation process. 
In addition, when observed after acute isolation both dy/dy and unaffected sciatic 
nerve cells appeared rounded and without residual processes and were 
indistinguishable. However examination of sciatic nerve cultures 3 hours post 
plating under phase contrast microscopy revealed that while dy/dy Schwane cells 
had extended processes unaffected Schwane cells were still lacking any processes 
(fig. 6.3a, b). This implies that dy/dy Schwane cells may be in a more "activated" 













Figure 6.2: dy/dy sciatic nerves yields a greater number of dissociated 
Schwann cells than unaffected sciatic nerves. Graph showing the average 
number of S 100 immunoreactive Schwann cells counted on each laminin- 
1-coated coverslip 3 hours after plating. Each coverslip contained Schwann 
cells yielded from 1 cm of sciatic nerve. An average of 2656.5 ± 695.3 
(n = 4) Schwann cells were counted in cultures of unaffected (ua) sciatic 
nerve cells and 4433.8 ± 864.3 (n = 4) Schwarm cells were counted in 
cultures of dy/dy sciatic nerve cells. The difference in the number of 
Schwann cells yielded from dy/dy sciatic nerves was found to be significant 





Figure 6.3: Morphological differences in dr/dr Schwann cells are revealed 
in living cultures of unaffected and dy/dy sciatic nerve. Sciatic nerve cells 
were dissociated from P15-20 dy/dy or unaffected (ua) mice and observed 
under a phase contrast microscope at various timepoints following plating. 
(a, b) 3 hours after plating dy/dy Schwane cells (b) have extended processes, 
whereas unaffected Schwane cells (a) have yet to do so (arrowheads). 
(c, d) 16 hours after plating, some unaffected Schwann cells (c) have started 
to extend processes, dy/dy Schwann cell (d) process extension is more wide- 
spread and some Schwann cells are multipolar (arrows). (e, t) 40 hours after 
plating, unaffected Schwann cells (e) have extended processes and the maj- 
ority have a bipolar morphology (arrow). dy/dy Schwann cells (f) appear to 
be more numerous and many are multipolar in morphology (arrows). A few 
fibroblasts (Fb) are also visible after 40 hours in vitro. Magnification x40. 
Scale bar = 50µm. Live cultures were observed during the course of 3. Live 
cultures were observed during the course of 3 experiments. 
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6.2.3: dv/dy Schwann cells survive better in vitro than unaffected Schwann cells 
on a variety of ECM substrates 
Poly-L-lysine pre-coated glass coverslips were incubated with either laminin-1, 
laminin-2 or fibronectin to provide a variety of different ECM substrates for 
dissociated sciatic nerve cells from P15-20 unaffected and dy/dy mice. As before, 
each coverslip was plated with cells from lcm lengths of sciatic nerve. Examination 
of living sciatic nerve cell cultures using phase contrast microscopy, showed that 
after 16 hours in vitro the number of Schwann cells which had extended processes 
still appeared to be greater in cultures of dy/dy sciatic nerve cells (fig. 6.3c, d). 
After 40 hours in vitro sciatic nerve cell cultures were fixed and stained with an 
antibody to S100. Approximately twice as many Schwann cells were found in 
cultures of dy/dy sciatic nerve cells after 40 hours in vitro than in cultures of 
unaffected sciatic nerve cells on all ECM substrates tested (fig. 6.4). Laminins-1 
and 2 were preferred substrates relative to fibronectin for both dy/dy and unaffected 
Schwann cells in vitro. The "survival rate" of Schwann cells in vitro was calculated 
by comparing the number of Schwann cells 2-3 hours after plating with the number 
of Schwann cells at the final 40 hour time-point (Dong et al., 1995; Dong et al., 
1999; Gavrilovic et al., 1995; Jessen et al., 1994). It was found that irrespective of 
substrate, a substantially greater proportion of dy/dy Schwann cells (41%) were 
able to survive in vitro than unaffected Schwann cells (30.5%). Preliminary 
experiments using 5-Bromo-2'-deoxyuridine (BrdU) labelling in vitro showed that 
a higher proportion of dy/dy Schwann cells were proliferating than unaffected 
Schwann cells. 
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Figure 6.4: dy/dy Schwann cells survive better in vitro than unaffected 
Schwann cells on a variety of ECM substrates. Graph showing the aver 
-age number of S100 immunoreactive Schwann cells counted per coverslip 
after 40 hours in vitro on fibronectin (fn), laminin-1 (In-1) and laminin-2 
(In-2) substrates. Sciatic nerve cells from Icm of sciatic nerve were plated 
onto each coverslip. On fibronectin substrates an average of 714.8 ± 128 
unaffected (ua, n= 19) and 1467.3 ± 156.8 dy/dy (n = 21) Schwann cells 
were counted. On a laminin-1 substrate, an average of 837 ± 227.2 unaff 
-ected (n = 11) and 2141.2 ± 507.4 dy/dy (n = 11) Schwann cells were 
counted per coverslip. On a laminin-2 substrate, an average of 927.1 ± 225 
unaffected (n = 13) and 2110.8 ± 473.6 dy/dy (n = 13) Schwann cells were 
counted. The increase in the number of Schwarm cells in cultures of dy/dy 
sciatic nerve was significant at p< 0.005, on fibronectin (*), laminin-1 (**) 
and laminin-2 (***). Mean ± s. e. m. This experimental paradigm was carried 
out at least 5 times. 
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6.2.4: dy/dy Schwann cells migrate faster than unaffected Schwann cells in vitro 
DRG explants from P15-20 unaffected or dy/dy DRG's were placed on laminin- 
coated glass coverslips to compare the rate of migration of dy/dy and unaffected 
Schwann cells. After 40 hours in vitro the explants were stained with a fluorescent 
cell tracker dye, CMFDA, which was taken up by both DRG neurons and Schwann 
cells in the explant but more avidly by the latter. The cultures were immediately 
fixed and the distance migrated by the fluorescently-labelled Schwann cells from 
the DRG explants assessed. There was a significant difference (p<0.001) in the rate 
of migration of dy/dy Schwann cells (fig. 6.5). While unaffected Schwarm cells 
migrated at 17.17 µm/hr, the rate of dy/dy Schwann cell migration was 23.2% 
greater at 21.16 pm/hr. Both these rates of migration are comparable to previously 
published estimates of rat Schwann cell migration in vivo during regeneration 
(Anderson et al., 1991; Daniloff, 1991; Feneley et al., 1991) and to rat Schwann 
cell migration in cryoculture (chapter 5.2.1). Again, Schwann cell division may be 
a factor in the distance migrated by Schwann cells from DRG explants. 
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DRG explant type 
Figure 6.5: dy/dy Schwann cells migrate at a faster rate on laminin-I 
than unaffected Schwann cells in vitro. DRG explants from P 15-20 dy/dy 
and unaffected (ua) mice were placed on to coverslips coated with laminin 
-1. After 40 hours in vitro, the explants were stained with the cell tracker dye 
CMFDA and fixed, the distance migrated was assessed from digitised images. 
dy/dy Schwane cells were found to have migrated a distance of 846.5 ± 20.2 
tm (n = 7), significantly further (*, p, 0.001) than the 686.8 ± 26.1 µm (n = 8) 
migrated by unaffected Schwann cells. Mean ± s. e. m. This experimental para 
-digm was carried out 4 times. 
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6.2.5: dy/dy Schwann cells display an unusual multipolar morphology in vitro 
Dissociated sciatic nerve cells from P15-20 dy/dy or unaffected mice were plated 
onto either laminin-1 or laminin-2 pre-coated glass coverslips. After 40 hours in 
vitro the cultures were fixed and stained with an antibody against S100 and the 
morphology of the Schwann cells assessed. The numbers of Schwann cells with 
two or less processes (bipolar) and those with more than 2 processes (multipolar) 
were counted and expressed as a percentage of the total number of Schwann cells. 
Multipolar Schwane cells were observed in cultures of both unaffected and dy/dy 
sciatic nerve cells on both laminin-1 and laminin-2 substrates but a much higher 
proportion of dy/dy Schwann cells were multipolar (fig. 6.6 b, d, f, 6.7) compared 
with unaffected Schwann cells (fig. 6.6a, c, e, 6.7). On either a laminin-1 or 
laminin-2 substrate approximately 12% of unaffected Schwann cells were 
multipolar. In contrast 64% of dy/dy Schwann cells were multipolar on a laminin-1 
substrate and 48% on a laminin-2 substrate (fig. 6.7). 
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Figure 6.6: dy/dy Schwarm cells display a multipolar morphology in vitro. 
Dissociated Schwann cells from the sciatic nerves of P15-20 unaffected (ua) and dy/dy 
mice were plated onto laminin-1 (In-1) and laminin-2 (In-2) coated coverslips. After 40 
hours in vitro the Schwann cells were fixed and stained with an S 100 antibody to 
distinguish the Schwann cells. (a) At low power it can be seen that in cultures of 
unaffected sciatic nerve cells on a laminin-1 substrate, the Schwann cells appear to be 
largely bipolar in morphology. (b) At low power magnification it can be seen that there 
is a wide distribution of multipolar Schwann cells in cultures of dy/dy sciatic nerve 
cells plated onto laminin-1 substrates. (c) The bipolar morphology of unaffected 
Schwann cells can be clearly seen on laminin-1 substrates (arrows). (d) A dy/dy 
Schwann cell on a laminin-1 substrate is clearly multipolar, extending several primary 
processes and exhibiting some branching of processes too (arrowheads). (e) Unaffected 
Schwann cells are bipolar on laminin-2 substrates too (arrows). (f) Even in the 
presence of laminin-2, many dy/dy Schwann cells are still multipolar with several 
primary processes and branching (arrowheads). Magnification: (a, b) x20, (c-f) x40. 
Scale bar: (a, b) 100 µm, (c-f) 50 µm. 
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Figure 6.7: dy/dy Schwann cells have a multipolar morphology in vitro 
which is partially compensated on a laminin-2 substratum. Unaffected 
(ua) and dy/dy Schwann cells were plated onto coverslips coated with laminin 
-1 (In-1) or laminin-2 (In-2). After 40 hours in vitro cultures were fixed and 
stained with an antibody to the Schwann cell marker S 100 and the percentage 
of bipolar and multipolar Schwarm cells determined. 11.52% ± 1.38% of un 
-affected Schwann cells on the laminin-1 substrate were multipolar, signific 
-antly less (*, p<0.001) than the 64.2% ± 3.71 % of dy/dy Schwann cells on 
the laminin-1 substrate which were multipolar. There were significantly fewer 
(* *, p<0.001) multipolar Schwarm cells in cultures of unaffected Schwarm 
cells on laminin-2 than in cultures of dy/dy Schwann cells. On a laminin-2 
substrate, 12.21 ± 1.15% of Schwann cells were multipolar whereas 47.99 ± 
4.12% of dy/dy Schwarm cells were multipolar. There was a significant dec 
-rease (***, p<0.05) in the number of multipolar Schwann cells in cultures of 
dy/dy Schwarm cells on laminin-2 compared to laminin-I substrates. Mean ± 




dy/dy Schwann cells have distinct survival, migratory and morphological 
properties in vitro 
Isolated dy/dy Schwann cells are unable to produce laminin a2 chain and I have 
shown in this chapter that this has a number of consequences for Schwann cell 
behaviour in vitro. Normal isolated Schwann cells and fibroblasts are capable of 
expressing the al (weakly), a2, ß1, (32 and yl laminin chains (Hsiao et at., 1993). 
The a2 chain immunoreactivity I observed in cultures of unaffected sciatic nerve 
cells was punctate in the absence of the axonal contact required for Schwarm cells 
to incorporate a continuous basal lamina (Clark and Bunge, 1989). In co-cultures of 
unaffected Schwann cells with either unaffected or dy/dy DRG neurons basal 
lamina coverage was almost 100% whereas in co-cultures of dy/dy Schwane cells 
with either unaffected or dy/dy neurons basal lamina coverage was this fell to 55- 
60% but was restored to complete coverage with the addition of normal fibroblasts 
(Cornbrooks et al., 1982). Thus a2 chain production by Schwann cells and 
fibroblasts is essential for basal lamina incoroporation in vitro. The inability of 
dy/dy Schwann cells to produce a2 chain protein not only prevents the 
incorporation of a continuous basal lamina but also results in Schwann cells with 
distinctly different phenotypes. 
The ability of isolated P20 dy/dy Schwann cells to extend processes earlier than 
unaffected Schwann cells of the same age was reminiscent of the properties that 
normal neonatal Schwann cells display in culture (data not shown). Like dy/dy 
Schwann cells, these were often seen to extend processes within 2-3 hours of 
plating, whereas almost no process extension was observed in cells plated from 
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adult sciatic nerves. This is consistent with the Schwann cells dissociated from 
dy/dy sciatic nerve displaying properties characteristic of immature Schwann cells. 
dy/dy Schwane cells survive dissociation better in the short-term than unaffected 
Schwann cells, possibly because in situ they are less tightly associated with axons. 
Mutant Schwann cells also have a higher rate of survival in the long-term. The rate 
of survival was independent of the culture substratum, implying that the ability of 
the dy/dy Schwane cells to survive in vitro was linked to some intrinsic properties. 
Survival in the long term may also be linked to the loose association of dy/dy 
Schwane cells with axons in vivo, which may mean that mutant Schwane cells are 
less traumatised during trituration and dissociation. The higher rate of survival may 
also be a consequence of either a higher rate of proliferation or a lower rate of 
apoptosis or both. 5-Bromo-2'-deoxyuridine (BrdU) labelling in vivo, by 
intraperitoneal injection for example, may have determined if adult dy/dy do have 
large numbers of Schwann cells that more actively proliferate. 
In vitro Schwann cells proliferate and continue differentiating in the absence of 
ECM (Carey et al., 1986). Previous evidence suggests that there may be a 
population of "uncommitted cells", most probably immature Schwane cells, in 
adult dy/dy nerves that remain at the margins of axons bundles and do not ensheath 
the axons normally (Perkins et al., 1980). These "uncommitted cells" resemble 
Schwane cells in developing nerves and are blocked from differentiating fully or 
normally and are thus still able to proliferate unless grafted into the sciatic nerves 
of normal mice where they differentiate, ensheath and myelinate the axon (Perkins 
et al., 1981; Perkins et al., 1980). Thus in vivo dy/dy Schwane cells can be induced 
to differentiate normally and associate with axons in normal nerves and in contact 
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with intact endoneurial basal laminae, it is possible that in dy/dy nerves this contact 
is either lost or never achieved with the patchy basal lamina. 
Further evidence that dy/dy Schwann cells are not as fully differentiated and in a 
rather more "activated" state stems from their increased motility. The fact that 
dy/dy Schwann cells extend processes earlier than unaffected Schwann cells gave 
an indication that they may be more motile. This was supported by results from an 
assay of in vitro Schwarm cell migration in which dy/dy Schwann cells migrated at 
a faster rate than unaffected Schwann cells. Time-lapse microscopy in a previous 
study showed that Schwann cell precursors are approximately ten times more 
motile than neonatal Schwarm cells in vitro (Jessen et al., 1994). This is also true of 
CNS oligodendrocytes, where undifferentiated progenitors are more motile than 
their mature counterparts (Noble et al., 1988). 
One of the most striking differences between isolated dy/dy and unaffected 
Schwann cells was in their morphology. Whereas the majority of unaffected 
Schwarm cells assumed a bipolar morphology in vitro, dy/dy Schwann cells were 
largely multipolar. Addition of exogenous laminin-2 as a substrate for dy/dy 
Schwann cells significantly lowered the proportion of multipolar Schwann cells 
although this remained greater than in cultures of unaffected Schwann cells on 
laminin-2. These morphological differences manifested in vitro may reflect the 
differences seen in vivo following nerve crush injury (chapter 4.2.2), with Schwann 
cell processes interacting with several axons. In addition the multipolarity of dy/dy 
Schwann cells may reflect their increased motility in vitro. 
The ability of the laminin a2 chain to influence Schwann cell morphology means 
that it is likely to have a role in polarising Schwann cells during both development 
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and regeneration and in the normally functioning PNS. Ectopic extension of 
Schwann cell processes into the synaptic cleft in dy/dy mice (Banker et al., 1979) 
and in mice lacking the laminin-11 heterotrimer (Patton et al., 1998) is consistent 
with a role for specific laminins in controlling the polarity of Schwann cells. It 
seems likely that both the a2 and a5 chains are capable of inhibiting Schwann cell 
process extension. Thus laminin-2 in endoneurial basal lamina could constrain 
myelin-forming Schwann cells from extending processes to more than one axon 
and enable myelin forming Schwann cells to form the one-to-one relationship 
between axon and Schwann cell that is a prerequisite for myelination in the PNS. 
At the NMJ the a2 chain containing laminin-4 and the a5 chain-containing 
laminin-11 ensure that terminal Schwann cells extend processes only around the 
axon shaft but excludes them from the synaptic cleft. 
The morphological differences between dy/dy and unaffected Schwarm cells in vitro 
are also likely to be linked to differences in their relative stages of maturity. As has 
been described previously, Schwane cell precursors are normally multipolar with 
extensive cell-cell contacts (Dong et al., 1999; Jessen et al., 1994). As Schwann 
cells mature they adopt more simple tri- or bipolar shapes in vitro. When Schwane 
cells come into contact with the basal lamina they cease proliferating, differentiate 
and undergo morphological changes as they elongate and align themselves along 
axons (Carey et al., 1986; Obremski and Bunge, 1995; Obremski et al., 1993a; 
Obremski et al., 1993b). Thus the Schwane cell basal lamina clearly has a role in 
regulating Schwann cell morphology, either directly in the case of glial processes in 
the synaptic cleft or as a result of controlling the differentiation of Schwann cells. 
The specific deficiency of the laminin a2 chain in dy/dy Schwarm cells results in 
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distinct differences in vitro in the properties of dy/dy and unaffected Schwane cells, 
consistent with a significant role for the a2 chain/laminin-2 heterotrimer in 
regulating Schwann cell maturation, motility and polarity in vivo. 
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Chapter 7: The role of laminin-2 in the interaction of Schwann cells 
with neurons 
7.1: Introduction 
Laminin-2 has been shown to promote neunte outgrowth in vitro by a variety of 
types of neurons (Agius and Cochard, 1998; Anton et al., 1994a; Cho et al., 1998; 
Cohen and Johnson, 1991; Engvall et al., 1992) and has been implicated in the 
regulation of axon growth and guidance in vivo. However, the absence of overt 
axon targeting errors in dy/dy mice suggests that whatever its role may be in axonal 
guidance, there is evidently compensation by the intervention of alternative 
molecules in development. However, in vitro studies with dy/dy Schwann cells and 
neurons offer the possibility to explore the impact of laminin-2 deficiency on the 
specific interactions between axons and Schwann cells. A quantitative assessment 
of primary and terminal branches showed that neurite branching by DRG neurons 
was less complex on laminin-2-deficient dy/dy Schwann cell substrates. The 




7.2.1: dy/dy Schwann cells provide a poor substrate for neurite outgrowth 
The ability of laminin-2 to influence neunte outgrowth and branching was 
investigated by culturing DRG neurons isolated from both dy/dy and unaffected 
mice on a layer of cultured sciatic nerve cells, derived from either dy/dy or 
unaffected mouse sciatic nerves. The sciatic nerve cultures were prepared 48 hours 
prior to plating with neurons to provide a cell coverage close to confluence, to act 
as a uniform substrate for neunte growth. DRG neurons were distinguished from 
Schwarm cells in these co-cultures using a GAP-43 immunoreactivity. Whilst GAP- 
43 is strongly expressed by growing neurons it is also found in non-myelin forming 
Schwane cells both in vivo and in vitro, and by denervated myelin forming 
Schwann cells (Curtis et al., 1992; Scherer et al., 1994b; Woolf et al., 1992). 
However at the antibody dilution used in this study, Schwann cells were only ever 
weakly immunopositive and clearly distinguishable from intensively labelled 
neurons. In addition Schwane cells and neurons displayed very different sizes and 
morphologies. 
Several characteristics of the cultured DRG neurons were analysed to determine 
differences in patterns of neunte outgrowth: the numbers of primary processes 
which extended from each neuronal cell body (a measure of the initiation of neunte 
outgrowth); the number of terminal neunte branches (a measure of the extent of 
subsequent neunte growth); and the number of terminal neunte branches per 
primary process (a measure of branching frequency) were evaluated in each case. 
Firstly, it was found that the number of primary processes extended by neurons was 
largely independent of the source of Schwann cells with which dy/dy and 
240 
unaffected DRG neurons were co-cultured (fig. 7.2a). 
The source of the Schwann cells was the key factor in determining subsequent 
neurite outgrowth and branching (fig. 7.1a, c, e, g). Both the number of terminal 
branches (fig. 7.2b) and, consequently, the branching frequency (fig. 7.2c) was 
significantly reduced (p<0.01) in co-cultures with dy/dy Schwann cells. Thus the 
source of the Schwann cells rather than of the DRG neurons was the instrumental 
factor in patterning neurite outgrowth. 
7.2.2: Exogenous laminin-2 restores a normal pattern of neurite outgrowth in 
co-cultures of DRG neurons and dy/dy Schwann cells 
To determine whether the reduction in complexity of DRG neunte outgrowth 
patterns in co-cultures with dy/dy Schwane cells was a consequence of the laminin- 
2 deficiency, we compared the morphology of DRG neurons in co-cultures with or 
without pre-treatment with exogenous laminin-2 (10 pg/ml). Whilst addition of 
exogenous laminin-2 had no significant effect on the number of primary processes 
extended in DRG neuron-dy/dy Schwann cell co-cultures (fig. 7.2a), it did affect the 
branching complexity of neuntes extended on dy/dy Schwann cells, but not on 
unaffected Schwann cells (fig. 7.1). Addition of exogenous laminin-2 produced 
significant increases (p<0.01) in both the number of terminal branches and the 
branching frequency (fig. 7.2b, c) of DRG neurons co-cultured with dy/dy Schwann 
cells. Thus neunte outgrowth patterns of DRG neurons co-cultured with dy/dy 
Schwann cells in the presence of exogenous laminin-2 resembled those growing on 
unaffected Schwann cells (fig. 7.1b, d, f, h). 
241 
Figure 7.1: Neurite branching is diminished in DRG neuron-dy/dy Schwann cell 
co-cultures. DRG neurons from unaffected (uan) and dy/dy (dyn) mice were co- 
cultured with Schwarm cells from unaffected (uas) and dy/dy (dys) mice on laminin-1 
(a, c, e, g) and with cultured Schwann cells pre-treated with exogenous laminin-2 
before addition of DRG neurons (b, d, f, h). 18 hours after the DRG neurons had been 
plated onto the Schwann cells, the cultures were fixed and stained with a rabbit anti- 
GAP-43 antibody. (a) Unaffected DRG neurons cultured with unaffected Schwann 
cells display profuse and highly branched neunte outgrowth. (b) Addition of 
exogenous laminin-2 to co-cultures of unaffected Schwann cells and DRG neurons 
does not appear to affect the morphology of the DRG neurons. (c) dy/dy DRG neurons 
co-cultured unaffected Schwann cells also have profuse and highly branched neunte 
outgrowth. (d) Addition of exogenous laminin-2 does not alter the morphology of the 
co-cultures in (c). (e) In co-cultures of unaffected DRG neurons with dy/dy Schwane 
cells the branching pattern of the neuntes is less complex than those co-cultured with 
unaffected Schwann cells. (1) This lack of complexity appears to be corrected by 
treating dy/dy Schwane cells with laminin-2, which restores the branching complexity 
of the neuntes. (g) dy/dy DRG neurons co-cultured with dy/dy Schwane cells also lack 
complexity in their branching pattern. (h) Addition of exogenous laminin-2 appears to 
correct the deficit in branching frequency of the neuntes observed in co-cultures of 
dy/dy DRG neurons with dy/dy Schwane cells. Magnification x20. Scale bar = 100µm 
242 
+laminin-2 
Figure 7.2: Exogenous laminin-2 converts the neurite branching pattern of DRG 
neurons to a normal appearance on dy/dy Schwann cells. Unaffected and dy/dy 
DRG neurons were plated onto confluent cultures of unaffected and dy/dy sciatic nerve 
cells. After 18 hours in vitro the co-cultures were fixed and immunostained with a 
rabbit anti-GAP-43 antibody. The number of primary neunte processes (a), terminal 
neunte processes (b), and the complexity of neunte branching (the number of terminal 
processes per primary process) (c) was assessed from digitised images. (a) There is a 
significant difference in the number of primary processes extended by both dy/dy (*) 
and unaffected (**) neurons on dy/dy and unaffected Schwann cells (p<0.01) which is 
not significantly altered by addition of laminin-2 to the Schwann cells. (b) There is a 
large and significant decrease (p<0.01) in the number of terminal processes extending 
from both unaffected (*) and dy/dy (***) neurons cultured on dy/dy Schwann cells. The 
numbers of terminal processes extending from both unaffected (**) and dy/dy (****) 
neurons when co-cultured with dy/dy Schwann cells which had been treated with 
exogenous laminin-2 were significantly increased when compared to those plated on 
untreated Schwann cells (p<0.01). (c) Branching frequency of either unaffected (*) or 
dy/dy neurons (***) was significantly reduced in co-cultures with dy/dy Schwann cells 
(p<0.01), and significantly increased when either unaffected (**) or dy/dy (****) 
neurons were co-cultured with laminin-2 pre-treated dy/dy Schwann cells (p< 0.01). 
Experimental conditions: uasuan = unaffected neurons plated on unaffected Schwann 
cells (control, n= 100; exogenous laminin-2 treatment, n =54). uasdyn = dy/dy neurons 
on unaffected Schwann cells (control, n= 72; exogenous laminin-2 treatment, n =33). 
dysuan = unaffected neurons on dy/dy Schwann cells (control, n= 142; exogenous 
laminin-2 treatment, n= 60). dysdyn = dy/dy neurons on dy/dy Schwann cells (control, 
n= 131; exogenous laminin-2 treatment, n =26). Mean ± s. e. m. This experimental 
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7.3: Discussion 
dv/dy Schwann cells, lacking the laminin a2 chain, are a poor substrate for 
neurite branching in vitro 
The work described in this chapter shows that the deficiency of laminin-2 in dy/dy 
Schwann cells affects not only the properties of Schwann cells themselves but also 
exerts an effect on their interactions with axons. Both dy/dy and unaffected DRG 
neurons cultured on a substrate of dy/dy Schwann cells displayed morphological 
differences from those cultured on unaffected sciatic nerve Schwann cells. Analysis 
of the pattern of neunte branching confirmed that there was a significant decrease 
in the number of terminal branches and hence the branching frequency of neuntes 
on laminin-a2 chain-deficient dy/dy sciatic nerve cells. The ability of exogenous 
laminin-2 to remedy this deficiency is consistent with the lack of the a2 chain 
being the primary cause of this branching abnormality on dy/dy Schwann cells. As 
DRG neurons from mutant or unaffected mice responded identically in co-cultures 
with unaffected Schwann cells, it is evident that the neural abnormalities observed 
in the PNS of dy/dy mice are a consequence of abnormalities in Schwann cells (and 
possibly of other sciatic nerve cells, such as fibroblasts). This is consistent with the 
findings in an earlier study in which the extent of basal lamina formation was found 
to be diminished in co-cultures of dy/dy Schwann cells with either unaffected or 
dy/dy neurons but not in co-cultures of dy/dy neurons with unaffected Schwann 
cells (Combrooks et al., 1982). It is possible to rescue this basal lamina deficiency 
in vitro with the addition of normal mouse sciatic nerve fibroblasts. 
Partial inhibition of neuritic branching has also been observed when laminin-2 
activity is blocked on sciatic nerve sections used as a substrate for neurite 
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outgrowth and Schwann cell migration from DRG explants (Anton et al., 1994a). 
Whilst the ability of laminins such as laminin-2 to promote neunte outgrowth in 
vitro is well studied (Anton et al., 1994a; Cho et al., 1998; Cohen and Johnson, 
1991; Engvall et al., 1992), there are no descriptions of axon pathfinding defects in 
the dy/dy mouse. However appropriate regulation of axonal branching is critical 
during regeneration since the greater the number of axons sprouting along the 
bands of Büngner the more successful and precise will be the resulting 
regeneration. Recent work has shown that laminin-2 may exert a greater influence 
on axon outgrowth during regeneration. Thus in cryoculture, specific antibody 
blockade of laminin-2 function reduced neurite outgrowth from dissociated DRG 
neurons to a much greater extent on denervated sciatic nerve substrates than on 
intact sciatic nerve substrates (Agius and Cochard, 1998). These in vitro 
experiments are consistent with an important role for laminin-2 in vivo during 
regeneration in the PNS. It seems likely that as axons sprout along bands of 
Büngner, laminin-2 produced by Schwann cells not only fosters axonal sprouting 
but also the elaboration of terminal branches. In dy/dy mice with transected sciatic 
nerves axon sprouting in the distal stump is meagre (chapter 4.3.1). These data 
from Schwann cell-neuron co-cultures suggest that even if initial axonal sprouting 
is not inhibited in the regenerating nerves of dy/dy mice, the deficit in laminin-2 
leads to a reduced extent of branching and consequently less efficient axon 
regeneration in the distal stump. 
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Chapter 8: General Discussion 
8.1: Neural abnormalities in the dv/dy mouse 
The dy/dy mouse suffers from a form of muscular dystrophy that affects both the 
skeletal muscle and the PNS (Bradley and Jenkison, 1973; Michelson et al., 1955). 
This dystrophy is caused by a deficiency of the laminin a2 chain in skeletal muscle 
and in the endoneurial basal lamina of peripheral nerves (Arahata, 1993; Sunada et 
al., 1994; Xu et al., 1994a). The most prominent phenotype in peripheral nerves of 
dy/dy mice is the presence of many axons that are either unensheathed by Schwann 
cells and directly apposed or incompletely ensheathed with patchy myelination and 
elongated nodes of Ranvier (Bradley et al., 1977; Bradley and Jenkison, 1973; 
Bradley and Jenkison, 1975; Jaros and Bradley, 1979; Madrid et al., 1975; Okada et 
al., 1975; Okada et al., 1976). The abnormalities observed suggest that laminin a2 
chain-containing laminins play an important role in regulating appropriate Schwann 
cell-axon interactions in vivo. In this thesis I have therefore used the dy/dy mouse to 
further investigate the role of laminin-2 in different aspects of Schwann cell 
behaviour and in their interactions with axons both in vivo and in vitro. 
I firstly examined expression of a2 chain protein in myogenic and neural tissues 
and I have provided preliminary evidence from Western blotting and 
immunohistochemistry for the existence of a laminin a2 chain variant that is much 
reduced in the peripheral nerves of dy/dy mice but continues to be expressed in 
myogenic tissues. Although the level of laminin a2 chain protein and mRNA 
detected in the skeletal muscle of dy/dy mice appears to be dependent on the 
antibodies or probes used, it is clear that the expression of this chain is negligible in 
the PNS of dy/dy mice (Ringelmann et al., 1999; Sewry et al., 1998; Sorokin et al., 
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2000). 
In the intact PNS of dy/dy mice I confirmed the findings of previous studies 
showing that Schwann cells failed to ensheath axons fully or extended processes to 
and ensheathed both myelinated and unmyelinated axons and that many axons 
remained completely unensheathed. I showed that these abnormalities were re- 
established in regenerating nerves and moreover, remyelination was both delayed 
and less extensive in regenerating mutant nerves. Immunohistochemical analysis of 
sciatic nerves revealed morphological differences in the associations of Schwann 
cells with axons that could explain these differences. Immunostaining of 
cryosections with an antibody to S 100 showed that dy/dy Schwann cell morphology 
differed in vivo where many mutant Schwann cells were rounded rather than 
ellipsoid. In cultures of dissociated sciatic nerve, a large proportion of mutant 
Schwann cells displayed a multipolar rather than a bipolar morphology. Moreover, 
dy/dy Schwann cells were more motile than unaffected Schwann cells. In co- 
cultures of Schwann cells and DRG neurons, dy/dy Schwann cells acted as a poor 
substrate for promoting neurite branching of both unaffected and mutant DRG 
neurons. Complex neunte branching patterns of DRG neurons could be restored on 
mutant Schwann cells by preincubation with exogenous laminin-2. 
The pleiotropic nature of laminin-2 expression and the extensive neural 
abnormalities observed in the dy/dy mouse, especially when compared to other 
forms of muscular dystrophy raises the possibility that there is a substantial 
neurogenic component to this dystrophy. In a recent study, insertion of a human 
transgene under the control of a myogenic promoter alleviated some of the 
symptoms in mice with a targeted deletion of the laminin a2 chain and allowed 
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them to regenerate skeletal muscle (Kuang et al., 1999). However they still showed 
some characteristic symptoms of dy/dy and a24" mice including hind-limb flexion 
to the trunk when lifted up by the tail and progressive hind-limb paralysis. Thus 
some symptoms in dy/dy mice cannot be alleviated by restoring a2 chain 
expression only in skeletal muscle, supporting the idea of a significant neurogenic 
component 
8.2: Involvement of Schwann cell laminins in Schwann cell migration and 
axonal outirowth 
Previous studies have not revealed any abnormalities in axonal pathfinding in the 
PNS of dy/dy mice. However poor axonal sprouting into the distal stump following 
transection of mutant sciatic nerves (chapter 4.2.1) and a lower branching 
frequency of DRG neurons extending neuntes in co-cultures with dy/dy Schwarm 
cells (chapter 7.2.1) indicate a role for laminin-2 in promoting neunte branching, at 
least during regeneration. I have compared Schwarm cell migration on intact 
unaffected and dy/dy mouse sciatic nerve substrates (chapter 5.2) and shown that 
laminin-2 plays a significant role in promoting Schwann cell migration. Interactions 
with migrating Schwarm cells are essential for axonal outgrowth during both 
development and regeneration. Thus axonal re-growth is poor in the distal stump of 
regenerating axons in the bands of Btingner of dy/dy nerves, as both the interaction 
with migrating Schwann cells and the promotion of neunte branching by laminin-2 
of sprouting axons in the distal stump is compromised (fig. 8.1). 
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Figure 8.1: The possible roles of laminin-2 in Schwann cell development and 
differentiation and in Schwann cell-axon interactions. Neural crest cells 
differentiate into a variety of cells including neuronal cells and Schwann cell 
precursors. Differentiation towards the neuronal lineage is driven by BMP's and 
towards the Schwann cell lineage by GGF's and Delta-Notch signalling. The cells 
in cultures of dy/dy sciatic nerve cells differ in their morphology and in their 
motility and ability to survive and proliferate, this may be due to the continued 
presence of large numbers of multipotent neural crest cells. This would imply that 
laminin-2 (Ln-2) may be able to regulate BMP, GGF or Delta-Notch signalling. 
There is stronger evidence that laminin-2 is involved in regulating glial 
development once neural crest cells have differentiated towards the Schwann cell 
lineage. Autocrine survival loops regulated by growth factors ensure the survival of 
immature Schwann cells. Binding of laminins to integrins promotes the formation 
of complexes with growth factors that share the same signalling pathway, leading to 
growth factor receptor aggregation. A deficiency in laminin-2 could up or down- 
regulate the level of integrin receptors expressed and the number of ocupied 
integrin receptors, this could have downstream affects on the growth factors 
involved in Schwann cell autocrine survival loops. 
Motility of Schwann cells may also be regulated by levels of laminin-2 expression. 
Differentiating Schwann cells express specific integrin receptors that are able to 
promote laminin-2-mediated Schwann cell migration. Up or down-regulation of 
integrin receptor expression, continued expression of integrins that mediate 
migration by Schwann cells that fail to differentiate and a lack of laminin-2 
substrate for migrating Schwann cells to bind to, may all alter the motility of dy/dy 
Schwann cells. 
Laminin-2 regulates Schwann cell morphology, constraining the Schwann cells to 
the bipolar morphology necessary for myelin forming Schwann cells to align 
themselves along individual axons before ensheathing and myelinating them. 
Laminin-2 expressed by migrating Schwann cells can also promote neunte 
branching as well as neurite outgrowth. This property is particularly important in 
the bands of Bangner of regenerating nerves. 
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Figure 8.1: The role of laminin-2 in Schwann cell 
maturation and Schwann cell-axon interactions 
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Previous studies have indicated the importance of Schwann cells in regulating 
axonal outgrowth both during development and regeneration. Mice with a targeted 
deletion of either the ErbB2 or the ErbB3 neuregulin receptors lose the majority of 
their Schwann cells in early development. Consequently, the vast majority of both 
sensory and motor neurons die through apoptosis during development and 
surviving axons are extensively defasciculated (Morris et al., 1999; Riethmacher et 
al., 1997; Woldeyesus et al., 1999). This suggests a role for Schwann cells in 
guiding and possibly also leading axons to their peripheral targets during 
development. It has been claimed that columns of Schwann cells have extend up to 
100 µm ahead of motor axons into the chick forelimb bud from stages 24 to 27, but 
the antibody marker used could not reliably distinguish between Schwann cells and 
growth cones (Noakes and Bennett, 1987). 
During regeneration the presence of migrating Schwann cells is essential for axonal 
outgrowth. When Schwann cells are prevented from migrating within the bands of 
Büngner axonal regeneration is delayed and less extensive (Feneley et al., 1991; 
Hall, 1986a; Rodriguez et al., 2000). Regenerating axons are always associated 
with Schwann cells throughout the length of the axon and it is thought that the rate 
of Schwann cell migration may limit the extent of axonal sprouting in regenerating 
nerves. In axotomised nerves transplanted to a skeletal muscle substrate Schwann 
cell processes were seen extending ahead of associated axons (Son and Thompson, 
1995b). This is consistent with a possible guidance role for Schwann cells during 
regeneration. 
Laminin-2 has been shown to have neurite-promoting properties in intact and 
regenerating neurons in vitro (Anton et al., 1994a; Cho et al., 1998; Cohen and 
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Johnson, 1991; Engvall et al., 1992) and is produced by and expressed on Schwann 
cells (Hsiao et al., 1993; Leivo and Engvall, 1988). Blocking the activity of the 
laminin-2 heterotrimer inhibited neunte branching on denervated nerve substrates 
in cryoculture (Anton et al., 1994a). In an in vitro assay neunte outgrowth from 
motor neurons was also promoted on a laminin-1 substrate and on a combined 
substrate of laminins-2,4 (a2ßlyl) and 8 (a4ßlyl). Ectopic postnatal expression of 
laminin a4 chain has been detected in both endoneurial basal lamina and skeletal 
muscle of dy/dy mice (Patton et al., 1997; Ringelmann et al., 1999). Laminin a4 
chain-containing heterotrimers include laminins-8 and 9; laminin-8 is normally 
expressed in the endoneurial basal lamina only during development and is restricted 
to mesenchymal cells postnatally and the laminin-9 heterotrimer is normally 
restricted to synaptic and perineurial basal lamina (Miner et al., 1997). It may be 
that in dy/dy nerves the presence of a large number of Schwann cells that are not 
terminally differentiated results in the continued deposition of the laminin a4 chain 
in the endoneurium. However ectopic expression of the laminin a4 chain is clearly 
not sufficient to compensate structurally in the basal lamina or functionally in 
promoting axonal re-growth during regeneration and neunte branching in vitro. 
Whilst laminin-8 promotes neunte outgrowth in combination with laminins-2 and 
4, there is no evidence that it can alone support neunte outgrowth (Cho et al., 
1998). 
In the developing and regenerating nerve, complex interactions between various 
ECM molecules regulate axonal outgrowth and Schwann cell migration. For 
instance fibronectins are upregulated during development and regeneration (Lefcort 
et al., 1992) and can promote Schwann cell migration (Bailey et al., 1993; Milner et 
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al., 1997). Tenascin-C is also expressed in developing and regenerating peripheral 
nerves (Scholze et al., 1996; Zhang et al., 1995) and has both adhesive and anti- 
adhesive properties for Schwann cells and axons depending on which functional 
domain is activated (Gotz et al., 1996). CSPGs mask the activity of laminin-2 in 
intact nerves. Expression of MMPs-2 and 9, enzymes that degrade CSPGs, are 
increased during regeneration and addition of these enzymes to intact nerve 
substrates in cryoculture increases neurite outgrowth (Ferguson and Muir, 2000). 
Thus MMP-2 and 9 may remove the masking activity of CSPGs in regenerating 
nerves, enabling endoneurial laminin-2 in the bands of Biingner to promote neunte 
outgrowth and branching of sprouting axons. Specific laminin heterotrimers are 
also involved in inhibitory interactions with Schwann cells and motor axons. The 
laminin-11 heterotrimer found at the synaptic basal lamina is inhibitory to motor 
axons (Cho et al., 1998) and to Schwann cell process extension (Patton et al., 
1998), thereby preventing axons from extending beyond the motor end-plate once 
they have reached their target and terminal Schwann cells from extending processes 
into the synaptic cleft. 
8.3: Laminin-2 and Schwann cell maturation and myelination 
The appearance of both intact (chapter 3.2.1) and regenerated dy/dy peripheral 
nerve fibres (chapter 4.2) and the properties of dy/dy Schwarm cells in vitro such as 
increased motility and multipolar morphology (chapter 6.2) suggests that the deficit 
in laminin-2 affects the maturation of Schwann cells and their association with 
axons. The presence of basal lamina induces Schwane cells to differentiate, 
elongate, ensheath and myelinate axons (Carey et al., 1986; Clark and Bunge, 1989; 
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Obremski and Bunge, 1995; Obremski et al., 1993a; Obremski et al., 1993b). Loss 
of contact with axons following injury leads to dedifferentiation of myelin-forming 
Schwann cells to a premyelinating phenotype, downregulation of myelin proteins 
and proliferation (Bunge, 1993; Lemke and Chao, 1988; Mirsky and Jessen, 1996). 
In mutant nerves, the absence or incompleteness of the basal lamina means that 
many Schwann cells do not interact with axons appropriately and consequently 
Schwann cells either never contact an axon and mature fully or lose axonal contact 
and dedifferentiate. 
The inability of dy/dy Schwann cells to ensheath axons suggests a role for laminin- 
2 in regulating the adoption of the bipolar morphology necessary for Schwann cell 
ensheathment as a prelude to myelination. We observed aberrant dy/dy Schwann 
cell morphology in both ultrastructural and immunohistochemical analyses of 
sciatic nerves and in cultures of Schwann cells. Plating dy/dy Schwann cells onto a 
laminin-2 rather than laminin-1 substrate resulted in a switch from an aberrant 
multipolar morphology to a bipolar morphology in a significant proportion of dy/dy 
Schwann cells, consistent with laminin-2 regulating this process. The ability of 
specific laminin heterotrimers to determine cell morphology may be related to their 
spatial expression pattern in vivo. Thus laminin-2 expressed in the endoneurial 
basal lamina can induce a bipolar morphology in Schwann cells and laminin- 11, 
enriched at the NMJ, is able to regulate terminal Schwann cell morphology (Patton 
et al., 1998; Sewry et al., 1998). Laminin-11 appears to act as a "stop signal" to 
terminal Schwann cells, preventing process extension into the synaptic cleft. By 
analogy laminin-2 may act as a constraining influence, also preventing the 
extension of multiple processes and restricting Schwann cells to a bipolar 
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morphology. Consistent with this, I found that laminin-1, restricted to the 
perineurial basal lamina and therefore not in contact with Schwann cells, fails to 
promote the acquisition by dy/dy Schwann cells of a bipolar morphology in vitro. 
Skeletal muscle basal lamina is also rich in laminin-2 and may in a similar fashion 
regulate the morphology of skeletal muscle fibres. Thus cultures of control 
myoblasts adopted a bipolar morphology, whereas a substantial proportion 
(approximately 15-20%) of dy/dy myoblasts were multipolar, extending several 
"wispy" processes (Sorokin et at., 2000). Aberrant multipolar morphology may be 
less extensive in cultures of dy/dy myoblasts than Schwann cells as myogenic cells 
continue to express reduced but clearly detectable levels of the laminin a2 chain in 
dy/dy mice (Ringelmann et al., 1999; Sewry et at., 1998; Sorokin et al., 2000). 
The high number of phenotypically immature Schwann cells that may be present in 
dy/dy peripheral nerves could arise both as a direct consequence of the loss of 
continuous basal lamina and axon-Schwann cell interactions, but also indirectly as 
a result of changes in laminin receptor activity. The presence of a large number of 
abnormally differentiated Schwarm cells and the deficiency of laminin-2 could 
contribute to changes in integrin receptor expression in dy/dy mice. Thus DRG 
neurons cultured on low concentrations of laminin-1 increased surface expression 
of the a6ß 1 integrin (Condic and Letourneau, 1997). Regulation of integrin 
expression levels by laminins has also been observed in vivo. Patients with 
merosin-deficient CMD, dy/dy mice and laminin ß24- mice all display 
corresponding decreases in the levels of their cognate integrin subunits (Cohn et at., 
1999; Hodges et al., 1997; Martin et al., 1996; Vachon et al., 1997). The a6 
integrin is upregulated in dy/dy mouse skeletal muscle following injury (Sorokin et 
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al., 2000) but in this study I was unable to detect corresponding changes in the 
expression of the a6 integrin subunit on cultured dy/dy Schwane cells (data not 
shown). 
It is likely, however, that integrin receptor expression is affected in the PNS of 
dy/dy mice and this may have an impact on several aspects of Schwane cell 
development. For instance, complexes formed between laminin-bound integrins 
and growth factors sharing the same signalling pathways (Mainiero et al., 1996; 
Miyamoto et al., 1996; Plopper et al., 1995; Sundberg and Rubin, 1996) may be 
affected in dy/dy mice. This may consequently affect the activity of growth factors 
involved in the autocrine survival loops of immature Schwann cells (Meier et al., 
1999). 
Integrin dimers involved in laminin-2-mediated migration such as a 1(31 and a6ß 1, 
are expressed on undifferentiated Schwann cells (Milner et al., 1997) but 
substantially down-regulated in differentiated myelin forming Schwann cells and 
upregulated in these Schwann cells following nerve injury after loss of axonal 
contact (Fernandez-Valle et al., 1994; Stewart et al., 1997). Widespread expression 
of the a1ß1 receptor in mature peripheral nerves is mainly detectable on non- 
myelin forming Schwann cells, whereas myelin forming Schwann cells show 
increased expression of a6ß4. Increased numbers of undifferentiated or abnormally 
differentiated Schwann cells that are not in contact with axons in dy/dy nerves may 
result in their upregulation of the a1ß1 and a6ß1 receptors that mediate Schwann 
cell migration on laminin. This could account for the increased motility I observed 
of dy/dy Schwann cells migrating from DRG explants on a laminin-1 substrate. 
Blocking the activity of ß1 integrins inhibits laminin-mediated myelination in both 
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Schwann cells and oligodendrocytes, probably by weakening Schwann cell 
adhesion to the basal lamina (Buttery and ffrench-Constant, 1999; Fernandez-Valle 
et al., 1994) (fig. 8.1). 
The "aberrant" cells in dy/dy nerves are all S 100 immunoreactive, suggesting that 
they most closely resemble immature Schwann or non-myelin forming Schwann 
cells. However there may be a more complex explanation for the presence of 
"aberrant" cells in dy/dy peripheral nerves. Recently evidence has emerged that 
multipotent neural crest stem cells persist into late gestation; a sub-population of 
cells isolated from E14.5 rat sciatic nerve was able to generate both neurons and 
glia, well after neural crest cells have begun migrating (Morrison et al., 1999). It is 
thought that neural crest stem cells are directed first towards a neurogenic fate by 
the strong instructive signals of BMP-2 and that activation of the Notch receptor 
then causes the loss of neurogenic capacity in neural crest cells, resulting in glial 
differentiation (Morrison et al., 2000). Glial differentiation in the PNS is apparently 
irreversible. However, in the CNS oligodendrocyte precursors can be induced to 
revert back to multipotential neural stem cells through exposure to FCS and BMPs 
followed by bFGF (Kondo and Raff, 2000; Morrison et al., 2000). These CNS 
neural stem cells can then generate oligodendrocytes, astrocytes and neurons. 
Cultured neuroepithelial cells from the spinal cords of E10.5 to E13.5 rats are able 
to generate both CNS cell types and PNS neural crest stem cells and PNS cells such 
as Schwann cells and peripheral neurons (Mujtaba et al., 1998). An alternative 
explanation for the presence of cells with abnormal morphology and activity in 
cultures of dy/dy sciatic nerve cells may be linked to the persistence of neural crest 
stem cells in the PNS as a consequence of the laminin-2 deficiency (fig 8.1). 
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8.4: Conclusion 
This thesis has highlighted the different aspects of Schwann cell maturation and of 
Schwann cell-axon interactions that laminin-2 may be involved in. Laminin-2 is 
clearly a vital factor in conferring the appropriate morphology for myelin forming 
Schwann cells as a prerequisite to axonal ensheathment and myelination. Adoption 
of a bipolar morphology is part of the process of differentiation in Schwann cells as 
they mature from precursors and defines the relationship between a terminally 
differentiated myelin-forming Schwann cell and the individual axon it ensheaths. 
One study detected laminin a2 chain immunoreactivity in the basal lamina of 
myelinated axons in human peripheral nerves, but found that a2 chain 
immunoreactivity was barely detectable in the basal lamina surrounding non- 
myelin forming Schwann cells and the axons that they ensheath (Malandrini et al., 
1997). Oligodendrocytes that myelinate CNS axons are not surrounded by a 
laminin-2 rich basal lamina and extend several processes in order to myelinate 
many axons. The Schwann cell-axon interaction in dy/dy peripheral nerves has been 
compared to the pattern of myelination in the CNS (Jaros and Bradley, 1979). It 
seems likely that laminin-2 is required in the basal lamina of the PNS to confer an 
appropriate morphology on myelin forming Schwann cells, enabling them to 
interact with individual axons and to differentiate towards a myelin forming 
phenotype (fig. 8.1). Myelination is possible in the absence of basal lamina in 
Schwann cell-neuron co-cultures, but it is substantially delayed and reduced, just as 
it is during development and regeneration in dy/dy mice lacking a continuous 
Schwann cell basal lamina (Podratz et al., 1998; Uziyel et al., 2000). 
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I have shown that laminin-2 not only influences Schwann cell properties but also 
regulates the interactions between Schwann cells and axons both in vitro and in 
vivo. Promotion of neunte branching appears to be laminin-2-mediated and this is 
probably an important aspect of axonal re-growth in regenerating nerves. The many 
facets of PNS development and regeneration that the laminin-2 heterotrimer is 
involved in, lends weight to the evidence that the dystrophy in dy/dy mice has a 
major neurogenic as well as a myogenic component. 
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